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Flavin compounds are found in Nature within a range of flavin-containing enzymes 
(flavoenzymes) that are responsible for metabolic, antioxidant and photoreception 
processes across animal, plant and bacteria kingdoms. Their broad redox and 
photochemistry has seen the field of flavin-based catalysis emerge as a powerful 
addition to sustainable catalysis thanks to being cheap, non-toxic and highly active. 
Flavin photocatalysis in particular has shown great promise in a range of synthetic 
procedures such as benzylic oxidations, sulfoxidations, decarboxylative 
transformations, isomerisations and [2+2] cycloadditions to name a few. It has been 
shown that flavin photocatalysts can be tuned to a specific application either through 
chemical structure modification or by the design of advanced systems through 
heterogeneous or polymer carrier attachment. The latter has shown encouraging 
results to widen flavin photocatalyst applicability within organic synthesis but has 
lacked in displaying characteristics like flavoenzymes which enable highly efficient and 
selective catalysis of industrially relevant products with precise stereochemical control. 
This thesis details the design and application of novel flavin photocatalysts through the 
combination of polydopamine (PDA). It is shown that PDA not only acts as a carrier of 
the flavin, but actively engages in the catalytic mechanism and improves flavin 
photostability.  
 In the first instance, copolymer flavin-polydopamine (FLPDA) nanoparticles 
were synthesised and their photocatalytic activity was characterised through model 
oxidation and reduction reactions. This study revealed enzyme-like kinetics of the 
catalysed reactions and improved photostability of the conjugated flavin moieties. 
Additionally, the biocompatibility of the nanoparticles was assessed through in vitro 
cell studies to ensure applicability to other fields such biomedicine or water 
remediation. Subsequently, the flavoenzyme specific oxidation of indole to indigo and 
indirubin dyes was explored using the FLPDA photocatalyst. The results showed that 
the nanoparticle system exhibited higher production of the valuable dyes over a 
homogeneous flavin photocatalyst. This increase in activity was investigated through 
reactive oxygen species (ROS) scavenging experiments which revealed that FLPDA’s 
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mechanism of action in this reaction partially resembled natural flavoenzymes and 
therefore enhanced key product formation. 
 Finally, reduction reactions catalysed by flavoenzymes were investigated using 
FLPDA and a chiral flavin-polydopamine system (RCPDA). The light-driven reduction of 
azobenzene dyes was first explored using FLPDA which provided evidence that hydride 
could be transferred from PDA-conjugated flavin moieties to a substrate upon 
irradiation in the presence of an electron donor reagent. Next, the reduction of C=C 
bonds within α,β-unsaturated ketones and aldehydes was explored by initially 
screening buffered electron donor reagents and homogeneous flavin photocatalysts 
with key substrates. The optimal conditions and compatible substrates were then 
applied to the nanoparticle RCPDA system which produced the saturated products in 
comparable yields to the homogeneous photocatalysts with very low catalyst loading 
(<1 mol% vs. 10 mol%). The inclusion of a chiral linkage between PDA and flavin and its 
effect on the stereochemical outcome of the reaction was also explored, with 
preliminary data showing that adopting such a strategy could enable some 
enantioselectivity over the product. 
 In summary, this thesis provides new methodologies to design advanced flavin 
photocatalysts with enzyme-like characteristics that will help to further develop the 
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Chapter 1: Introduction 




Flavins are organic redox cofactors found within enzymes (flavoenzymes) in the form 
of flavin adenine dinucleotide (FAD) or flavin mononucleotide (FMN) derived from 
Vitamin B2, riboflavin (Figure 1.1). Flavoenzymes are involved in a wide range of 
biological metabolic processes thanks to a number of radical and ionic states (Figure 
1.2) that allow for the catalysis of both one and two electron transfer reactions.[1,2] 
They can mediate both reduction and oxidation reactions, acting as either a 
nucleophile or electrophile on a range of substrates including amines, amino acids, 
dithiols, aldehydes, ketones, and carboxylic acids.[3] Interestingly, although 
flavoenzymes have been shown to induce oxidative stress through production of 
superoxide, they are also antioxidative by being involved in the reduction of 
hydroperoxides.[4,5]  
 
Figure 1.1: Structures and nomenclature of flavins found in nature. 
 In addition to their catalytic roles, flavins are also found within 
photoreceptors across bacteria, plant and animal kingdoms. More specifically, BLUF 
(Blue-Light-Utilising FAD) domains, found primarily in bacteria, control enzyme activity 
or gene expression in response to blue light,[6] LOV (Light Oxygen Voltage) domains are 
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crucial to phototropism and adjusting circadian rhythm within many plants,[7] as well 
as CRY (cryptochrome) domains being mainly responsible for circadian rhythm in 
animals.[8] Flavins are also crucial to the activity of light activated processes such as 
DNA repair by photolyase[9] and also the light emission by bacterial luciferase.[10] 
 
Figure 1.2: Redox and acid-base equilibria of flavins. Adapted from Heelis et al.[2] 
 Their significant biological role has prompted numerous studies of their 
properties and function.[1,2,11–13] As a result, there have been many applications of 
flavoenzymes and related flavin compounds within green chemical synthesis and 
biotechnology. This thesis is mainly concerned with the application of flavins within 
green chemical synthesis as photocatalysts. Therefore, the following literature review 
will focus on the recent developments of flavin-based catalysis and their applications 
within biocatalysis, organocatalysis and photocatalysis. 
1.1.1 Flavoenzyme biocatalysis 
Flavoenzyme use in biocatalysis is wide-spread due to their extremely varied chemistry 
that allows for a range of organic transformations to be achieved with regio- and 
enantiospecific control over the product, which is for the most part almost impossible 
to achieve by traditional synthetic means.[14] Some of the key catalytically active flavin 
redox states within flavoenzymes and their related catalytic transformations are 
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shown in Figure 1.3 and will be discussed in order to introduce the main flavin redox 
states relevant to this thesis. 
 The oxidised flavin cofactor (FLox, Figure 1.3A) can undergo reduction to yield 
oxidised substrates. A key example of such a reaction is imine formation from amines - 
a transformation catalysed by monoamine oxidases (MAOs) involved in the 
neurochemical removal of neurotransmitters.[15] Engineering of this class of enzymes 
pioneered by the Turner group has seen MAOs being exploited for enantioselective 
amine resolution and functionalisation to prepare numerous active pharmaceutical 
ingredients.[16] Recently, the Hyster group discovered the ability of ene-reductase (ER) 
enzymes to catalyse dehalogenation reactions through the single electron reduction of 
FLox to form the anionic radical flavin semiquinone (FLsq–, Figure 1.3B). This allowed 
them to perform enantioselective hydrodehalogenation on a range of α-
bromoesters.[17] 
 Further single electron reduction of flavin semiquinone, FLsq or the direct 
reduction of FLox via hydride transfer from NAD(P)H results in the fully reduced flavin 
hydroquinone (FLhq, Figure 1.3C). FLhq is responsible for the activity of ene-reductases 
(ERs), a group of enzymes derived from the Old Yellow Enzyme (OYE) family, that are 
capable of C=C bond reduction via hydride transfer from FLhq to the substrate followed 
by protonation. These enzymes have been employed in several reaction cascades and 
industrially relevant processes due to inherent substrate promiscuity and excellent 
stereoselectivity over products (a more detailed discussion of this enzyme class can be 
found in Chapter 4).[18,19]  
 Finally, FLhq can react with molecular oxygen to form peroxyflavin, FLOO- 
(Figure 1.3D) which can also be protonated to form the hydroperoxyflavin species, 
FLOOH (Figure 1.3E). These peroxy-flavin species are present in a large group of 
enzymes known as flavin-containing monooxygenases (FMOs) and have been among 
the most widely exploited enzymes in biocatalysis. There are several classes (A-F) of 
FMOs that are generally classified by the type of chemical reaction that is catalysed, 
the nature of the reducing and oxidising substrates, or the sequence and structural 
data of the enzyme.[20]  
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Figure 1.3: Catalytically active species of flavin utilised in biocatalysts. (A) FLox within 
MAOs can oxidise amines to imines. FLox can also act as a one or two electron acceptor 
to afford either (B) flavin semiquinone (FLsq) that can catalyse dehalogenation 
reactions, or (C) reduced flavin hydroquinone (FLhq) that can perform two-electron 
reduction of activated olefins within ERs. FLhq can also react with molecular oxygen to 
form the C4a-peroxy (D) or hydroperoxy flavin (E) which can undergo Baeyer-Villiger 
oxidation or hydroxylation of a substrate. Halogenation of a substrate can occur 
through a chloride anion binding to FLOOH to form hypochlorous acid (F). Adapted 
from Baker Dockrey et al.[21] 
 Class A FMOs are primarily attributed to the hydroxylation of aromatic species 
which serves an important biological function in xenobiotic degradation (a more 
detailed discussion of this topic can be found in Chapter 2).[22–25] Within biocatalysis, 
such FMOs have been employed in natural product synthesis to achieve sorbicilin 
natural products through site- and stereoselective oxidative dearomatisation 
steps.[26,27] Hydroxylation of a particular substrate by this class is mediated by the 
electrophilic hydroperoxyflavin species, FLOOH (Figure 1.3E) which has also been 
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identified in other classes of FMOs such as class B Baeyer-Villiger monooxygenases 
(BVMOs). Although BVMOs show promiscuous catalytic activity towards epoxidation 
and heteroatom oxidation reactions, their primary mechanism of action utilises FLOO- 
for the nucleophilic oxygenation of carbonyl compounds to form lactones or esters 
(Baeyer-Villiger oxidation, Figure 1.3D).[28] As a result, BVMOs have been used to 
prepare various enantioenriched pharmaceuticals, fragrance compounds and Nylon 
precursors, as well as some applications towards large scale industrial processes.[29] 
 Another industrially relevant class of FMOs are the class F halogenases also 
employ the hydroperoxyflavin cofactor in their catalytic activity, however, bind halide 
ions which are oxidized by the C4a-hydroperoxide to form hypochlorous or 
hypobromous acid. These reactive intermediates then interact with active site residues 
to enable aromatic halogenation.[30] As a result, halogenases have been widely applied 
to the production of valuable halogenated tryptphan/indole derivatives for use as 
agrochemicals and pharmaceuticals.[31] 
 In general, biocatalytic reactions are carried out using whole-cells or purified 
enzymes, however the latter suffers from limitations in terms of initial protein 
purification and external NAD(P)H cofactor recycling. Consequentially, various 
NAD(P)H recycling strategies have been developed using other enzymes,[32,33] 
nicotinamide derivatives,[34] electrochemistry[35] or photochemical strategies 
(discussed in more detail in Section 1.1.3.1).[35–39] The wide-ranging catalytic activity of 
the flavin cofactor has also been exploited in organocatalytic applications within green 
chemistry, utilising the flavin compound outside of a protein environment. This helps 
to address some of the other disadvantages associated with biocatalysis such as 
limited access, stability, and scale-up of protein enzymes whilst providing cheap and 
environmentally friendly reagents. 
1.1.2 Flavin organocatalysis 
The most prominent use of flavins in organocatalysis are within oxidation reactions 
catalysed by an N5-ethyl flavinium cation (1, Figure 1.4). By the addition of reducing 
agents to 1 in the presence of air via dihydroquinone 2, or by directly adding H2O2 the 
stabilised hydroperoxyflavin species, 3 can be formed effectively resembling natural 
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FMO activity. This can then interact with a substrate, such as an aryl sulfide, and finally 
eliminate water as the only by-product to regenerate 1.  
 This methodology was initially developed in the late 20th century by Bruice 
and coworkers as a model for flavoenzyme activity because hydroperoxyflavins derived 
from neutral flavins are extremely unstable outside of an enzyme and almost 
immediately release H2O2.[40–42] Since then, a number of synthetic strategies using this 
methodology have been exemplified such as Baeyer-Villager oxidations,[43–45] S- and N-
oxidations,[46,47] hydroxylations,[48] as well as aryl aldehyde oxidations to carboxylic 
acids[49] or hydroxyls (Dakin oxidation).[50,51] Another successful route to enable FMO-
like activity has been the combination of flavinium cations with inorganic cocatalysts 
such as OsO4 or I2 to perform hydroxylations[52,53] and oxidative sulfenylations 
respectively.[54–57]  
 
Figure 1.4: General reaction mechanism N5-ethyl flavinium catalysed oxidations using 
H2O2 or air. S = substrate and AH2 = reducing agent or sacrificial electron donor.  
 Another interesting approach was taken by Imada and co-workers by 
designing a neutral flavin-tripeptide conjugate which acted as an effective BVMO 
mimic through amino acid residue stabilisation of the C4a-hydroperoxyflavin.[58] This 
conjugate demonstrated efficient sulfoxidation of thioanisole as well as the 
chemoselective Baeyer–Villiger oxidation of 3-phenylcyclobutanone. The Imada group 
have also used both neutral and cationic flavins in the presence of hydrazine to 
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achieve aerobic hydrogenation of C=C bonds.[59,60] As shown in Figure 1.5, the flavin (5) 
acts as a catalyst to generate diimide from hydrazine via an initial reduction of 5 to 
form a reduced flavin and diimide complex (6). This can then react with olefins to 
afford hydrogenated products and N2. Fully reduced flavin 7 can then interact with 
oxygen to generate the short lived hydroperoxyl flavin 8 that either eliminates H2O2 or 
oxidises another hydrazine species to form an oxidised flavin diimide complex (9). A 
similar reaction with an olefin can then regenerate 5 to complete the catalytic cycle. 
The mechanism for cationic flavinium is analogous to this, however it is shows faster 
kinetics for the initial rate determining step of flavin reduction.[60] 
 
Figure 1.5: Mechanism of aerobic hydrogenation by a neutral flavin catalyst in the 
presence of hydrazine. R = ribityl tetrabutyrate.  
 More recently, the Cibulka group introduced an N1-N10 ethylene bridged 
flavin catalyst with PPh3 to prepare esters via an N5-PPh3 adduct flavin intermediate 
similar to the Mitsunobu reaction.[61] Rather than using a conventional dialkyl 
azodicarboxylate reagent at a stoichiometric amount, this method benefits from using 
the flavin at 10 mol% without the need for low temperature activation with PPh3. In 
addition, this N5-adduct position is rarely observed in natural flavoenzymes as most 
mechanisms proceed via the C4a position, which demonstrates that there is scope for 
flavin organocatalysts to resemble a range of flavoenzyme activity. 
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 Enantioselective transformations are crucial to the synthesis of many high 
value pharmaceutical products. Often, this involves several steps and range of complex 
chiral catalysts, all of which could be replaced by use of flavoenzymes or flavins that 
contain optically active modifications. Attempts have been made to carry out 
enantioselective flavin organocatalysis using chiral flavinium derivates, such as the 
enantiomerically pure flavinophanes, 10 and 11 (Figure 1.6) prepared by Shinkai and 
co‐workers for enantioselective sulfoxidation reactions in 1988.[62] These derivates 
were shown to mediate the enantioselective oxidation of aryl methyl sulfides (ee 
values up to 65%) and methyl 2‐naphthyl sulfide (ee of 72%), however the reactions 
were carried out at -20 oC and over 5 days, which limits any potential for scale-up.[62,63] 
Later, Murahashi and Imada reported the chiral bisflavin 12 that mediated the 
enantioselective Baeyer-Villiger oxidation of  3‐arylcyclobutanones with ee values up 
to 67% at -30 oC after 6 d using H2O2.[44] It was found that yields and ee values were 
dependent on the solvent used, favouring a protic aqueous solvent system 
(CF3CH2OH/MeOH/water) in order to maximise hydrophobic π–π stacking interactions 
between the aromatic ring of the catalyst and that of the substrate. The addition of 
sodium acetate also improved the ee by neutralising perchloric acid formed as a by-
product from the reaction of H2O2 and the flavinium counter anion.  
 A series of chiral flavinium catalysts (13) were developed by the Cibulka group 
by installing an phenyl “cap” that covers one face of the isoalloxazinium structure 
allowing the access of hydrogen peroxide and a substrate to only the uncovered face 
of the catalyst.[64,65] They performed a range of asymmetric sulfoxidation reactions on 
para-substituted thioanisoles with ee values ranging from 15-65%. These values 
depended on the type substrate functional groups and R3/7/8 group substitution on the 
catalyst, however reaction conditions still required low temperatures (-20 oC) and long 
reaction times (72 h). 
 To further improve optical purity, two-component organocatalytic systems 
were introduced employing a flavin catalyst and auxiliary chiral co-catalysts. For 
example, Yahsima et al. utilised a chiral triazolium‐derived N‐heterocyclic carbene 
(NHC) and N3-benzyl protected riboflavin tetraacetate (RTA) to afford asymmetric 
esterification of aldehydes with various alcohols.[66] More recently, Poudel et al. 
combined a flavinium catalyst with a cinchona alkaloid dimer that enabled the 
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asymmetric Baeyer-Villiger oxidation of  3‐arylcyclobutanones using H2O2 with 
impressive ee values up to 98%.[67] The observed enantioselectivity was attributed to 
ionic pairing and an intermolecular assembly of the flavinium and substrate on the 
chiral alkaloid dimer through both π–π stacking and ionic pairing. 
 
Figure 1.6: Chiral flavinium catalysts used for enantioselective oxidation reactions. 
 Clearly, flavins can be successfully used to catalyse several flavoenzyme-like 
reactions and can be employed as green organocatalysts for a variety of organic 
transformations.[68,69] Another branch of flavin catalysis takes advantage of their 
photochemical properties. This enables the catalysis of higher potential reactions due 
to the increased redox potential of excited state flavin (reduction potential of excited 
state for riboflavin tetraacetate = 1.67 V vs SCE).[70] 
1.1.3 Flavin photocatalysis 
Visible light photoredox catalysis has gained a lot of momentum over the past decade, 
providing a mild means of accessing radical chemistry for complex synthesis utilising an 
energy source which is potentially limitless. The use of organic photosensitisers has 
developed greatly within the field in order to offer a more sustainable alternative to 
the classical ruthenium and iridium complexes that are costly and scarce resources.[71] 
Naturally occurring flavin compounds therefore pose as an even greener addition to 
organic photoredox catalysis.  
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 Riboflavin (RBF) and its derivative, riboflavin tetraacetate (RTA) have been 
shown to mediate a range of organic transformations using visible light (Figure 1.7). 
The most prominent examples of flavin photocatalysis are the aerobic photooxidation 
of benzyl alcohols,[72–77] benzyl amines,[78] and sulfides[79,80] (Figure 1.7A-C). Other 
substrates include a range of methylbenzenes, styrenes and phenylacetic acids, all 
forming benzyl aldehydes.[81] More recently, flavoenzymes and other natural systems 
have been used as inspiration for flavin photocatalysis. For example, aromatic 
chlorination performed by halogenases was successfully achieved (Figure 1.7D),[82] and 
the catalytic E-Z isomerisation of activated olefins was inspired by retinal (Figure 1.7E). 
[83–87] The versatility of flavin photocatalysis is further highlighted by their 
demonstrated photocatalytic ability towards ester formation,[88,89] nitration of 
protected aniline derivatives (Figure 1.7F),[90] the cyclisation of thiobenzanilides 
(Figure 1.7G),[91] as well as a number of aliphatic decarboxylative transformations to 
yield fluorinated,[92] cyanated[93] and alkylated/arylated products (Figure 1.7H).[94,95] 
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Figure 1.7: Key examples of the organic transformations demonstrated by RBF and 
RTA photocatalysts using visible light: (A) benzyl alcohol, (B) amine and (C) sulfide 
oxidation; (D) aromatic chlorination; (E) E-Z isomerisation; (F) aromatic nitration; (G) 
thiobenzanilide cyclisation; (H) decarboxylative transformations. EDG = electron 
donating group, EWG = electron withdrawing group, PG = protecting group. 
 Such versatility of flavin-mediated photocatalysis can be explained through 
their photochemical transitions that result in both energy and electron transfer 
processes, as well as the generation of reactive oxygen species (ROS).[2] As shown in 
Figure 1.8, the excitation of ground state FLox induces the formation of a singlet 
excited state flavin (1FL*) that can then undergo intersystem crossing (ISC) to form the 
triplet state flavin (3FL*). This reactive species can then interact with an electron-rich 
substrate/donor (D) to generate the anionic semiquinone flavin (FLsq–) and radical 
cation substrate (D•+) via a single electron transfer process. Consequently, FLsq– can 
interact with O2 to regenerate FLox, yielding a superoxide radical species (O2•–). Finally, 
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superoxide can then react with a substrate of interest in a Type I photooxidation 
which is the most common flavin photooxidation mechanism.  
 FLsq– can also undergo a second electron transfer process with a 
substrate/donor to yield the fully reduced flavin hydroquinone (FLhq) which is finally 
reoxidised by O2 to FLox producing H2O2 as a by-product. This by-product has been 
shown to be deleterious to flavin photocatalytic activity but can be removed by the use 
of a scavenging additive such as molecular sieves.[88]  
 In addition, 3FL* can undergo an energy transfer process with molecular 
oxygen to form singlet oxygen (1O2) and oxidise a substrate within a Type II 
photooxidation. This has been shown to be the primary mechanism of riboflavin 
sensitized degradation of amino acids[96] and photooxidation of sulfides to sulfoxides in 
alcoholic solvent systems.[79] However, this is often occurring in tandem with the free 
radical mediated Type I process.[80,97] Another advantage of 3FL* is its ability to 
undergo energy transfer to a substrate which allows for photoinduced E-Z 
isomerisation and [2+2] cyclisation events using visible light.[83–87,98–100]  
 Finally, single electron transfer processes can occur between a substrate and 
3FL* to access radical chemistry mechanisms. This has been utilised to achieve 
decarboxylative transformations[92–95] and thiobenzanilide cyclisations.[91] Interestingly, 
photochemically generated FLsq- and an amine electron donor has been utilised in 
reductive dehalogenation processes,[101] and FLhq has been utilised in the 
photocatalytic reductive activation of PtIV prodrugs.[102–105]  There are however, no 
photocatalytic examples of an enzyme-like hydride-transfer from FLhq to a substrate to 
achieve hydrogenation reactions. 
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Figure 1.8: Photochemical pathways of flavins in the presence of oxygen that 
generates ROS species, either by a Type I photooxidation to yield superoxide or a Type 
II photooxidation to produce singlet oxygen via energy transfer. ISC = intersystem 
crossing, D = electron donating substrate.[2] 
 In recent years, several strategies have been developed to enhance flavin 
photocatalysis and allow for more advanced transformations with higher redox 
potentials. Fukuzumi et al. demonstrated that the redox potential of RTA can be 
increased by metal ion coordination,[70,106] and the oxidation of benzylic C–H bonds in 
the presence of Sc3+ ions was achieved which was otherwise not possible using RTA 
alone.[107] This methodology however, was not as effective for electron-deficient 
benzylic substrates prompting the design of cooperative systems. For example, Wolf et 
al. employed a biomimetic iron co-catalyst which utilised H2O2 produced as a by-
product from flavin photooxidation to enable further oxidation of electron-deficient 
substrates.[108] Tang et al. improved this strategy by employing cheap ferric chloride 
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and N-hydroxy succinimide (NHS) to achieve the photooxidation of benzylic C-H bonds 
in presence of RTA.[109] The Lin group have recently advanced this further by use of 
photoelectrochemistry to enable facile aliphatic C-H oxidation mediated by RTA and a 
thiourea additive.[110] 
 Other than the use of additives, chemical modification of the flavin 
chromophore has also proven to be a useful tool to achieve higher level 
transformations. The Cibulka group have shown that flavin redox potentials and 
related photoactivity can be tuned through structural modifications to the 
(iso)alloxazine ring system (Figure 1.9). Such modifications have enabled them to 
achieve the photooxidation of electron-deficient benzylic substrates using flavin 
derivates 14 and 15 without a co-catalyst.[111,112] Further changes to the core flavin 
structure obtained deazaflavin 16 and alloxazine 17 that showed enhanced activity 
towards [2+2] cycloadditions using visible light.[98–100] The group also found that the 
alloxazinium salt 18 is a useful tool for oxidative [2+2] cyclobutane ring cycloreversion 
using visible light, which was previously only achievable by the addition of a strong 
acid to RTA.[113] 
 
Figure 1.9: Structures of the flavin derivates developed by the Cibulka group utilised 
for benzylic C-H and alcohol oxidations (14, 15),[111,112] [2+2] cycloadditon reactions 
with visible light (16, 17),[98–100]  and [2+2] cycloreversion reactions using visible light 
(18).[113] 
1.1.3.1 Flavin photobiocatalysis 
The combined use of enzymes and photocatalysts has seen great interest in the last 
decade thanks to the ability of photosensitisers, such as flavins, being able to act as 
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electron mediators to activate enzyme redox activity upon irradiation in the presence 
of a sacrificial electron donor.[36,39] 
 In 1978, Massey reported a protocol which employed flavins as electron 
mediators to activate several flavoenzymes using visible light in the presence of 
ethylenediaminetetraacetic acid (EDTA) as the electron donor.[114] This was inspired by 
Frisell’s initial observation of free flavin photoreduction by a variety of amino acids, 
carboxylic acids, and amines.[115] Since then, the Hollmann group in 2007 applied this 
methodology to drive enantioselective Baeyer-Villiger oxidations of cyclic ketones 
using a Baeyer-Villiger monooxygenase (BVMO) enzyme, FAD as the flavin 
photosensitiser and EDTA as the sacrificial electron donor (Figure 1.10).[116] This report 
showed, for the first time, that light could be employed as an alternative to existing 
NAD(P)H recycling methods for biocatalysis and the field of photobiocatalysis has since 
developed significantly.[35–39] This methodology has been applied to various 
flavoenzymes such as FMOs and ERs,[116–125] as well as a halogenase.[126] A limiting 
factor in these applications however, is generation of ROS by the flavin photosensitizer 
that inhibits flavoenzyme activity. To combat this, flavin derivatives such as 
deazaflavins have been utilised with some success as they exhibit low reactivity with 
molecular oxygen.[127–129]  
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Figure 1.10: Photobiocatalysis using FAD as the photosensitiser and electron mediator 
for a Baeyer-Villiger monooxygenase (BVMO) enzyme (PDB entry - 4D03) in the 
presence of EDTA and light. R = adenine dinucleotide.[116] 
 More recently, morpholine-based buffer systems have been successfully used 
as sacrificial electron donors for flavin photoreduction in order to activate Pt 
prodrugs,[102–104] and activate flavoenzymes without damaging side reactions.[130,131] In 
the context of flavoenzyme activation, buffers such as 3-(N-
morpholino)propanesulfonic acid (MOPS) show enhanced activity compared to EDTA 
due to spin ion pair correlation with reduced anionic flavin semiquinone (FLsq–).[130] 
This formation was shown to prolong the lifetime of FLsq– and reduce ROS generation 
in an aerobic environment that would otherwise destroy the flavin and/or enzyme. 
 Besides using free flavins as electron mediators for enzyme activation, 
innovative examples of direct illumination of a flavoenzyme itself has provided access 
to chemistry not naturally seen in the dark. In particular, the identification of a flavin-
based algal enzyme responsive to blue light to produce hydrocarbons from fatty acids 
has sparked great interest in utilising flavin-containing ‘photoenzymes’ for microbial 
biofuel and feedstock production.[132–136] Additionally, the Hyster group discovered 
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catalytic promiscuity within ene-reductase (ER) enzymes such that they can perform 
enantioselective hydrogen atom transfer on a range of α-bromo substituted ethyl 
esters.[17] This methodology was extended by directly irradiating the flavoenzyme itself 
with cyan LEDs to access unnatural stereoselective radical cyclisation chemistry via an 
initial electron transfer from the excited semiquinone flavin (FLsq*) to an α-chloro 
amide substrate.[137] A follow-up study using a different ER enzyme utilised a similar 
methodology to achieve redox-neutral radical cyclisation of α-halo-β-amidoesters to 
yield 3,3-disubstituted oxindoles, however the ground state FLsq was found to be 
responsible for initiating the reaction in this case.[138]  
 The Hyster group has also combined the use of ERs with ruthenium 
photocatalysts to achieve synergistic photoenzymatic ketone reduction and 
hydrogenation of heteroaromatic olefins, however the use of such photosensitisers are 
unfavourable from a sustainability perspective.[139,140] Hartwig and colleagues on the 
other hand, developed a cooperative photoenzymatic catalytic system using FMN as 
the photocatalyst to first carry out the E-Z photoisomerisation of an olefin which is 
then asymmetrically reduced by an ER enzyme (a glucose dehydrogenase/NADPH 
recycling system was also used, Figure 1.11).[141]  
 
Figure 1.11: Hartwig’s combination of photocatalytic isomerization and enzymatic 
reduction of alkenes. The asterisk indicates the chiral centre. ER = ene-reductase, GDH 
= glucose dehydrogenase. Adapted from Litman et al. [141] 
 This methodology achieved a variety of biologically active molecules and 
valuable synthetic intermediates at preparative scale which clearly demonstrates the 
excellent potential of flavin-based photocatalysis and enzymes in organic synthesis. 
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1.1.4 Advanced flavin catalyst systems  
 
1.1.4.1 Polymeric and heterogeneous systems 
Despite the relative ease and high yields of flavin catalytic reactions either in the dark 
using cheap oxidants (air/H2O2) or under irradiation with LEDs, there are issues relating 
to their long-term stability, separation of the products from catalyst in a homogeneous 
reaction mixture and catalyst reuse. In general, the (photo)stability of flavins are 
significantly reduced when removed from a protein environment due to a lack of H-
bonding, aromatic stacking and other electrostatic interactions  between amino acid 
residues, all of which have been shown to stabilise and modulate flavin redox 
potentials.[142] Model systems for flavoenzyme activity have been developed by the 
Rotello group and others using cyclodextrins,[143–145] polymers,[146,147] 
dendrimers,[148,149] peptides,[150] nanoparticles[151–153] and sol-gels[154,155] which has led 
to the preparation of stable and catalytically active heterogeneous flavin systems 
(Figure 1.12).  
 
Figure 1.12: Key examples of reported polymeric and heterogeneous flavin catalyst 
systems: cyclodextrin-flavin conjugates,[156–159] polystyrene-based polymer,[160] 
mesoporous polymer networks,[161] electrostatically bound flavin polymers,[162–164] 
dendrimers,[165–167] and heterogeneous silica immobilisation.[75,168,169] 
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 Thanks to their cavity-forming structure, cyclodextrins are a particularly useful 
scaffold in developing flavoenzyme mimetic catalysts. For example, D’Souza showed 
that flavin-cyclodextrin conjugates were effective catalysts for benzyl mercaptan 
oxidation and photooxidation of benzyl alcohols with greater efficiency than riboflavin 
(Figure 1.13A).[158] The Cibulka group later prepared alloxazine- and alloxazinium-
cyclodextrin conjugates (Figure 1.13B and C) that were able to catalyse a range of 
enantioselective sulfoxidations of aryl methyl sulfides obtaining near-quantitative 
conversions with ee values up to 91% with very little catalyst loading (0.2-1 mol%) at 
room temperature.[156,157] The rate enhancement and enantioselectivity of these 
reactions are the consequence of preorganisation of the substrate in the chiral 
cyclodextrin cavity covalently attached to the flavin. 
 
Figure 1.13: Examples of flavocyclodextrin conjugates synthesised by D’Souza (A)[158] 
and Cibulka (B and C).[156,157] Chirality of the cyclodextrin (CD) cavity enables 
enantioselectivity of the catalysed oxidations. 
 Polymeric flavin systems prepared using both covalent and non-covalent 
strategies have been widely explored for dark organocatalytic transformations.[170] For 
example, the free radical copolymerisation of styrene derivatives 20 and 21 and 
styrene-riboflavin monomer, 19 (Figure 1.14) resulted in a series of insoluble 
polystyrene-supported flavin catalysts that showed activity towards aerobic reduction 
of olefins with hydrazine.[160] It should be noted that this activity was related to the R 
group of 20 and the type of substrate, such as hydroxyl and carboxylate styrene 
derivatives showed enhanced activity towards phenolic substrates. Furthermore, the 
recyclability of these catalysts was demonstrated up to 10 times which highlights their 
suitability for heterogeneous applications.  
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Figure 1.14: Free radical copolymerisation of styrene derivatives, 20 and 21 with 
styrene-riboflavin monomer, 19 forming polystyrene-based flavin catalysts.[160] 
 A recent study using a similar radical polymerisation strategy employed the 
riboflavin derivative, 22 and ethylene glycol dimethacrylate (EGDMA) to form a flavin-
containing mesoporous network polymer (Figure 1.15).[161] This mesoporous catalytic 
polymer mediated the aerobic reduction of a range of olefins in the presence of 
hydrazine and was recyclable up to 5 times. The photooxidation of 4-methoxybenzyl 
alcohol was also demonstrated by the polymeric system at a higher yield than the 
monomer 22 however recyclability of this reaction was not demonstrated. 
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Figure 1.15: Free-radical copolymerisation of methacrylate-riboflavin monomer 22 and 
EGDMA forming a mesoporous flavin polymer network.[161] 
 Non-covalent strategies to formulate heterogeneous flavin catalysts have 
been developed such as the self-assembly of flavinium cations onto anionic cation‐
exchange resins[162] and sulphated chitin.[164] The latter strategy proved most 
successful, showing enhanced activity towards Baeyer-Villiger oxidation and 
sulfoxidation in the presence of alkali metals and H2O2. The heterogeneous catalyst 
was also reusable and showed activity up to 7 runs for the sulfoxidation of aromatic 
sulfides.  
 Another non-covalent strategy to formulate artificial flavoenzyme mimetic 
catalysts employed FMN which was incorporated into a hydrophobic 
microenvironment utilising a guanidinium and octyl functionalised polyethyleneimine 
(PEIgaun-oct, Figure 1.16).[163] This catalyst mediated the Baeyer-Villiger oxidation of 
bicylo[3.2.0]hept‐2‐en‐6‐one in the presence of O2 and NADH, however more 
challenging cyclic ketone substrates (5- and 6-membered rings) were not assessed, nor 
was the recyclability of the catalyst. Although the discussed non-covalent strategies to 
form heterogeneous flavin catalysts showed interesting enzyme-like kinetics and 
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recyclability in some cases, their applicability to larger scale heterogeneous catalysis is 
limited due to the lack of robust flavin conjugation. 
 
Figure 1.16: Self-assembly of FMN within PEIgaun-oct to form a flavoenzyme mimetic 
polymer catalyst.[163] 
 Dendron-based flavin systems were originally developed by the Rotello group 
using a covalent attachment strategy which showed enhanced catalytic activity 
compared to homogeneous riboflavin towards the aerobic oxidation of NADH 
analogue, 1-benzyl-1,4,-dihydronicotinamide (BNAH).[148] In another example, Imada 
and colleagues utilised the non-covalent assembly between flavin and a 
diaminopyridine-based poly(benzyl ether) dendrimer (Figure 1.17) to obtain a catalytic 
system for the aerobic reduction of olefins in the presence of hydrazine as well as the 
oxidation of sulfides using a flavinium cation (1).[165–167] 
 
Figure 1.17: Self-assembly of lumiflavin within diaminopyridine-based poly(benzyl 
ether) dendrimer.[165–167] 
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 To date, there are only a few examples of heterogeneous photocatalytic flavin 
systems. One of the first examples prepared heterogeneous flavin catalysts capable of 
benzyl alcohol photooxidation by immobilising flavin derivatives onto fluorous silica 
gel, reversed phase silica gel and polyethylene pellets via physical absorption or 
mechanical entrapment respectively.[75] Although the photocatalytic activity of the 
heterogeneous flavin systems was analogous to the equivalent homogeneous flavin 
system, the reaction rates decreased by a factor of 8-20 for the silica gel derivative and 
by a factor of 50 for the flavin-containing polyethylene pellets, most likely due to 
inefficient light absorption. Recyclability of the best performing systems was observed 
for up to 3 runs without loss of activity.   
 Recently, the Cibulka group utilised mesoporous silica (MCM-41) to covalently 
attach flavin derivatives, 23 and 24 (Figure 1.18), to perform benzyl alcohol oxidations, 
sulfoxidation, photoesterification and [2+2] cycloadditions.[168,169] This method showed 
improved yields and ease of product-catalyst separation, but reuse of the catalyst 
resulted in drastic decrease of activity due to flavin decomposition.[168] Additionally, it 
was shown that solvent polarity also played a role in the stability of these 
heterogeneous systems through cleavage of the flavin moiety from the 24-derived 
silica catalyst being observed in aqueous acetonitrile reaction mixtures which was 
circumvented by the use of alcoholic solvent systems.[169] 
 
Figure 1.18: Synthesis of heterogeneous flavin-silica catalysts derived from alloxazine 
23 and riboflavin-derivate 24 using amino-functionalised MCM-41 silica.[168,169] 
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1.1.4.2 Micro- and nanostructured flavin catalysts 
The rate and efficiency of heterogeneous catalytic systems are well known to be 
improved using nanoparticles (NPs) or nanostructured elements due to an large 
increase in surface-to-volume ratio.[171] Examples of flavin-NP conjugates have been 
known for some time thanks to the work of the Rotello group and others, however the 
application of this work was aimed at molecular recognition as a model for 
flavoenzyme activity rather than catalysis.[151–153] Various catalytic flavin-NP hybrids 
have now been reported (Figure 1.19) and riboflavin-NP conjugates were also 
developed for biomedical applications in order to enable the targeting of 
overexpressed riboflavin receptors on cancer cells.[172–178]  
 
Figure 1.19: Key examples of micro- and nanostructured flavin catalyst systems using 
nanoparticles[179,180] and metal oxide semiconductors.[181–183] 
 One of the first examples of flavin-NP conjugates for catalysis was from Imada 
and Noata using PPh3 stabilised Au NPs conjugated with octylthiol flavin-derivatives 
(Figure 1.20A and B).[179] The system was used for organocatalytic sulfoxidation and 
olefin reduction in the presence of hydrazine. Interestingly, an increase in the kinetic 
rates of both reaction was observed for the nanoparticle catalyst over the analogous 
free flavin catalyst. This was explained using a Michaelis-Menten-type mechanism in 
which substrates could coordinate into cavities on the Au NP surface through -
stacking and hydrophobic interactions to the PPh3 layered surface thereby improving 
reaction efficiency. 
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Figure 1.20: Flavin-functionalised gold nanoparticles (stabilised by PPh3) prepared by 
Imada and Noata.[179] 
 Another approach recently reported by Metternich et al. was based on the 
covalent immobilisation of riboflavin (RBF) to silica micro- and nanoparticles using an 
atom transfer radical polymerization (ATRP) strategy (Figure 1.21).[180] The silica 
particles were first functionalised with an ATRP initiator and then copolymerisation of 
riboflavin-acrylate conjugates and 2-hydroxyethylacrylate successfully immobilised the 
catalyst to yield the heterogeneous system. This was utilised to mediate the E-Z 
photoisomerisation of cinnamonitrile, with enhanced rates of reaction observed for 
the 60 nm particle system compared to 500 nm particle system. However, the system 
could not be recycled due to decomposition of the photocatalyst, most likely induced 
by the acidic silica.[180] 
 
Figure 1.21: Design and structure of riboflavin-functionalised silica nanoparticles via an 
ATRP linker strategy.[180] 
 Other photocatalytic examples have investigated the combination of flavins 
with semiconducting nanomaterials primarily for water remediation applications, using 
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the flavin to sensitise activity in the visible light range (dye-sensitised semiconductor 
photocatalysis). The Paz group reported two separate flavin-conjugated semiconductor 
systems in 2016 using BiOCl microparticles[181] and Degussa P25 TiO2 nanoparticles,[182] 
to carry out the aerobic photocatalytic degradation of salicylic acid and ethanol 
respectively. Conjugation of the flavin to the semiconductor was achieved using N3 
phosphonic acid-functionalised flavin species 25a-d (Figure 1.22). In the case of BiOCl 
particles, it was found that aromatic linker 25d showed the highest photocatalytic 
activity compared to aliphatic chains (25a-c). The reason for this can be derived from 
its conjugated electronic structure which enhances photo-induced charge transfer to 
the semiconductor. As a results of this, ROS generation increased and subsequentially 
more salicylic acid was degraded.[181]  
 The TiO2 system showed a relationship between the photoexcitation 
wavelength of light used and the photostability of the attached flavin. For example, 
under UV light irradiation, an increase in the photooxidation of ethanol was achieved 
accompanied by stabilisation of flavin against degradation. In contrast, irradiation of 
the system with visible light led to flavin degradation. These results were attributed to 
the propensity for charge transfer from excited flavin moieties to the semiconductor 
under certain excitation wavelengths. UV light excites the flavin to its S2 and S3 
electronic states, which can transfer charge to the TiO2 conduction band whereas 
excitation with visible light excites the flavin to an S1 state that is less likely to transfer 
charge to the semiconductor and induces flavin photodecomposition.[182] 
 
Figure 1.22: Structures of phosphonic acid functionalised flavin derivatives synthesised 
by the Paz group.[181,182] 
 Another class of semiconducting material that has been explored in 
combination with flavin is CeO2–reduced graphene oxide (RGO).[184] In this example, 
riboflavin (RBF) was non-covalently immobilised within a CeO2-RGO nanohybrid for use 
in aerobic photocatalytic degradation of methyl orange and p-nitrotoluene using 
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visible light (>400 nm).[184] In this case, the photostability of RBF was shown to be 
enhanced through immobilisation within the nanohybrid and was able to be recycled 
up to 4 runs using TEOA as the sacrificial electron donor.  
 Other than water remediation, dye-sensitised semiconductor photocatalysis 
(DSSPC) is widely utilised in solar fuel applications[185] and some of the design 
strategies developed in this field have now been applied to an example of 
heterogeneous flavin photocatalysis. Dongare et al. prepared photocatalytic glass 
substrates utilising phosphate-bearing FMN and fluorine-doped indium oxide (FTO) 
glass featuring mesoporous 4-μm films of 10 nm ZrO2 or 15–20 nm TiO2 NPs to 
efficiently oxidise a range of benzyl alcohol substrates.[183] Atomic layer deposition was 
used to coat a 1.0 nm overlayer of Al2O3 in order to stabilise the system as FMN 
leaching was observed without an additional layer. Catalytic activity was achieved with 
very low catalyst loading (<0.1 mol%) in presence of MnO2 as a H2O2 scavenging co-
catalyst. The system also benefitted from easy reaction workup which simply involved 
removing the catalyst-loaded glass from the reaction mixture. However, the 
recyclability of the system was not explored, so it is hard to conclude whether this 
system could be suitable for implementation into large scale heterogeneous 
photocatalytic flow reactors.[186] 
 In summary, artificial flavin catalysis has shown great promise over the last 
few decades in providing a green methodology to facilitate several redox reactions, 
like their natural flavoenzyme counterparts. Flavin photocatalysis poses as an exciting 
extension to this methodology thanks to the use of a naturally abundant sensitiser 
with wide ranging capabilities under light irradiation. The development of polymer and 
other heterogeneous flavin catalysts has demonstrated their applicability to large-scale 
synthetic process as well as in applications outside of organic synthesis such as energy 
and environmental applications. 
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1.2 Polydopamine 
Polydopamine (PDA) is a polymer, inspired by the adhesive proteins secreted by 
mussels, originally developed by the Messersmith group to act as a universal surface 
coating.[187,188] As such, it has been widely exploited over the past decade in a number 
of research fields such as biomedicine, environmental remediation and energy thanks 
to its ease of synthesis in weakly alkaline aqueous conditions from dopamine 
hydrochloride, strong adhesive properties used to form uniform coatings on organic, 
inorganic and superhydrophobic surfaces, and its ease of functionalisation through 
reactive amine, catechol and quinone moieties (see Figure 1.23).[189–192] PDA is 
structurally analogous to naturally occurring melanin pigments (eumelanin) and 
consequently displays similar optical, magnetic and electrical properties to eumelanin 
including biocompatibility.[193]  
 
Figure 1.23: Polymerisation of dopamine hydrochloride in basic aqueous conditions to 
form PDA (general structure of major repeating units).[194] 
 The mechanism of formation and resulting structure of PDA has been widely 
debated, however it is agreed that its structure is comprised of conjugated oligomers 
bound together via supramolecular interactions such as H-bonding and π-stacking, 
analogous to that of eumelanin.[193,194] Ultimately, the synthesis conditions chosen will 
play a role in the resulting PDA structure and a wide range of synthetic methodologies 
have been developed to fit the end application.[195–197] Classically, synthetic conditions 
to achieve film formation on a substrate surface involved the use of TRIS buffer (pH 
8.5) in presence of oxygen to initiate the autooxidative polymerisation of dopamine 
hydrochloride.[188] Since then, polymerisation onto surfaces has been demonstrated 
using chemical oxidants in acidic conditions[198–200] as well as in neutral conditions by 
UV-light irradiation.[201,202]  
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 Besides the use of PDA as a surface coating, the synthesis of PDA 
nanomaterials such as nanoparticles (NPs) and rods have also been developed.[196] 
Typically, PDA nanoparticles are prepared analogous to the Stöber process used to 
prepare silica nanoparticles featuring ethanol-water mixtures in the presence of 
NH4OH or NaOH as a catalyst.[203–205] Particle size can be tuned according to the 
amount of base catalyst used, whereby increased pH results in smaller particle size. 
PDA nanomaterials have been prominently used within biomedicine applications, 
mainly as drug delivery vehicles and in the design of theranostic agents.[196,206] The 
nature of their structure  allows for loading of aromatic drugs via π-π stacking and 
chelation of metal cations or radionuclides by catechol coordination.[206] The relatively 
low reduction potential of catechol (dihydroxyindole) moieties within PDA (0.428 V vs. 
NHE)[207] also allows for in-situ metal cation reduction to obtain M0-PDA NP composites 
which have been utilised for antimicrobial[208] and energy storage[192] applications as 
well as catalysis.[209]  
 The applications and literature surrounding PDA is vast, however the 
exploitation of PDA within catalysis is less explored. The state-of-the-art surrounding 
its use in catalysis shall be discussed, focussing on topics relevant to this thesis 
concerning organo- and photocatalytic behaviour.  
1.2.1 Polydopamine in catalysis 
PDA within catalysis has primarily been used as a support material for various metal 
NPs (M0-PDA). This is due to its ability to chelate and reduce metal cations 
independent of additional reducing agents, efficient stabilisation of embedded metal 
NPs and biocompatibility that makes it well suited for green chemistry applications. 
The most studied reaction using M0-PDA composites is the reduction of nitroarenes, 
such as the toxic 4-nitrophenol (R1 = OH, Figure 1.24A), which has been demonstrated 
using Au,[210–217] Ag,[218–222] Pd,[223–226] and Pt[227] metals using an excess of NaBH4 as the 
hydrogen source. Most of these formulations utilise M0-PDA in combination with 
additional functional materials/supports such as magnetic Fe3O4 NPs,[212,214,217,221,227,228] 
or immobilisation into  polymer membranes[218,219,229,230] and cellulose[220] to enhance 
catalyst recovery and recyclability.  
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 The role of PDA within these reactions has been shown to enhance catalysis 
by allowing favourable coordination of the substrate to the M0-PDA surface.[231–233] 
Furthermore, PDA alone has been shown to mediate the reduction of other pollutant 
dyes in the presence of NaBH4 via redox mediation through catechol/quinone 
moieties, illustrating PDA’s catalytic potential as not just an inert carrier 
material.[234,235] 
 
Figure 1.24: Key examples of M0-PDA catalysis relating to dye degradation and organic 
synthesis: (A) nitroarene reduction,[236] (B) carbonyl reduction,[236] (C) Heck,[236,237] and 
(D) Suzuki coupling.[236,238–241] 
 Pd0-PDA composites have been employed to achieve a wider range of 
nitroarene reductions (Figure 1.24A),[236] carbonyl reductions (Figure 1.24B),[236] and 
cross-coupling reactions such as the Heck,[236,237] and Suzuki reactions (Figure 1.24C 
and D).[236,238–241] Similarly to dye degradation applications, M0-PDA composites used 
for organic synthesis are often combined with additional support materials to improve 
recyclability, such as magnetic Fe3O4[238,241], cellulose sponge[239] and within reactor 
walls through silicone nanofilaments.[237] M-PDA composites have also been employed 
as catalysts for oxidation reactions such as benzylic C-H oxidation (Au and reduced 
graphene oxide),[242] benzylic alcohol oxidation (Pd immobilised onto silica gel) [243] and 
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sulfide oxidation (oxo-vanadium chelated to Fe3O4@PDA NPs).[244] In all of these 
examples, PDA plays a key role in enhancing recyclability and activity of the catalytic 
system through actively engaging in a synergistic mechanism. 
 Besides being used as a metal carrier, PDA has also been utilised for enzyme 
immobilisation to enhance enzyme loading, activity and stability thus potentially 
decreasing the costs associated with industrial biocatalysis.[245] The Messersmith group 
demonstrated the ease of biomolecule attachment to PDA films through covalent 
attachment of amino/thiol-containing residues to quinone moieties in PDA.[246] Since 
then, lipase enzyme immobilisation onto Fe3O4@PDA NPs greatly increased the 
enzyme loading capacity in reactions, improved thermal and pH stability compared to 
the free enzyme, and magnetic separation of the catalyst, all of which allowed 
retention of 70% activity up to 21 cycles.[247] A different approach utilised 
colloidosomes by inducing interfacial polymerisation of dopamine within the oil/water 
phase of silica particles to allow covalent attachment of encapsulated lipases. This 
system demonstrated improved esterification activity compared to the free lipase, as 
well as efficient recycling which retained 86.6% of enzyme activity after 15 cycles.[248] 
 Many other enzymes have been immobilised using PDA to various solid 
supports such as trypsin on silica/titania monoliths,[249] alkaline phosphatase on quartz 
glass,[250] laccase on halloysite nanotubes,[251] formate dehydrogenase on Fe3O4 
NPs,[252] and glucose oxidase with a metal-organic framework.[253] PDA has also been 
involved in the formulation of various multienzyme cascade systems, maintaining a 
strong adhesion/entrapment of the enzymes without the loss of activity.[254–256] For 
example valuable isomalto-oligosaccharide (IMO) was produced from starch by 
immobilisation of glucosidase, α- and β-amylase within PDA microcapsules.[254]  
 Interestingly, PDA has also been coated on bacterial Rhodotorula glutinis cells 
that led to improved biocatalytic activity towards the asymmetric reduction of 
acetophenone.[257] A five times increase in catalytic activity (product yield) was 
observed for the PDA coated cells when compared to native cells, as well as an eight 
times increase in biocatalyst reusability.  The authors propose that the PDA coating 
acts as a redox shuttle for the transfer of two protons and two electrons, thus 
accelerating the rate of electron transfer in the reduction or from the cytoplasm to the 
extracellular environment. Additionally, the PDA coating allowed further 
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functionalisation with other inorganic components such as Fe3O4 for magnetic 
retrievability and TiO2 for UV protection.  
 Overall, the use of PDA in catalysis as a support material has demonstrated a 
key role in enhancing the catalytic properties of both metal and biological catalysts 
through interplay of its inherent redox chemistry. The utilisation of this chemistry has 
been further investigated through organo- and photocatalytic applications within 
catalysis. 
1.2.2 Polydopamine organocatalysis 
PDA has demonstrated intrinsic organocatalytic activity towards a small number of 
organic transformations as a result of reactive catechol, quinone and amino moieties 
that also enable H-bonding, π-interactions and electrostatic stabilisation of 
intermediates. For example, in 2014 the Liebscher group reported that PDA could 
catalyse aldol condensation reactions between aryl aldehydes and cyclohexanone 
under mild aqueous conditions in both its pure and Fe3O4 NP coated forms (Figure 
1.25A).[258]  Aldehydes with electron-withdrawing groups (R1 = NO2, Br) reacted well 
however without activation (R1 = H, OMe) low or no activity was observed. 
Mechanistically, the authors proposed a transition state whereby cyclohexanone forms 
an imine with PDA and undergoes nucleophilic attack to the non-covalently bound aryl 
aldehyde (Figure 1.25A). The PDA catalyst was found to be reusable up to 5 runs 
however, decreasing activity was apparent and more pronounced when using 
Fe3O4@PDA NPs due to PDA leaching.[258] 
 In the same year, Yang et al. utilised PDA NPs in combination with KI to 
synthesise cyclic carbonates from a range of epoxides and CO2 in solvent-free 
conditions (Figure 1.25B).[259] It should be noted that catalysis was only observed in the 
presence of KI, and recyclability was demonstrated up to six runs. The authors 
proposed a synergistic mechanism between PDA and KI through H-bonding activation 
of the epoxide by catechol residues in order to facilitate KI integration, CO2 addition 
and cyclisation, similar to that observed with cellulose/KI.[260]  
 PDA NPs were also used as a catalyst for the formation of disulfide bonds 
between a range of thiols under aqueous aerobic conditions (Figure 1.25C).[261] The 
catalyst showed excellent recyclability up to five runs with no changes in the 
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morphology of particles. It was proposed that the thiol conjugates via Michael addition 
to quinone moieties within the PDA polymer and then reacts with another thiol to 
form the disulfide bond and dissociate from the polymer. It should be noted that thiol 
conjugation to PDA is a primary way to functionalise the material post synthesis,[188,262]  
which indicates that anaerobic conditions must be employed to avoid catalytic thiol 
oxidation. 
 
Figure 1.25: Examples of PDA organocatalysis: (A) aldol condensation,[258] (B) synthesis 
of cyclic carbonates from epoxides using CO2 and KI,[259] and (C) oxidative thiol 
coupling.[261] 
 Recently, the organocatalytic activity of PDA has been extended by taking 
advantage of the similarity between PDA catechol/quinone moieties and naturally 
occurring quinone redox cofactors within copper amine oxidases (CuAOs) to synthesise 
a series of N-heterocycles in aqueous solvent conditions (Figure 1.26).[263] PDA 
particles (100 wt%) were utilised as a heterogeneous catalyst to synthesise a series of 
benzimidazole and quinoxaline compounds were synthesised at 80 oC in either H2O or 
H2O/EtOH (1:1, v/v) under O2 atmosphere with yields up to 92% after 6-24h depending 
on R1 and R2/3 substituents (Figure 1.26A). Similarly, quinazolinone derivatives were 
obtained using analogous conditions but the substrate scope was more limited as 
electron-withdrawing groups (R4 = CF3, Figure 1.26B) show no activity. Secondary 
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amine oxidation was also demonstrated using the same reaction conditions through 
the dehydrogenation of some tetrahydroquinolines and indole with isolated yields up 
to 84% over 24h (Figure 1.26C). Furthermore, a large-scale reaction (1.5 mmol) and 
recycling of both pure PDA and Fe3O4@PDA was demonstrated up to 3 runs with no 
considerable loss of catalytic activity, however the magnetic system displayed longer 
reaction times and lower yields due to less catalytically active PDA being present in the 
reaction.  
 The mechanism proposed by the authors for the heterocycle formation 
involves the formation of PDA-imine adducts with the substrate which then undergoes 
transamination with the aniline and subsequent cyclisation-oxidation steps to yield the 
final product. The oxidation of secondary amine substrates was presumed to proceed 
through a similar imine adduct followed by hydrolysis and oxidation to form the 
oxidized quinolines and indole.  
 
Figure 1.26: Synthesis of N-heterocycles using PDA as an amine oxidase mimetic 
catalyst: (A) substituted benzimidazole or quinoxaline formation, (B) substituted 
quinazolinone formation and (C) oxidative aromatisation of substituted 
tetrahydroquinolines or indoline. 
 In summary, this work alongside the previously mentioned examples, clearly 
demonstrate that PDA shows promising biomimetic catalytic activity that has the 
potential to expand and improve modern green chemistry methodology. 
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1.2.3 Polydopamine photocatalysis 
The structure of PDA features conjugated dihydroxyindole oligomers of varying length 
and character stacked via π-interactions, resembling that of naturally occurring 
melanins.[193] As a result, melanin has historically been described as an amorphous 
organic semiconductor due to its broad absorption spectrum, electrical conductivity 
and photoconductivity,[264,265] however recent reports have shown that melanin acts 
more as an electronic-ionic hybrid conductor.[266] In either case, PDA has been utilised 
in a number of photocatalytic applications thanks to its close relation to melanin and 
related optical and electrical properties.[209,267]   
 The use of PDA in photocatalysis has mainly been in conjunction with 
semiconducting metal oxides or related materials to achieve water pollutant dye 
degradation.[209] Photocatalytic dye degradation using semiconductor-PDA (SC-PDA) 
composites share many of the same advantages as previous examples of ‘dark’ M0-PDA 
catalysis, whereby PDA helps to immobilise the catalytic metal into an elaborated 
support material, and also enhances activity through redox mediation and/or 
improved substrate binding. For wide-band gap semiconductors like TiO2, PDA is also 
employed to sensitise visible light activity due to broad absorption over the UV-Vis 
light spectrum.[268–271] Other examples include the addition of plasmonic metal 
photocatalysts such as Au,[272,273] and Ag/AgCl,[274–276] as well as other semiconductors 
such as carbon nitride,[275,277] ZnO,[278] Cu2O,[279] and β-FeOOH.[280] All these examples 
however, focus on the degradation of organic dye compounds such as methylene blue, 
rhodamine B or methyl orange as model substrates for water remediation applications. 
There are fewer examples however, utilising PDA enhanced photocatalysis to achieve 
useful organic transformations in synthesis.  
 Xie et al. demonstrated that PDA enhanced the activity of Pd NPs (10-30 nm) 
towards Suzuki cross-coupling reactions under white LED irradiation.[281] The Pd NPs 
were supported on an inert carrier material such as carbonised loofah (CL), utilising a 
PDA nanofilm to attach the Pd NPs after initial in-situ reduction of Pd(OAc)2. Without 
irradiation, the reaction between iodobenzene and phenylboronic acid using the CL 
supported catalyst gave only trace amounts of product at room temperature after 2h. 
Using white LED irradiation resulted in an increase up to 96% isolated yield and overall, 
Design and Application of Nanostructured Flavin Photocatalysts 
36  L. B. Crocker – August 2020 
very good substrate scope was demonstrated, however amino substituents were not 
compatible due to interaction with the PDA film. Recyclability of the catalyst system 
(using CL support) was demonstrated up to five runs with very little loss of activity and 
Pd NP content. The authors proposed a mechanism to explain their observations 
whereby charge separation within PDA upon irradiation enables the accumulation of 
electrons on Pd NPs and positive charge on PDA (Figure 1.27). Addition of aryl 
substrates to PDA via π-stacking could subsequently undergo rapid addition to Pd NPs, 
with Ar-B(OH)3- being activated by interaction with h+ on PDA. Reductive elimination of 
the aryl-Pd complexes yields the biphenyl products. 
 
Figure 1.27: Proposed mechanism of the photochemically enhanced Suzuki coupling 
catalysed by a supported Pd/PDA catalyst. Adapted from Xie et al.[281] 
 In another example, PDA-coated TiO2 nanotubes have been reported to 
oxidise benzyl alcohol wherein the PDA coating acts as a visible light sensitiser for 
TiO2.[282] The mechanism proposed by the authors involves charge injection from 
photoexcited PDA to the TiO2 conduction band which leads to the generation of O2•– 
from dissolved O2. The superoxide radical then oxidises the benzyl alcohol substrate to 
benzaldehyde. Interestingly, the system showed recyclability up to three runs of 24 h 
reactions with no decomposition of PDA reported, however quantities of 
benzaldehyde produced were low at around 30 µmol or 3.2 mg per 24 h run. 
 It is clear from these examples that the applicability of PDA in photocatalysis 
for organic synthesis is far from being fully explored but also demonstrates it could be 
very useful in heterogeneous photocatalyst design. Outside of organic synthesis or 
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water remediation, the photoactivity of PDA has also shown great potential in artificial 
photosynthesis,[283,284] dye-sensitised solar cells (DSSCs) [285] and CO2 reduction.[286–288] 
 To summarise, the use of PDA within catalysis is broad and despite its use 
primarily being as a support for metals or other inorganic materials, it has shown the 
ability to enhance (photo)catalytic processes by synergistic redox chemistry and 
biomimetic organocatalytic ability. Collectively, these attributes position PDA as a good 
candidate to advance green heterogeneous catalyst design.  
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1.3 Aims & Objectives 
This thesis aims to develop novel heterogeneous flavin photocatalysts using PDA 
nanoparticles. So far, the only reported organic (metal-free) heterogeneous 
photocatalysts systems comprise of carbon nitrides and related materials such as 
carbon dots.[289,290] The use of PDA as a catalytic support material has already 
demonstrated interesting synergy between the carried catalyst (metal, semiconductor 
or biological) and PDA’s inherent redox chemistry that enhances activity. This redox 
chemistry has been further utilised in organocatalytic transformations and within 
photocatalysis to sensitise semiconductor activity.  The use of PDA-based 
heterogeneous photocatalysts to achieve biomimetic transformations has not yet been 
reported as well as its combination with an organic photosensitiser such as flavin. It is 
therefore envisaged that the combination of flavin with nanostructured PDA, which is 
not just a passive carrier of the photoactive moiety but actively engages in the catalytic 
process, could yield a system with enhanced photocatalytic activity and give rise to a 
new class of organic heterogeneous photocatalysts. 
Hence, the major objectives of this thesis are to rationally design flavin-PDA 
hybrid nanoparticles and characterise their photocatalytic activity. There is a distinct 
lack of reports regarding flavin photocatalysis of reduction reactions as well as efficient 
heterogeneous/supramolecular systems that can mimic flavoenzyme activity. 
Therefore, following initial characterisation using model redox substrates, 
photocatalysis of flavoenzyme-specific oxidation and reduction reactions using 
flavin-PDA will be investigated. This therefore extends the current repertoire of 
catalytic flavin systems towards efficient, biomimetic heterogeneous photocatalysts 
which could be useful not only in organic synthesis but also in biomedical and energy 
applications due to its expected biocompatibility. 
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2 SYNTHESIS AND PHOTOCATALYTIC 
ACTIVITY OF FLAVIN-
POLYDOPAMINE NANOPARTICLES  
 
2.1 Introduction 
This chapter details the synthesis and characterisation of flavin-polydopamine (FLPDA) 
copolymer nanoparticles (NPs) as well as their related photocatalytic activity. A flavin-
DOPAC monomer (FLDA, Figure 2.1A) was first designed to mimic flavin adenine 
dinucleotide (FAD, Figure 2.1A) and subsequently copolymerised with dopamine to 
form self-assembled FLPDA NPs (Figure 2.1B). Initial characterisation of FLPDA’s 
photocatalytic capabilities was assessed by monitoring both oxidation and reduction 
reactions using a redox dye system based on resorufin (RF). There is far less data 
available on photoreductions catalysed by flavins when compared to photooxidations, 
so it was deemed important to establish this ability for FLPDA to widen the scope of 
flavin photocatalysis. By probing the whole spectrum of the photocatalytic action of 
FLPDA, a deeper insight into the mechanism can be gained to help in the design of 
even more effective catalytic systems useful for industrially relevant organic 
transformations. In order to demonstrate the green potential of enzyme inspired 
FLPDA and its potential applicability in fields other than photocatalysis, the in vitro cell 
biocompatibility of the system is also assessed. 
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Figure 2.1: Structures of flavin-DOPAC (FLDA) monomer and flavin-polydopamine 
(FLPDA) nanoparticles. (A) Comparison of naturally occurring flavin cofactor FAD and 
FLDA synthesized in this work. (B) General structure of FLPDA NPs. 
2.2 Collaborative Work 
Resorufin photocatalytic assays were performed in collaboration with Philipp Koehler 
in the group of Dr. Tijmen Euser (Nanophotonics Centre, University of Cambridge). Cell 
culture and biocompatibility assays were performed by Patrick Bernhard in the group 
of Dr. Ljiljana Fruk (Department of Chemical Engineering and Biotechnology, University 
of Cambridge).  
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2.3 Experimental 
2.3.1 Materials and Methods 
All materials were purchased from either Acros Organics, Alfa Aeser, Sigma-Aldrich or 
TCI Chemicals in the highest purity available and used without further purification. 1-
Azido-2-(2-(2-iodoethoxy)ethoxy)ethane (1) was synthesised according to the 
literature procedure by Deng et al.[291] 2-(2,2-Dimethylbenzo[d][1,3]dioxol-5-yl)acetic 
acid (5) was synthesised according to the literature procedure by Geiseler et al.[292]  
1H and 13C NMR measurements were carried out using a 500 MHz DCH 
Cryoprobe Spectrometer. HRMS was recorded on a ThermoFinnigan Orbitrap Classic 
(Fisher Scientific). UV-Vis absorption spectra were obtained with an Agilent Cary 300 
Spectrophotometer. Fluorescence emission spectra were obtained using a Varian Cary 
Eclipse Fluorescence Spectrophotometer using excitation and emission splits of 5 nm 
or 10 nm. DLS and zeta potential measurements were recorded using a Zetasizer Nano 
Range instrument (Malvern Panalytical). FTIR spectroscopy was carried out using a 
Bruker Tensor 27 spectrometer with samples pressed into KBr pellets. STEM images 
were obtained using a Hitachi S-5500 In-Lens FE STEM (2009) at an acceleration 
voltage of 1.0 kV. Samples were suspended in water (0.1 mg/mL) and drop cast on 
lacey carbon copper grids (Agar Scientific).  
2.3.2 Synthesis of FLDA 
N1-(2-(2-(2-azidoethoxy)ethoxy)ethyl)-4,5-dimethylbenzene-1,2-diamine (2):  
 
4,5-Dimethylbenzene-1,2-diamine (1.00 g, 7.34 mmol) and K2CO3 (2.03 g, 14.68 mmol) 
were dissolved in anhydrous DMF (30 mL) and heated to 50 oC under Ar atmosphere. 
1-Azido-2-(2-(2-iodoethoxy)ethoxy)ethane (2.09 g, 7.34 mmol) dissolved in anhydrous 
DMF (10 mL) was then added dropwise and the resulting mixture was stirred at 50 oC 
overnight.  DMF was removed under reduced pressure and the resulting residue was 
re-dissolved in DCM (50 mL) and washed with water (3 x 50 mL) and brine (2 x 50 mL). 
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The organic layer was then dried over anhydrous Na2SO4 and evaporated. The crude 
product was then purified by silica gel column chromatography using the solvent 
system DCM/MeOH (99.5:0.5) to give the title compound as a red oil (1.50 g, 5.11 
mmol, 70%). 
1H NMR (500 MHz, CDCl3): δ = 6.52 (s, 1H, H-5), 6.48 (s, 1H, H-6), 3.74 (t, 2H, 3J = 5.2 
Hz, H-9), 3.70-3.67 (m, 6H, H-7, H-9), 3.39 (t, 2H, 3J = 5.1 Hz, H-10), 3.27 (br. s, 2H, H-
11), 2.15 (2 x br. s, 6H, H-12, H-13) ppm 
13C NMR (500 MHz, CDCl3): δ = 134.91 (C-1), 132.93 (C-2), 127.72 (C-3), 126.90 (C-4), 
118.24 (C-5), 115.11 (C-6), 70.68 (C-7), 70.35 (C-8), 70.11 (C-9), 50.71 (C-10), 44.45 (C-
11), 19.24 (C-12), 18.84 (C-13) ppm 




Compound 2 (2.50 g, 8.52 mmol), B2O3 (1.19 g, 17.04 mmol) and alloxan monohydrate 
(1.21 g, 8.52 mmol) were dissolved in glacial acetic acid (25 mL) and left to stir in the 
dark at room temperature under Ar atmosphere for 2 days. Water was added (25 mL) 
and extracted with DCM (3 x 50 mL). The organic layer was evaporated and then co-
evaporated with toluene (3 x 50 mL) to remove any traces of water and acetic acid. 
The crude product was purified by silica gel column chromatography using a gradient 
solvent system of DCM/acetone (4:1 - 1:1) to give the title compound as an orange 
solid (2.35 g, 5.89 mmol, 69%) 
1H NMR (500 MHz, DMSO-d6): δ =11.30 (s, 1H, H-19), 7.82 (s, 1H, H-9), 7.81 (s, 1H, H-
10), 4.76 (t, 2H, 3J = 5.8 Hz, H-15), 3.81 (t, 2H, 3J = 5.8 Hz, H-14), 3.54 (m, 2H, H-13), 
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3.45 (m, 4H, H-11, H-12), 3.25 (t, 2H, 3J = 5.8 Hz, H-16), 2.47 (s, 1H, H-17), 2.36 (s 1H, H-
18) ppm 
13C NMR (500 MHz, DMSO-d6): δ = 160.33 (C-1), 155.98 (C-2), 150.66 (C-3), 146.65 (C-
4), 137.48 (C-5), 136.20 (C-6), 134.10 (C-7), 131.83 (C-8), 131.18 (C-9), 117.30 (C-10), 
70.67 (C-11), 70.06 (C-12), 69.73 (C-13), 67.24 (C-14), 50.39 (C-15), 44.56 (C-16), 21.06 
(C-17), 19.22 (C-18) ppm 




Flavin 3 (0.50 g, 1.25 mmol) was added to a dried 100 mL 3 neck round bottom flask 
and dissolved in degassed glacial acetic acid (50 mL). The vessel was purged with Ar by 
water aspiration before adding Pd/C (10 mg), rinsing any residual powder off of the 
flask walls with degassed acetic acid. The vessel was purged with Ar again before 
replacing the atmosphere with H2 from a balloon. The reaction was then left to stir for 
18 h at room temperature. The atmosphere was then replaced by Ar and the reaction 
mixture filtered through celite, washed with methanol and evaporated. The crude 
residue was subjected to flash silica gel column chromatography using the solvent 
system DCM/MeOH/AcOH (70:20:10 - 20:70:10) to give the title compound as a red 
residue (0.43 g, 1.05 mmol, 84%). 
1H NMR (500 MHz, CD3OD): δ = 8.20 (s, 1H, H-9), 8.14 (s, 1H, H-10), 5.17 (t, 2H, 3J = 5.0 
Hz, H-15), 4.13 (t, 2H, 3J = 5.0 Hz, H-14), 3.68 (m, 2H, H-13), 3.64 – 3.59 (m, 4H, H-11, 
H-12), 3.08 (t, 2H, 3J = 5.0 Hz, H-16), 2.68 (s, 3H, H-17), 2.55 (s, 3H, H-18) ppm 
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13C NMR (500 MHz, CD3OD): δ = 158.9 (C-1), 151.6 (C-2), 150.8 (C-3), 145.9 (C-4), 140.6 
(C-5), 137.1 (C-6), 134.4 (C-7), 131.3 (C-8), 130.5 (C-9), 117.3 (C-10), 70.4 (C-11), 69.8 
(C-12), 67.7 (C-13), 66.4 (C-14), 42.8 (C-15), 39.2 (C-16), 20.3 (C-17), 18.2 (C-18) ppm 




Compound 5 (0.42 g, 2.02 mmol) was dissolved in anhydrous DCM (40 mL) before 
adding SOCl2 (1.46 mL, 20.17 mmol) and refluxing for 2 h under Ar atmosphere. The 
reaction mixture was evaporated to remove the solvent and excess SOCl2 was removed 
by toluene co-evaporation (3 x 20 mL). The resulting dark brown oil was immediately 
used in the following step without further purification (0.46 g, 2.02 mmol, quant). 
Flavin 4 (0.40 g, 0.98 mmol) was dissolved in anhydrous DMF (40 mL) under Ar 
atmosphere and protected from light. Et3N (0.27 mL, 1.95 mmol) was added and the 
solution turned form dark red to dark green. The mixture was then cooled to 0 oC 
before adding the acyl chloride activated 5 (0.44 g, 1.95 mmol) dissolved in anhydrous 
DMF (10 mL) dropwise over 20 minutes. The resulting dark red reaction mixture was 
left to stir and warm to room temperature over 18 h. The solvent was then removed in 
vacuo and the crude residue purified by silica gel column chromatography using the 
solvent system DCM/MeOH/AcOH (98.5:1:0.5 – 90:6:4) to give the title compound as 
an orange solid (0.355 g, 0.63 mmol, 64%). 
1H NMR (500 MHz, CD3OD): δ = 7.94 (s, 1H, H-13), 7.91 (s, 1H, H-16), 6.64 (m, 2H, H-17, 
H-18), 6.59 (d, 1H, 3J = 8.1 Hz, H-14), 4.97 (t, 2H, 3J = 5.4 Hz, H-23), 3.98 (t, 2H, 3J = 5.4 
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Hz, H-22), 3.58 (m, 2H, H-19), 3.46 (m, 2H, H-20), 3.36 (t, 2H, 3J = 5.6 Hz, H-21), 3.34 (s, 
2H, H-24) 3.21 (t, 2H, 3J = 5.6 Hz, H-25), 2.56 (s, 3H, H-27), 2.46 (s, 3H, H-28), 1.58 (s, 
6H, H-26) ppm 
13C NMR (500 MHz, CD3OD): δ = 173.0 (C-1), 157.8 (C-2), 150.6 (C-3), 147.8 (C-4), 147.5 
(C-5), 146.4 (C-6), 137.5 (C-7), 137.2 (C-8), 136.2 (C-9), 135.7 (C-10), 134.8 (C-11), 132.2 
(C-12), 130.9 (C-13), 121.3 (C-14), 117.6 (C-15), 117.1 (C-16), 108.7 (C-17), 107.5 (C-18), 
70.5 (C-19), 69.9 (C-20), 69.0 (C-21), 67.5 (C-22), 45.0 (C-23), 42.1 (C-24), 39.0 (C-25), 
24.5 (C-26), 20.0 (C-27), 18.0 (C-28) ppm 




Flavin 6 (0.20 g, 0.35 mmol) was dissolved in DCM (20 mL) and TFA (4 mL) was added 
dropwise at 0 oC. The reaction mixture was then left to stir at room temperature until 
TLC analysis showed completion (2 h). The solvent and excess TFA were removed 
under reduced pressure and co-evaporated with toluene (3 x 20 mL) to give the title 
compound as a red solid (0.184 g, 0.35 mmol, 99%) 
1H NMR (500 MHz, CD3OD): δ = 7.84 (s, 1H, H-13), 7.82 (s, 1H, H-15), 6.67 (d, 1H, 4J = 
2.1 Hz, H-16), 6.64 (d, 1H, 3J = 8.0 Hz, H-17), 6.54 (dd, 1H, 3J = 8.0 Hz, 4J = 2.1 Hz, H-14), 
4.90 (t, 2H, 3J = 5.5 Hz, H-22), 3.94 (t, 2H, 3J = 5.5 Hz, H-21), 3.55 (m, 2H, H-18), 3.44 (m, 
2H, H-19), 3.36 (t, 2H, 3J = 5.5 Hz, H-20), 3.29 (s, 2H, H-23) 3.21 (t, 2H, 3J = 5.5 Hz, H-
24), 2.52 (s, 3H, H-25), 2.42 (s, 3H, H-26) ppm 
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13C NMR (500 MHz, CD3OD): δ = 174.8 (C-1), 162.3 (C-2), 151.7 (C-3), 149.4 (C-4), 146.4 
(C-5), 145.3 (C-6), 138.9 (C-7), 138.7 (C-8), 137.3 (C-9), 136.1 (C-10), 133.5 (C-11), 132.2 
(C-12), 128.2 (C-13), 121.5 (C-14), 118.5 (C-15), 117.2 (C-16), 116.4 (C-17), 71.9 (C-18), 
71.3 (C-19), 70.5 (C-20), 68.8 (C-21), 46.4 (C-22), 43.3 (C-23), 40.4 (C-24), 21.4 (C-25), 
19.4 (C-26) ppm  
HRMS (ESI) m/z: [M + H]+ Calcd for C26H29O7N5Na 546.1959; Found 546.1948. 
2.3.3 Synthesis of DOPAC-free flavin (FLOH) 
2-(2-(2-((2-Amino-4,5-dimethylphenyl)amino)ethoxy)ethoxy)ethan-1-ol (7): 
 
4,5-dimethylbenzene-1,2-diamine (1.41 g, 10.32 mmol) and TEA (2.40 mL, 17.20 mmol) 
were dissolved in dry THF (40 mL) and heated to 60oC before adding an excess of NaI 
(5.16 g, 34.40 mmol) and the dropwise addition of 2-(2-(2-chloroethoxy)ethoxy)ethan-
1-ol (1.00 mL, 6.88 mmol) dissolved in THF (5 mL). The resulting heterogeneous 
mixture was then stirred overnight under inert atmosphere at 60oC. After cooling, the 
mixture was diluted with water (100 mL) and extracted with DCM (5 x 50 mL). The 
combined organic layers were dried over anhydrous Na2SO4 and reduced under 
reduced pressure. The resulting dark red residue was purified by silica gel column 
chromatography in DCM-methanol (98:2) to yield a red oil (1.242 g, 4.63 mmol, 67%). 
1H NMR (500 MHz, CDCl3): δ = 6.52 (s, 1H, H-5), 6.47 (s, 1H, H-6), 3.76 (t, 2H, 3J = 5.1 
Hz, H-10), 3.70 (t, 2H, 3J = 5.1 Hz H-9), 3.67 (br. s, 4H, H-7), 3.59 (m, 2H, H-8), 3.26 (t, 
2H, 3J = 5.1 Hz, H-11), 2.16 (s, 3H, H-12), 2.12 (s, 3H, H-13)  ppm 
13C NMR (500 MHz, CDCl3): δ = 135.15 (C-1), 132.44 (C-2), 128.01 (C-3), 126.71 (C-4), 
118.45 (C-5), 114.82 (C-6), 72.79 (C-7), 70.36 (C-7), 70.00 (C-8), 69.63 (C-9) 50.71 (C-
10), 44.2 (C-11), 19.27 (C-12), 18.82 (C-13) ppm 
HRMS (ESI) m/z: [M + H]+ Calcd for C14H24O3N2Na 291.167914; Found 291.16703. 
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Compound 7, B2O3 (0.778 g, 11.18 mmol) and alloxan monohydrate (0.894 g, 5.59 
mmol) were dissolved in glacial acetic acid (17 mL) and left to stir in the dark at room 
temperature under Ar atmosphere for 2 days. Water was added (25 mL) and the 
mixture extracted with DCM (3 x 50 mL). The organic layer was evaporated and then 
co-evaporated with toluene (3 x 50 mL) to remove any traces of water and acetic acid. 
The crude product was purified by silica gel column chromatography using a gradient 
solvent system of DCM/acetone (4:1 - 1:1) to give the title compound as a yellow solid 
(1.49 g, 3.98 mmol, 71%) 
1H NMR (500 MHz, DMSO-d6): δ =11.19 (s, 1H, H-19), 7.84 (s, 1H, H-9), 7.82 (s, 1H, H-
10), 4.79 (t, 2H, 3J = 5.9 Hz, H-15), 4.40 (t, 1H, 3J = 5.5 Hz, H-20), 3.85 (t, 2H, 3J = 5.9 Hz, 
H-14), 3.56 (t, 2H, 3J = 5.9 Hz, H-13), 3.45 (m, 4H, H-11, H-12), 3.34 (m, 2H, H-16), 2.47 
(s, 1H, H-17), 2.36 (s 1H, H-18) ppm 
13C NMR (500 MHz, DMSO-d6): δ = 160.12 (C-1), 155.76 (C-2), 150.58 (C-3), 146.56 (C-
4), 137.34 (C-5), 136.05 (C-6), 134.05 (C-7), 131.74 (C-8), 131.14 (C-9), 117.18 (C-10), 
72.74 (C-11), 70.59 (C-12), 70.10 (C-13), 67.13 (C-14), 60.60 (C-15), 44.56 (C-16), 20.91 
(C-17), 19.05 (C-18) ppm 
HRMS (ESI) m/z: [M + Na]+ Calcd for C18H22O5N4Na 397.1482; Found 397.1467. 
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2.3.4 Synthesis of Flavin-Polydopamine 
General Procedure: A mixture of ammonia solution (0.1 mL, 28%), ethanol (1.5 mL) 
and Milli Q water (4.5 mL) was stirred at room temperature for 30 minutes in reaction 
vessels protected from direct sunlight. Dopamine hydrochloride* dissolved in Milli-Q 
water (0.5 mL) and FLDA** dissolved in ethanol (0.5 mL) were mixed before being 
added dropwise to the reaction mixture. The resulting dark brown/black mixture was 
left to stir in the presence of air for 24 h. The mixture was then centrifuged at 25000 x 
g for 30 min and the supernatant was removed. The precipitate was washed with Milli-
Q water (3 x 40 mL) and then suspended in Milli-Q water (20 mL), frozen in liquid N2 
and lyophilised to yield a dark brown/black powder. 
Sample 
*Dopamine 
Hydrochloride / mg 
**FLDA / mg 
Molar Ratio 
(DA·HCl:FLDA) 
FLPDA- 5 15.80 8.73 5:1 
FLPDA-10 17.24 4.76 10:1 
FLPDA-20 18.06 2.49 20:1 
PDA 18.96 - - 
2.3.5 Fluorescence Calibration Curve 
 
Figure 2.2: Fluorescence calibration curve of FLDA at λ527 in 0.05 M KPi buffer pH 7.4 
(ex/em slits = 10 nm). All measurements were carried out in 200 μL total volume. 
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Table 2.1: Correlation data obtained from the calibration curve. All measurements 



















FLPDA-5 5:1 325.35 536.73 55.51 1.11 
FLPDA-10 10:1 248.16 409.39 42.10 0.84 
FLPDA-20 20:1 210.82 347.79 35.61 0.71 
2.3.6 Laser Diode Emission Spectrum and Experimental Setup 
 
Figure 2.3: (A) Intensity spectrum of the OSRAM laser diode used in the setup (B) 
Experimental setup of laser diode and fibre-optics. 
The time-dependent sample concentrations and reaction rates during excitation with 
an OSRAM laser diode (Figure 2.3A) were measured with a custom-built modular 
absorption spectroscopy setup as shown in Figure 2.3B. A fibre-coupled white light 
halogen light source (Ocean Optics DH-2000) was collimated with a 4x Olympus Plan N 
objective and penetrates the sample in a clear 1x1 cm plastic cuvette. The outgoing 
beam is coupled with a 7.86mm focal length lens into a 300 µm multimode fibre, which 
was connected to an Ocean Optics QE65000 spectrometer. The reaction is driven with 
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an OSRAM 458 nm laser diode, spectrum shown in Figure 2.3A, through the cuvette 
perpendicular to the spectroscopy beam. 
2.3.7 Photooxidation of Amplex Red 
General Procedure: FLPDA catalyst (1-10 μg/mL) and Amplex Red (100 μM) were 
added to a cuvette containing KPi buffer (2 mL, 10 mM, pH 7.4) under stirring in the 
dark. The cuvette was then irradiated with a laser diode (458 nm) and spectra were 
recorded over time. Absorbance values were converted to molar equivalents using the 
molar extinction coefficient of resorufin at pH 7.4 (67 700 M-1cm-1).[293] 
2.3.8 Photoreduction of Resazurin 
General Procedure: FLPDA catalyst (1-10 μg/mL), EDTA (100 μM) and resazurin (25 
μM) were added to a cuvette containing KPi buffer (2 mL, 10 mM, pH 7.4) with stirring. 
The mixture was purged with N2 in the dark for 15 minutes. It was then irradiated with 
a laser diode (458 nm) under N2 atmosphere and spectra were recorded over time. 
Absorbance values were converted to molar equivalents using the molar extinction 
coefficient of resorufin at 572 nm (67 700 M-1cm-1, pH 7.4)[293] and for resazurin at 602 
nm (35 510 M-1cm-1, pH 7.4) which was calculated using known concentrations of 
resazurin. 
Recycling experiments were carried out by irradiating FLPDA-5 (50 μg/mL) in the 
presence of RZ (0.2 mM) and EDTA (1 mM) in KPi buffer (0.1 M, pH 7.4) for 1 hour 
under Ar atmosphere. The catalyst was then removed by centrifugation (4000 rpm, 30 
min) and washed with MilliQ water (2 x 10 mL). 
2.3.9 Cell studies 
 
2.3.9.1 Cell Culture 
A549 cells were cultured within 25, 75 or 175 cm² flasks in Dulbecco’s Modified Eagle’s 
medium (DMEM) supplemented with 10 % (v/v) sterile filtrated (0.2 µM CA membrane 
filter) fetal bovine serum (FBS), 100 U/mL penicillin and 100 μg/mL streptomycin 
sulphate (PS) at 37 °C and 5 % CO2 in a humidified incubator and sub-cultured at 80 % 
confluency. For passaging cells, the medium was removed, cells were washed with 2-5 
mL Dulbecco’s Phosphate buffered saline (PBS) before incubating the adherent cells 
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for 5 min with 2-5 mL trypsin-EDTA solution (0.25 % v/v) in order to detach the 
adherent cells from the culture flask. After stopping trypsinization by adding at least 
the same volume of DMEM, the cells were separated from the medium by 
centrifugation (5 min, 100 x g, RT). Subsequently, the cell pellet was resuspended and 
diluted in DMEM according to the desired size and cell density of the following cell 
passage. 
2.3.9.2 LDH release cytotoxicity assay 
To evaluate the in vitro cytotoxicity of FLPDA NP treatment on A549 cells, the activity 
of the cytosolic enzyme lactate dehydrogenase (LDH) present in the culture media was 
determined by using the commercially available fluorometric LDH assay kit in a 96-well 
plate format (abcam, UK) monitoring with an excitation of 535 nm and emission at 587 
nm.  
2.3.9.3 MTS viability assay 
To evaluate the in vitro viability of FLPDA NP treatment on A549 cells, the metabolic 
activity of the cells was determined by using the commercially available MTS viability 
assay kit in a 96-well plate format (Promega, USA) monitoring with colorimetric 
detection between 450-540 nm.  
2.3.9.4 Superoxide detection assay 
To evaluate the level of oxidative stress on A549 cells by FLPDA NPs treatment, the 
amount of intracellular ROS was detected using the commercially available superoxide 
detection kit in a 96-well plate format (Enzo Life Sciences Ltd., UK) monitoring with an 
excitation of 550 nm and emission at 620 nm. 
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2.4 Results and Discussion 
2.4.1 Synthesis and Characterisation 
The FLDA monomer was synthesised according to the route shown in Figure 2.4. First, 
the functionalised triethylene glycol, 1 was used in a mono-substitution reaction with 
4,5-dimethylbenzene-1,2-diamine to form compound 2. Isoalloxazine formation was 
achieved through the double condensation reaction with alloxan monohydrate to 
obtain flavin derivative 3. The azide functionality was then reduced via catalytic 
hydrogenation to yield the amine-bearing flavin derivative 4. Conjugation of this 
compound to the activated catechol-protected dopamine analogue 6 resulted in 
protected FLDA derivative 7, which was subsequently deprotected to afford the target 
FLDA monomer. Copolymerisation of dopamine and FLDA was carried out following a 
room temperature procedure adapted from Ai et al. and using ammonia addition to a 
water/ethanol solvent system in the presence of air (Figure 2.4).[204] The reaction 
vessels were protected from direct light exposure to avoid any possible side reactions 
through the excitation of flavin moieties. 
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Figure 2.4: Synthesis of FLDA and FLPDA. Reaction conditions: a) 4,5-dimethylbenzene-
1,2-diamine, K2CO3, DMF, 50 oC, 12 h (70%); b) alloxan monohydrate, B2O3, AcOH, RT, 
dark, 48 h (69%); c) Pd/C, H2, AcOH, RT, dark, 18 h (84%); d) i) 5, SOCl2, DCM, reflux, Ar, 
2h then ii) 4, TEA, DMF, RT, dark, 18 h, (62%) e) TFA/DCM, RT, dark, 2 h (99%); f) 
dopamine hydrochloride, NH4OH, EtOH/H2O, RT, 24 h. 
Design and Application of Nanostructured Flavin Photocatalysts 
54  L. B. Crocker – August 2020 
a Measured by DLS 
b Measured by STEM 
 In order to explore the effect of the amount of the FLDA monomer on the 
copolymerisation and formation of NPs, different molar ratios of dopamine to FLDA 
were used (5:1, 10:1 and 20:1) resulting in NPs referred to as FLPDA-5, FLPDA-10, 
FLPDA-20 respectively. Prepared samples were washed extensively and lyophilized to 
avoid any thermal decomposition of the polymer that could occur through vacuum 
heating. Flavin modified NPs were noticeably browner in colour when compared to 
black unmodified PDA NPs. The zeta potential values ranged from -35.7 mV for FLPDA-
5 to -41.5 mV for FLPDA-20 indicating good colloidal stability and dispersibility (see 
Table 2.2). The size and shape of FLPDA particles were further investigated by STEM 
(Figure 2.5) showing that all samples contained spherical NPs of similar size (approx. 
200 nm) with relatively large size distribution (± ~50 nm). Some conjoined particles and 
the largest size distribution were observed in FLPDA-5 (see Figure 2.5A/B and Table 
2.2). In contrast, PDA NPs synthesized under the same conditions displays a narrow 
size distribution with an average size of 110 ± 18 nm (see Figure 2.5G/H), which 
indicates that the presence of flavin moieties affects the polymerization mechanism 
and oligomer aggregation leading to particle formation. This change in shape and size 
is most likely a consequence of H-bonding and electrostatic interactions between the 
flavin group and oligomeric units. 










Particle size (nm)b 
FLPDA-5 5:1 577.3 ± 37.32 0.448 -35.7 ± 0.3 202 ± 110 
FLPDA-10 10:1 495.5 ± 23.05 0.382 -37.7 ± 0.8 207 ± 53 
FLPDA-20 20:1 389.4 ± 16.83 0.334 -41.5 ± 0.8 201 ± 58 
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Figure 2.5: STEM images of FLPDA NPs prepared with different molar ratios of 
dopamine to FLDA monomer. (A and B) FLPDA-5 (5:1), (C and D) FLPDA-10 (10:1), (E 
and F) FLPDA-20 (20:1), (G and H) PDA (1:0). 
  To validate the presence of flavin moieties, particles were first analysed by 
UV-Vis absorption and fluorescence spectroscopy. The UV-Vis spectrum of the FLDA 
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monomer shows absorption bands at λmax = 445 nm and 373 nm corresponding to the 
transitions from the ground state (S0) to the S1 (λmax ∼ 442–450 nm) and S2 (λmax ∼ 
360–375 nm) excited states (see Figure 2.6A).[2] These bands are red-shifted to ∼ 456 
nm for the S0 → S1 transition and ∼ 376 nm for the S0 → S2 transition in FLPDA (Figure 
2.6B). This can be explained by an increase in proton donation from PDA,[294] and by 
electron-withdrawing inductive effects on the flavin moieties due to incorporation into 
the highly conjugated PDA system.[295] 
 
Figure 2.6: UV-Vis absorption spectra of (A) FLDA (80 μM in H2O) and (B) FLPDA 
samples with PDA reference (50 μg/mL in 0.05 M KPi buffer pH 7.4 ).  
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 The fluorescence emission spectrum of FLDA is characterized by emission 
maxima at ∼ 527 nm  (λex = 450 nm) which correlates well to other known flavin 
compounds (see Figure 2.7A).[296] FLPDA samples also exhibit this signal, as shown in 
Figure 2.7B, confirming the presence of flavin moieties in the particles. An earlier study 
in which flavin compounds were incubated with melanin (structurally analogous to 
PDA) showed that the fluorescent properties of flavins did not change upon binding 
and there was no significant fluorescence quenching by the polymer.[297] That study, 
however, focussed on the non-covalent binding of flavin derivatives to melanin, and 
not on the covalent attachment used in this work.  
 
Figure 2.7: Fluorescence emission spectra of (A) FLDA (80 μM in H2O) and (B) FLPDA 
samples with PDA reference (50 μg/mL in 0.05 M KPi buffer pH 7.4). 
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 In order to validate the assumption that flavin content can be indeed 
quantified via fluorescence measurements of particles, a DOPAC-free flavin analogue, 
FLOH was prepared and compared to the DOPAC conjugated monomer FLDA (Figure 
2.8). Despite the UV-vis absorption of FLDA being only slightly weaker in signal that 
FLOH (Figure 2.8), the fluorescence intensity is much lower for FLDA when compared 
to same concentration of FLOH (Figure 2.9A) This observation indicates some 
intramolecular isoalloxazine-catechol fluorescence quenching similar to that found for 
FAD and adenosine due to a possible formation of a ‘closed’ structure.[298] Kozik et al. 
suggested that the key phenolic and indolic groups in the melanin polymer do not 
incur any fluorescence quenching due to their inability to form charge-transfer 
complexes with the isoalloxazine ring.[297] Although it was initially observed that there 
was a fluorescence decrease when FLOH was incubated with PDA NPs, this was no 
longer valid after correcting for the absorbance of PDA at the excitation and emission 
wavelengths. A correction factor was therefore applied by multiplying the λmax 
intensity value at 527 nm by the percentage absorbance of PDA (50 μg/mL) at λ = 450 
nm (41%) followed by the percentage absorbance of PDA at λ = 527 nm (17%). As a 
result, a representative emission spectrum of FLOH was obtained showing negligible 
quenching by PDA and indicates that any attenuation in intensity is absorbance 
dependent (Figure 2.9B). Additionally, it can be observed that the emission of the 
absorbance corrected FLOH + PDA spectrum exhibits a red-shift to 527 nm. This is the 
same value as FLDA and FLPDA but in this case, the emission has the same intensity as 
FLOH alone. It can therefore be assumed that there is negligible fluorescence 
quenching of the flavin moiety bound covalently to the PDA backbone and the only 
appreciable quenching is derived from the catechol moiety attached to the monomer 
FLDA.  
 A fluorescence calibration curve was subsequently obtained using known 
concentrations of FLDA to approximate flavin concentration within the NPs. As 
expected, FLPDA-5 contains a higher proportion of flavin than FLPDA-10 and FLPDA-
20; approximately 1.11, 0.84, 0.71 μmol/mg FLPDA respectively (see Section 2.3.5 for 
full details). Clearly, the relative amounts of flavin do not exactly match the initial 
monomer ratios used for the synthesis. This could be explained by base-catalysed 
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cleavage and/or hydrolysis of some flavin moieties during the polymerization, which 
was previously reported for other flavins.[299,300] 
 
Figure 2.8: Comparison of FLOH and FLDA structures and their corresponding UV-Vis 
spectra (100 μM in H2O). 
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Figure 2.9: Fluorescence emission spectra of (A) FLDA and FLOH (20 μM in H2O) and (B) 
the effect of PDA (50 μg/mL) incubation which decreases fluorescence emission 
intensity that can be corrected by factoring in the absorbance of PDA. 
 Flavin presence within nanoparticles was additionally confirmed by Fourier 
transform infrared (FTIR) spectroscopy by comparing FLPDA samples with FLDA and 
PDA. As shown in Figure 2.10, the FTIR spectrum of PDA (Figure 2.10A) contains 
characteristic bands at 3356 cm-1 relating to O-H and N-H stretching vibrations. The 
spectrum of FLDA has a much broader band at 3414 cm-1 relating to these vibrations, 
and as a result, FLPDA samples show very similar bands through the contributions of 
both modes. Unlike PDA, the spectra of FLPDA samples clearly contain C-H stretching 
vibration bands at 2924 and 2855 cm-1 that correlate well to the spectrum of FLDA. As 
seen in Figure 2.10B, the main characteristic bonds corresponding to the flavin 
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moieties in the polymer can clearly be observed when compared to the monomer 
FLDA, from the sharp bands at 1545 cm-1 and 1580 cm-1 relating to ν(C=N) modes in 
the isoalloxazine ring.[301] Contributions from the flavin carbonyl ν(C=O) (1711 and 
1680 cm-1) and ν(C=C) be seen in FLPDA samples in combination with C=O and C-O 
vibrational modes of PDA, seen at 1610 and 1512 cm-1 respectively in its spectrum. 
Further C=N and C=C combined contributions can also be observed at lower 
wavenumbers in the spectra of FLPDA (1292 cm-1). 
 
Figure 2.10: FTIR spectra of FLPDA samples including PDA and FLDA references at (A) 
full scale and (B) zoomed scale. All samples were measured as KBr discs. 
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2.4.2 Photocatalytic Assays 
Following the preparation and characterization of the FLPDA NPs, their photocatalytic 
activity was initially investigated using model chromogenic dyes to explore both 
oxidation and reduction reactions (Figure 2.11). Amplex Red (AR), a common 
peroxidase enzyme substrate and marker for oxidation[302–304] was chosen as a suitable 
substrate to monitor FLPDA photooxidation activity. The fluorescent product, resorufin 
(RF, absorption λmax = 572 nm) can also be produced by the reduction of blue dye 
resazurin (RZ, absorption λmax = 602 nm), a commonly utilised marker for enzymatic 
reduction activity.[305] Thanks to the differences in characteristic absorption bands of 
the substrates and product, monitoring the reaction progress can easily be achieved 
using real-time UV-Vis absorption spectroscopy (see Section 2.3.6 for full custom set-
up). 
 
Figure 2.11: Schematic of photo-redox catalytic cycles of resorufin (RF) production 
from Amplex Red (AR photooxidation) and resazurin (RZ photoreduction) in presence 
of FLPDA. 
2.4.2.1 Amplex Red Photooxidation  
Initially, 10 μg/mL FLPDA-5 NPs (~10 mol% flavin) were incubated with AR (100 μM) in 
KPi buffer at pH 7.4 (10 mM, 2 mL) and then irradiated with a blue laser diode (458 
nm). Clear oxidative conversion of AR to RF was observed upon irradiation evidenced 
by a rapid increase in absorption at 572 nm (Figure 2.12A). FLPDA-5 showed the 
highest reaction rate of 3.69 µM/h using an excitation intensity of 1.19 mW/cm2, when 
Chapter 2: Synthesis and Photocatalytic Activity of Flavin-Polydopamine Nanoparticles 
L. B. Crocker – August 2020   63 
compared to the other FLPDA samples, which can be correlated to the higher 
concentration of flavin moieties within the particles.  
 
Figure 2.12: FLPDA catalysed photooxidation of Amplex Red (AR) to resorufin (RF). A) 
Plot of the absorbance changes observed for the photooxidation of AR to RF by FLPDA-
5 (10 μg/mL) in KPi Buffer (10 mM, pH 7.4, 2 mL) using 6.40 mW/cm2, excitation 
intensity. (B) Comparative plot of AR photooxidation in presence of FLPDA 
photocatalysts and controls (10 μg/mL, [FLDA] = 10 mol%) using 2.95 mW/cm2 
excitation intensity.  
 Control experiments were performed using FLDA (10 mol%) which showed 
that in comparison to FLPDA, the reaction was far less efficient with only 0.43 µM RF 
being produced per hour. Such as significant difference between the monomer and 
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polymer NP indicates a potential synergistic relationship between PDA and flavin 
within the hybrid particles, which results in stabilization of reactive intermediates 
and/or enhancement of charge transfer. Further control experiments using PDA (10 
μg/mL) and without any catalyst exhibited no or very little activity. The blank control 
experiment without any catalyst was carried out as it has been previously reported 
that trace amounts of excited state RF can catalyse the oxidation of AR.[306] Indeed, 
there was some conversion, however, it was at a significantly slower rate (0.24 µM/h 
vs. 3.69 µM/h for FLPDA-5). In addition, the reaction displayed a dependence on laser 
power indicated by accelerated conversion at higher laser powers, as shown in Figure 
2.13. This clearly demonstrates the photocatalytic character of FLPDA as one would 
expect more absorbed photons would to lead to higher activity. Furthermore, no 
reaction occurred between the catalyst and substrate in dark (0 mW) over a period of 
>10 hours.  
 
Figure 2.13: Plot of laser diode power (458 nm) dependence (including dark 
measurement at 0 mW) on the photooxidation of AR (100 μM) in KPi buffer (10 mM, 
pH 7.4, 2 mL) with FLPDA-5 (10 μg/mL). 
 Following these experiments, the temporal control of the photooxidation 
reaction was investigated by performing intermittent ON/OFF irradiation cycles over a 
period of 9 h as shown in Figure 2.14. A clear increase in absorption of the product RF 
at 572 nm is observed when the system is irradiated (ON state) and no further reaction 
takes place when the laser is switched off for 30 min (OFF state) as evidenced by the 
absorption plateau. Such behaviour demonstrates that the catalytic activity of FLPDA 
towards substrate oxidation is light-dependent and has excellent capacity for temporal 
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control, a feature that is widely sought after in green chemistry to minimize the cost 
and maximize the efficiency of a reaction.[307] 
 
Figure 2.14: Photooxidation of AR by FLPDA-5 under intermittent ON/OFF irradiation 
cycles. Reaction conditions: AR (100 μM), FLPDA-5 (10 μg/mL) in KPi Buffer (10 mM, 
pH 7.4, 2 mL) using 2.95 mW/cm2 excitation intensity (458 nm). 
 To gain a better understanding into FLPDA’s oxidative mechanism, the kinetic 
profile of AR photoxidation by FLPDA-5 was modelled using Michaelis-Menten theory. 
As seen in Figure 2.15, the catalyst’s kinetic behaviour fits the model well over the 
majority of substrate concentrations indicating a possible enzyme-like mechanism 
involving substrate binding, followed by reaction and product dissociation. However, 
as these data do not fit perfectly, a deeper investigation into the modelling the kinetic 
profile of the catalyst should be investigated in future work as this model may not be 
the best for this system. The Km value obtained from the Michaelis-Menten fit was 
166.7 μM and a Vmax of 1.66 μM/min (Figure 2.15A and B). Compared to enzymes with 
high specificity to Amplex Red, such as horseradish peroxidase (HRP), these values 
indicate less specificity and efficiency (6.4 μM and 2.2 μM/min for HRP respectively), 
but still in a range to be considered as an effective enzyme mimic.[308]  
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Figure 2.15: Michaelis-Menten plot (A) and reciprocal Lineweaver-Burke plot (B) for 
the photooxidation of AR by FLPDA-5 (10 μg/mL) in KPi buffer (10 mM, pH 7.4, 2 mL) 
using 50.3 mW laser diode (458 nm). 
 The enhanced photocatalytic activity of FLPDA compared to the FLDA 
monomer can therefore be attributed to aromatic stacking and other intermolecular 
interactions between AR, PDA and flavin, similar to previously reported flavin-PPh3‐
functionalised gold nanoclusters,[179] which allows for favourable orientation for 
catalysis to occur (Figure 2.16). It is also possible that non-specific binding of AR to the 
PDA surface is responsible for a decrease in activity for FLPDA-10 (less flavin, more 
PDA) when compared with FLPDA-5 (less PDA, more flavin). 
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Figure 2.16: Possible intermolecular interactions between AR, PDA and flavin moiety 
that could enhance catalytic activity. 
2.4.2.2 Resazurin Photoreduction  
After successful demonstration of efficient photocatalytic activity of FLPDA towards 
oxidation, the photoreduction of resazurin (RZ) was then investigated. In this case, 
EDTA was utilised as the electron donor to first reduce flavin moieties within FLPDA to 
afford RF.[114,309] As with previous experiments, 10 μg/mL FLPDA-5 NPs (~10 mol% 
flavin) were irradiated with a blue laser diode (458 nm) at different excitation 
intensities now in the presence of RZ (25 μM) and EDTA (100 μM) in degassed 10 mM 
KPi buffer at pH 7.4 (2 mL) under N2 atmosphere. The spectral changes were then 
monitored in real time, following the decrease of RZ absorption at 602 nm and the 
increase of RF absorption at 572 nm (Figure 2.17A). Fast reduction of RZ substrate and 
production of RF was observed showing complete conversion after 4 min of irradiation 
(Figure 2.17B). Further decrease in RF concentration after 4 min can be attributed to 
the product bleaching.  
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Figure 2.17: Photoreduction of resazurin (RZ) to resorufin (RF) in the presence of 
FLPDA and EDTA. (A) Plot of the absorption changes observed for the photoreduction 
of RZ to RF by FLPDA-5 (10 μg/mL) in the presence of EDTA (100 μM) in KPi Buffer (10 
mM, pH 7.4, 2 mL). (B) Plot showing the relative consumption of RZ and production of 
RF by FLPDA-5 (10 μg/mL) in the presence of EDTA (100 μM) in KPi Buffer (10 mM, pH 
7.4, 2 mL). (C) Comparative plot of RZ photoreduction in presence of FLPDA 
photocatalysts and controls (10 μg/mL, [FLDA] - 10 mol%). All experiments were 
carried out under N2 atmosphere and using 458 nm light source with 6.40 mW/cm2 
excitation intensity. 
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 Control runs were also performed (Figure 2.17C) showing that PDA (10 μg/mL) 
displayed almost no activity whereas, some conversion of RZ to RF (0.58 µM/min 
compared to 5.7 µM/min for FLPDA-5) was observed in the blank measurement 
containing EDTA, but no catalyst. Such behaviour has been previously reported and is 
attributed to the interaction of triplet state RZ and electron dense tertiary aliphatic 
amines.[310] Irradiation of RZ without EDTA led to RZ bleaching and no conversion to 
RF. Following the trend observed in the photooxidation assay, the conversion was 
doubled for FLPDA-5 compared to FLPDA-10 due the larger number of flavin active 
sites. 10 mol% of FLDA showed 6 times lower reaction rate (0.95 µM/min) providing 
further evidence of the enhanced activity of FLPDA through substrate-PDA-flavin 
interactions. 
 Finally, the recyclability of FLPDA-5 was explored by removing the catalyst 
post-reaction via centrifugation. The catalyst was then washed and reused in 
subsequent reactions, maintaining good activity for up to 4 runs (see Figure 2.18). 
Note that increases in RF concentration for runs 2 and 3 are as a result of random 
experimental error. Due to the inherent losses experienced during catalyst recovery by 
washing/centrifugation future work should look at developing a continuous flow 
system using immobilised films of FLPDA. 
 
Figure 2.18: Recycling experiments for RZ photoreduction using FLPDA-5 (50 μg/mL) in 
the presence of RZ (0.2 mM) and EDTA (1 mM) in KPi buffer (0.1 M, pH 7.4) for 1 hour 
runs under Ar atmosphere. 
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2.4.3 Photostability and decomposition 
In order to fully characterise the photocatalytic activity of FLPDA NPs, the 
decomposition of the system under irradiation was explored due to the photostability 
issues of flavin compounds. Namely, upon irradiation the absorbance of flavin at ~445 
nm decreases due to dealkylation to either lumichrome or lumiflavin as well as scission 
of the isoalloxazine ring.[311]  
 As an initial assessment of the prepared flavin system’s stability, the 
photodegradation of monomer FLDA and its analogue FLOH was analysed to observe 
the effect of a catechol functionality. Homogeneous solutions of FLDA and FLOH were 
irradiated using 458 nm light (50.3 mW) under N2 atmosphere and in air over 30 mins 
at pH 7.4. Remarkably, in both air and under N2 atmosphere, FLDA exhibits almost no 
photodecomposition (Figure 2.19A and B) when compared to FLOH (Figure 2.19C and 
D). This could be explained by a stabilising charge-transfer process between 
isoalloxazine and catechol in a ‘closed’ conformation akin to FAD as rationalised based 
on the previous fluorescence quenching data (Figure 2.9). This process can stabilise the 
flavin by limiting the amount of degrading ROS formed in an aerobic environment 
which is clearly seen in the case of FLOH in air (Figure 2.19C). 
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Figure 2.19: Photostability of flavin compounds investigated by UV-Vis absorption. (A) 
FLDA in air (B) FLDA under N2 atmosphere, (C) FLOH in air, (D) FLOH under N2 
atmosphere. All experiments contained 0.5 mM flavin, 50 mM KPi buffer (pH 7.4) using 
458 nm light source with 6.40 mW/cm2 excitation intensity. 
 The same study was also performed for FLPDA-5 by recording the UV-Vis 
absorption and fluorescence spectra of the particles before and after 30 minutes 
irradiation, as well as the supernatant after centrifugation of washed particles (see 
Figure 2.20). The absorption spectra of the washed particles in both air and nitrogen 
still showed presence of characteristic flavin bands (Figure 2.20A) but the fluorescence 
of the particles after irradiation had decreased (Figure 2.20B). Analysis of the 
supernatant revealed an emission at ~524 nm that most likely indicates the presence 
of lumiflavin[311] or another detached flavin species (Figure 2.20A). The cleavage of 
flavin moieties from the particles could be remedied by the inclusion of a sacrificial 
electron donor, such as EDTA, which very effectively limited the extent of this 
degradation (Figure 2.20A and B).[102]  
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Figure 2.20: Changes in UV-Vis absorption and fluorescence of FLPDA-5 (50 μg/mL) 
after 30 min irradiation (50 mW, 458 nm) in KPi buffer (50 mM, pH 7.4) with or without 
EDTA (5 mM). (A) UV-Vis spectra of FLPDA-5 in air and under N2 atmosphere. (B) 
Fluorescence spectra of FLPDA-5 after irradiation in air and under N2 atmosphere and 
respective supernatants after centrifugation of particles (inset).  
 Despite the loss of some flavin species, analysis of FLPDA-5 particles by STEM 
showed no considerable changes to their size and shape after both photooxidation 
(Figure 2.21C and D) or photoreduction (Figure 2.21E and F).  
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Figure 2.21: STEM images of FLPDA-5 (A and B) before, (C and D) post photooxidation 
reaction and (E and F) post photoreduction reaction. 
 Overall, it is clear from these data that the incorporation of PDA does enhance 
photostability of the flavin moieties through the formation of charge-transfer 
complexes that increase its recyclability. 
2.4.4 Biocompatibility studies 
Finally, a preliminary investigation of the inherent toxicity of FLPDA nanoparticles 
using three in vitro assays was performed. First, FLPDA was PEGylated to increase the 
stability in cell culture media (DMEM) and to reduce immunogenicity when applied to 
future in vivo experiments.[312] This was achieved through the covalent attachment of 
amino terminated mPEG5000 to FLPDA by incubation in TRIS buffer (10 mM) at pH 8.5 
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for 18 h. Cell viability was investigated via MTS assay after 24 h of incubation with the 
particles. As shown in Figure 2.22 (black diamonds), PEG-FLPDA has a negligible effect 
on cell proliferation over a wide dosage range until the concentration of particles is 
significantly increased (to 1.0 mg/mL) at which point the viability is reduced to 54.6%. 
The cytotoxicity of PEG-FLPDA was also investigated using a lactate dehydrogenase 
(LDH) assay, which measures release of LDH and signals significant cell damage. This 
was only observed for very high concentration dosages of 1.0 mg/mL after incubation 
for 24 h (Figure 2.22, blue dots), correlating well to the MTS assay. 
 
Figure 2.22: Summary of in vitro assay data for A549 cells showing the MTS assay data 
for cell viability (black diamonds), LDH assay data for cytotoxicity (blue dots) and 
superoxide generation (red squares) in the presence of PEG-FLPDA after 24 h. 
 To compliment these assays, the effect of PEG-FLPDA on cell oxidative stress 
using a superoxide detection assay was explored to monitor the induction or 
scavenging of superoxide within the cells due to the presence of the particles. The data 
in Figure 2.22 (red squares) show that amount of superoxide decreases (relative to 
untreated controls) upon incubation with up to 10.0 µg/mL PEG-FLPDA . This indicates 
that FLPDA has antioxidant properties similar to  PDA and melanin.[193,203,313] However, 
at a concentration of 0.1 mg/mL, incubated cells showed an increased accumulation of 
superoxide, although this seems not to impact the viability of the cells. Decrease of the 
superoxide production again at 1.0 mg/mL is correlated to widespread cell death at 
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this high concentration. However, these three assays clearly indicate that FLPDA NPs 
are non-toxic below concentrations of 1.0 mg/mL, and even show an antioxidative 
effect below 0.1 mg/mL. This initial study indicates that flavin-polydopamine systems 
could be useful not only for photocatalysis, but for potential use in nanomedicine as 
antioxidant drug carriers or photosensitisers for photodynamic therapy and water 
remediation. 
2.5 Conclusion 
Hybrid flavin-polydopamine (FLPDA) nanoparticles were prepared by the 
copolymerisation of a flavin-catechol monomer (FLDA) and dopamine yielding a 
system displaying versatile photocatalytic activity. Using model redox substrates, it 
was shown that FLPDA is capable of efficient oxidative and reduction catalysis upon 
irradiation. The hybrid catalyst was significantly more efficient than the flavin-catechol 
monomer, FLDA which was rationalised by enzyme-like kinetic mechanism that is 
enabled by PDA. Excellent temporal control was achieved for the photooxidation of 
Amplex Red (AR) through the demonstrated ON and OFF activity upon irradiation. In 
addition, fast and efficient photoreduction of resazurin (RZ) was achieved in presence 
of EDTA as the electron donor, and the catalyst could be reused over 4 cycles without 
significant loss of activity. Furthermore, the photodecomposition of the catalyst was 
investigated showing that catechol conjugation improves flavin photostability through 
a charge-transfer process which was evidence by fluorescence quenching 
measurements. Finally, in vitro assays demonstrated the non-toxicity of the system 
and indicated some antioxidative properties. Combined, these data show that flavin-
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3 LIGHT-DRIVEN 




This chapter will discuss the application of flavin-polydopamine to a flavoenzyme-
specific oxidation reaction which has not been reported in flavin photocatalysis. The 
investigation will also explore the system’s ability to access key reactive flavin 
intermediates upon irradiation through the cooperation of polydopamine and flavin. 
 Flavin-containing monooxygenases (FMOs) are an important group of 
xenobiotic-degrading enzymes present in both eukaryotic and prokaryotic organisms. 
They can add molecular oxygen to the lipophilic xenobiotic compounds, thereby 
increasing their solubility to allow excretion. As a result, organisms are protected from 
potentially toxic exogenous compounds derived from natural sources and, particularly 
important for humans, the metabolism of drugs and pollutants.[314,315] One of the 
substrates for FMOs, which is also widespread in nature is the N-heterocycle indole. 
Indole is considered to be an aromatic pollutant due to its toxicity and potential 
mutagenicity,[316] but it is also a versatile intermediate species and signalling molecule 
across families of organisms.[317–320] FMOs, as well as the other xenobiotic-degrading 
enzymes such as cytochrome P450s, have been shown to convert indole to the blue 
indigo dye through initial oxidation to indoxyl and subsequent dimerization to form the 
dye as shown in Figure 3.1.  
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Figure 3.1: Indole oxidation to indoxyl by flavin-containing monooxygenase (FMO from 
S. pombe, PDB Entry - 2GVC) and subsequent oxidation by O2 and dimerization to 
indigo.[321,322] 
 This transformation has been utilized as an enzymatic assay to screen for 
oxygenases,[323–326] but also as a greener alternative to the industrial manufacture of 
indigo and related indigoid dyes.[327–329] Indigo dyes are currently commercially 
produced starting from aniline, formaldehyde, and hydrogen cyanide to form 
phenylglycinonitrile. This is subsequently hydrolysed to yield phenylglycine and finally 
indigotin.[330] This chemical synthesis involves use of toxic chemicals and extensive 
purification steps, limiting the environmental viability and has prompted the design of 
greener synthetic strategies.[331] For example, whole cell biocatalysis relying on 
intracellular FMOs within E. Coli has hence been utilised to achieve more sustainable 
production of indigo and indirubin dyes.[327–329] However, some major challenges in 
whole cell biocatalysis are complex product separation and catalyst inhibition, which 
incurs large costs and reactor downtime periods.[332] An alternative strategy is use the 
isolated enzyme, however this suffers from limited amounts of the enzyme that can be 
isolated, low stability under non-physiological conditions, sensitivity to organic 
solvents, as well as challenging post-reaction isolation and reuse, hence limiting large 
scale industrial applications.[333,334] 
 Taken out of a protein environment, flavin analogues derived from flavin 
mononucleotide (FMN), flavin adenine dinucleotide (FAD) and riboflavin cofactors 
have shown huge potential in FMO-like organocatalytic oxidation reactions, however 
few photocatalytic examples of FMO mimetic reactions exist.[68,69,335,336] Despite the 
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relative ease of visible-light driven flavin photocatalysis, high yielding reactions, and 
low toxicity, there are still challenges related to their photostability and stabilisation of 
reactive intermediates, as well as the separation of the catalyst from the products and 
subsequent catalyst reuse. To address these issues, attempts have been made to 
immobilize flavins onto various solid carriers such as silica beads or resins to achieve a 
heterogeneous catalytic systems, although limited success has been reported in 
relation to recyclability and activity.[75,168,170] Taking this into account, we have 
rationalised that the use of PDA -  an active polymeric carrier - which not only permits 
immobilization of flavin but also displays some intrinsic properties similar to proteins 
such as H-bonding and electron transfer, could significantly improve both the activity 
and post-reaction recovery of the hybrid catalytic system.  
 To that end, the FMO-like activity of flavin-polydopamine (FLPDA) towards the 
oxidation of indole to form indigo dye was investigated using blue light irradiation to 
excite the flavin moieties, bypassing the use of external reducing agents or cofactors 
such as NAD(P)H (Figure 3.2). It is envisaged that PDA will not only act as the flavin 
carrier but will also play an active catalytic role resulting in improved product 
selectivity and photocatalyst stability. 
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Figure 3.2: Structure of flavin-polydopamine (FLPDA) units and the reaction scheme 
illustrating explored light-driven oxidation of indole to indigo in presence of FLPDA 
nanoparticles. 
3.2 Experimental 
3.2.1 General information 
All materials were purchased from either Acros Organics (UK), Alfa Aeser (UK), Sigma-
Aldrich (UK) or TCI Chemicals (BE) in the highest purity available and used without 
further purification. UV-Vis absorption spectra were obtained with an Agilent Cary 300 
Spectrophotometer. Fluorescence emission spectra were obtained using a Varian Cary 
Eclipse Fluorescence Spectrophotometer using excitation and emission slits of 10 nm. 
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DLS and Zeta Potential measurements were recorded using a Zetasizer Nano Range 
instrument (Malvern Panalytical). FTIR spectroscopy was carried out using a Bruker 
Tensor 27 spectrometer with samples pressed into KBr pellets. STEM images were 
obtained using a Hitachi S-5500 In-Lens FE STEM (2009) at an acceleration voltage of 
1.0 kV. Samples were suspended in water and drop cast on lacey carbon copper grids 
(Agar Scientific). HPLC was carried out on an Agilent 1260 Infinity Quaternary LC 
equipped with a Zorbax Eclipse Plus C18 column (5 μm, 4.6 mm x 1.5 mm, Agilent) and 
diode array detector (monitoring at 270 nm). The mobile phase consisted of Solvent A 
(water + 0.1% formic acid) and solvent B (ACN/MeOH, 50:50, v/v) running along the 
following gradient: 0-8 min 85% A and 15% B at a flow rate of 1 mL/min, 8-15 min 65% 
A and 35% B at a flow rate of 2 mL/min. Indole (99%), isatin (97%) and oxindole (98%) 
were purchased from Sigma-Aldrich (UK) and calibration curves were obtained from 0 - 
1.0 mM stock solutions in order to estimate product concentrations and % 
conversions. LC-MS was performed on an Agilent G6550 QTof mass spectrometer 
coupled to an Agilent 1200 Series Infinity LC system using a Zorbax Eclipse Plus C18 
column (5 μm, 4.6 x 150 mm, Agilent). The mobile phase consisted of Solvent A (water 
+ 0.1% formic acid) and solvent B (ACN + 0.1% formic acid) running along the following 
gradient: 0-14 min 85% A and 15% B to 5% A and 95% B at a flow rate of 0.8 mL/min. 
The electrospray source was operated with a capillary voltage of 3.0 kV and a nozzle 
voltage of 1.0 kV. Nitrogen was used as the desolvation gas at a total flow of 14 L/min. 
All m/z values stated are that of the [M+H]+ molecular ion. 
3.2.2 Synthesis of FLDA 
Synthesis of FLDA was carried out as described in Chapter 2, Section 1.5.2. 
3.2.3 Synthesis of FLPDA 
FLPDA was synthesised as described in Chapter 2, Section 1.5.4 for FLPDA-5: A mixture 
of ammonia solution (0.1 mL, 28%), ethanol (1.5 mL) and Milli Q water (4.5 mL) was 
stirred at room temperature for 30 minutes in reaction vessels protected from direct 
sunlight. Dopamine hydrochloride (15.80 mg, 0.083 mmol) dissolved in Milli-Q water 
(0.5 mL) and FLDA (8.73 mg, 0.017 mmol) dissolved in ethanol (0.5 mL) were mixed 
before being added dropwise to the reaction mixture. The resulting dark brown/black 
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mixture was left to stir in the presence of air for 24 h. The mixture was then 
centrifuged at 25000 x g for 30 min and the supernatant was removed. The precipitate 
was washed with Milli-Q water (3 x 40 mL) and then suspended in Milli-Q water (20 
mL), frozen in liquid N2 and lyophilized to yield a dark brown/black powder (5.5 mg, ρ = 
22% where ρ is the percent weight conversion of monomers).[337] Characterisation of 
the particles by UV-Vis absorption spectroscopy, fluorescence spectroscopy, FTIR,  DLS, 
zeta potential and STEM matched with previously described results for FLPDA-5 
(Chapter 2, Section 2.3.1). Flavin content was approximated using the same method as 
described in Chapter 2, Section 2.5.5 to give an approximate FLDA content of ~ 1.0 
μmol/mg FLPDA. 
3.2.4 Photooxidation of indole 
General procedure: FLPDA (50 μg/mL, ~5 mol%) and indole (1.0 mM) were added to 
H2O/MeCN (1:1, v/v, 2 mL) and the mixture was saturated with O2 gas for 10 minutes 
before irradiating with a custom-made blue LED strips setup (12 V) with cooling fan to 
maintain a temperature of ~25 oC. 100 μL aliquots were taken from the reaction 
mixture and diluted to 1 mL (H2O/MeCN, 1:1) for analysis by UV-Vis absorption 
spectroscopy. Post-irradiation (2 – 6 h), the reaction mixture was either diluted in 
H2O/MeCN (1:1, 10 mL) and the catalyst removed by centrifugation and washed with 
water (3 x 12 mL) for further use, or the catalyst was removed by centrifugation and 
the supernatant was concentrated under reduced pressure. The residue was then 
either diluted in H2O/MeCN and analysed by HPLC-UV and LC-MS or dissolved in DMF 
and analysed by ESI-MS and UV-Vis absorption spectroscopy to quantify indigoid dye 
amounts. 
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3.2.5 LED reactor setup 
 
Figure 3.3: The setup was built drawing influence from the LED strips setup described 
by the MacMillan group.[338] Blue LED strips (12 V) were sourced from a commercial 
retailer and around 3 strips were stuck into the inside of a 15 cm diameter copper ring. 
This was then placed on top of a magnetic stirrer with a small gap to allow a vent for 
cooling which was supplied by a CPU fan. Vials were placed ~1 cm from the LED strips. 
3.2.6 Hydrogen peroxide assay 
H2O2 assay was carried out by first creating a standard calibration curve using Amplex 
Red (Ampliflu Red, Sigma-Aldrich, 100 µM), horseradish peroxidase (HRP, 0.25 µM) and 
H2O2 (0-100 µM). Phosphate buffer (pH 7.4) was used to adjust final well volumes to 
100 µL. A microplate reader (Tecan Spark) was used to record the fluorescence signals 
of the resorufin product (λex = 540 nm, λem = 585 nm). To determine H2O2 amounts 
after irradiation, an aliquot (50 µL) of a reaction mixture was taken and used under the 
same conditions as above, comparing the fluorescent intensity of resorufin to the 
calibration curve. All error bars are the standard deviation of triplicate data. 
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Figure 3.4: H2O2 calibration curve using Ampliflu Red + HRP assay. All error bars are the 
standard deviation of triplicate data. To exemplify the size of the error bars, an 
example data point is given at [H2O2] = 5.00 nmol whereby the fluorescence (A.U.) is 
25770 ± 393.15. 
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3.3 Results and Discussion 
3.3.1 Synthesis and characterisation of FLPDA 
FLPDA was synthesised as described in Chapter 2, Section 1.5.4 for FLPDA-5. 
Characterisation of the particles by UV-Vis absorption spectroscopy, fluorescence 
spectroscopy, FTIR, DLS, zeta potential and STEM matched with previously described 
results for FLPDA-5 (Chapter 2, Section 2.3.1). Flavin content was approximated using 
the same method as described in Chapter 2, Section 2.5.5 to give an approximate 
FLDA content of ~ 1.0 μmol/mg FLPDA. 
3.3.2 Indole photooxidation 
The light-driven monooxygenase activity of FLPDA nanoparticles (NPs) was initially 
investigated by irradiating an O2 saturated mixture of indole (1.0 mM) and FLPDA (50 
μg/mL, ~5 mol% flavin) in H2O/MeCN (1:1, v/v). This particular solvent system was 
chosen to guarantee high flavin photooxidation efficiency (quantum yield), which is 
known to be optimal in aqueous acetonitrile mixtures.[339,340] The reaction was 
monitored by UV-Vis absorption spectroscopy by taking aliquots (100 µL) of the 
reaction mixture at specific time intervals. As shown in Figure 3.5A the absorption 
spectrum of indole (0 h) has a characteristic absorbance band at λmax = 287 nm. After 
0.5 h irradiation, this peak decreases in intensity and a new band appears at λmax ~ 380 
nm which is consistent with the consumption of indole and the production of 2 and 3-
position hydroxylated indole species.[341–343] These bands increase in intensity with 
time and a shoulder replacing the characteristic band belonging to indole at 2 h 
indicates its consumption.[341] The fluorescence emission (λex = 365 nm) of the reaction 
was also monitored as shown in Figure 3.5B and observed the formation of fluorescent 
indoxyl species (λem = 465 nm) at 0.5 h and 1 h.[344,345] After 1 h the signal disappears 
most likely due to indoxyl dimerization into the fluorescent, water-soluble leuco-indigo 
(λem = 523 nm).[344,346]  
 Control experiments without FLPDA in the reaction mixture, under Ar 
atmosphere and using PDA  instead of FLPDA, and in the dark over 18 h, all showed 
negligible changes in indole’s characteristic absorption band (Figure 3.6A-D). 
Collectively, this data confirms that FLPDA is responsible for the oxidation of indole 
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and the reaction proceeds only in the presence of oxygen and light. In addition, the 
substrate shows good photostability under the reaction conditions employed. Note 
that increases in absorption prior to indole’s characteristic absorption band around 
300-700 nm are the result of light scattering phenomena caused by the presence of 
nanoparticles. 
 
Figure 3.5: Spectroscopic data of indole (1.0 mM) photooxidation by FLPDA (50 μg/mL) 
in O2 saturated H2O/MeCN (1:1, v/v, 2 mL).  (A) UV-Vis absorption spectra over 2 h, (B) 
Fluorescence emission spectra (λex = 380 nm) over 2 h, (C) UV-Vis absorption spectra of 
produced indirubin (λmax = 540 nm) and indigo (λmax = 610 nm) in DMF. 
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Figure 3.6: UV-Vis spectra of indole photooxidation control experiments over 2 h. 
Conditions: (A) reaction without irradiation (inset: spectrum of indole), (B) without 
FLPDA catalyst, (C) under Ar atmosphere, and (D) in the presence of PDA NPs (50 
μg/mL) instead of FLPDA. Scattering occurs due to presence of nanoparticles in 
samples. 
 Further analysis of the reaction mixture after photooxidation with FLPDA 
revealed multiple indole oxidation products. Three major oxidation products were 
identified by HPLC and LC-MS (Figure 3.7): isatin 4 (7.07 min, m/z: 148), 2-oxindole 2 
(7.69 min, m/z: 134) and indoxyl 3 observed as its more stable keto-form 3a (4.23 min, 
m/z: 132). Other products with higher m/z values were also identified, including 
indigo/indirubin (two signals with m/z: 263) and two others with m/z values of 249 and 
281. The structures of these products are proposed in Figure 3.7 and labelled as 
Chapter 3: Light-Driven Monooxygenase activity of Flavin-Polydopamine 
L. B. Crocker – August 2020   87 
species 5 and 6. Their formation is particularly interesting as they have been observed 
in reactions catalysed by enzymes such as laccases and cytochrome P450s, that contain 
inorganic cofactors such as copper and iron (heme) respectively.[342,347,348] 
 The formation of indigo and indirubin were first observed by thin layer 
chromatography (TLC) of the reaction mixture and were then isolated after reaction 
workup and characterized by UV-Vis (indirubin λmax = 540 nm and indigo λmax = 610 nm 
as seen in Figure 3.5C). It should be noted that theses dyes were not observed to form 
during the reaction itself, but could be obtained either upon removal of the solvent, 
which initiated precipitation, or with the addition of weak acid to the reaction mixture 
and supernatant which increased the rate of their formation.[349] Yields of the dyes 
were measured by UV-Vis spectroscopy using published extinction coefficients,[346] but 
were generally low (≤5%) when precipitated out of solution during solvent removal in 
vacuo. However, these low values are comparable to other biomimetic systems such as 
Fe(II) and Mn(III) porphyrin complexes used in the presence of H2O2.[342,350] Such low 
yields are most likely the consequence of the non-specific binding to the surface of the 
FLPDA catalyst as the active site of FMO, which ensures specific binding and increases 
the product selectivity.[327] It was observed that the addition of weak acid to the 
reaction mixture after irradiation gave better yields of dye, but results in the formation 
of indirubin rather than indigo. Indigo was only found to precipitate from the reaction 
mixture upon solvent removal in vacuo (see Figure 3.5C).  
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Figure 3.7: Proposed reaction scheme for indole photooxidation in presence of FLPDA 
nanoparticles. 
 
Figure 3.8: LC-MS chromatograms of major photooxidation products of indole in the 
presence of FLPDA nanoparticles. (A) 3a, (B) 2, (C) 4 and (D) indigo. 
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 The light-driven oxidation of indole by FLPDA is clearly non-specific due to the 
range of identified oxidation products, however, these main products resemble those 
formed by FMOs and other xenobiotic degrading enzymes. This work provides the first 
example of an organic nanoparticle-based photocatalyst that shows such activity. In 
addition, the only other example of photocatalytic oxidation of indole to form indigo 
and related compounds are CdS quantum dots, the use of which has serious 
implications in terms of toxicity.[351,352] 
 The apparent FMO-like activity of FLPDA was then compared to a 
homogeneous flavin photocatalyst, riboflavin (RBF). Flavin loading in the reactions 
were decreased in order to avoid excess light scattering by the heterogeneous NP 
system to give a more valid comparison between reactions. UV-Vis analysis of the 
reaction mixture containing RBF showed an increased rate of indole consumption 
(shoulder formation at ~ 280 nm) after 0.5 h (Figure 3.9A). HPLC analysis (Figure 3.10 
and Table 3.1) confirmed that there is greater conversion of indole in presence of RBF 
(97%) compared to FLPDA (79%). As seen in both Figure 3.10 and Table 3.1, similar 
oxidation products were observed for both reactions however the selectivity of 
product formation differs between the two catalysts.  RBF showed higher selectivity 
for compound 4 than FLPDA, whereas compound 2 was found in higher concentration 
with FLPDA than RBF. After addition of 2 drops of 1M HCl to each reaction supernatant 
to initiate dimerization of hydroxylated indole species to form indigoid dyes, the 
resulting yield of the dyes also differed. As shown in Figure 3.9B, there was more 
indirubin obtained from the reaction conducted in the presence of FLPDA than RBF, 
which was expected as 2.5 times more precursor 3a can be detected in HPLC profile 
(Figure 3.10). Clearly, despite the decreased indole conversion, FLPDA appears to be 
more selective towards dye formation than the homogeneous counterpart.   
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Figure 3.9: Spectroscopic data for indole (1.0 mM) photooxidation in the presence of 
riboflavin (RBF, 20 µM) in O2 saturated H2O/MeCN (1:1, v/v, 2 mL). (A) UV-Vis 
absorption spectra over 2 h, (B) Plot comparing the concentrations of indirubin from 
RBF and FLPDA catalysed indole photooxidations post acid workup. 
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Figure 3.10: HPLC chromatograms of reaction mixture after 2h irradiation of indole 
(1.0 mM) in the presence of FLPDA (20 μg/mL) or RBF (20 μM) in H2O/MeCN (1:1, v/v, 
2 mL). LC = lumichrome. 
Table 3.1: Amounts and conversions of major compounds identified by HPLC after 















213 22 60 79% 5% 
RBF (20 μM) 24 16 80 97% 1% 
a ([𝑖𝑛𝑑𝑖𝑔𝑜𝑖𝑑]  × 2/[𝑐𝑜𝑛𝑠𝑢𝑚𝑒𝑑 𝑖𝑛𝑑𝑜𝑙𝑒]) [353] with [indigoid] being determined by UV-Vis 
spectroscopy. 
 It is also worth noting that after the irradiation, RBF could no longer be 
identified by TLC analysis within the reaction mixture and had degraded to lumichrome 
(LC), which was confirmed both by HPLC and LC-MS (9.22 min, m/z: 243) (Figure 3.10). 
Lumichrome is one of the major photodecomposition products of RBF that is 
photocatalytically inactive.[311] Although lumichrome was also observed in the FLPDA 
catalysed reaction, its concentration was 5 times lower compared to RBF (based on 
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HPLC integration), indicating that the PDA-based catalyst offers more protection 
toward photodecomposition of active flavin centres, and mitigates the loss of the 
catalysts observed in homogeneous systems. 
3.3.3 Recyclability 
The reusability of FLPDA in the photooxidation reaction was examined as this is a 
desirable property for scale up and industrial applications enhancing the green 
chemistry potential of the system. Previous work on a heterogeneous flavin-based 
photocatalytic system using mesoporous silica to immobilize flavin moieties suffered 
from a severe loss of activity after the first reuse, and a complete inactivation upon 
second and third attempt.[168] For our nanoparticle-based system, the catalyst was 
easily removed from the reaction mixture via centrifugation and maintained activity 
for 4 cycles. As a proof of concept study, activity was monitored by irradiation of 
FLPDA particles (50 µg/ml) with indole (1.0 mM) for 1.5 h and measuring the changes 
in absorption of the reaction mixture between 300-600 nm as shown in Figure 3.11. 
The area within this region was integrated and used as a measure for oxidized indole 
species production. The first run showed a decrease in relative activity compared to 
the initial run only by a factor of 1.36 (Figure 3.11B) and the subsequent three runs 
stayed within a similar range before minimum activity, although not a complete loss, 
was observed by run 6.  
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Figure 3.11: Study of FLPDA catalyst recyclability. Reaction conditions: indole (1.0 
mM), FLPDA (50 μg/mL) in O2 saturated H2O/MeCN (1:1, v/v, 2 mL) and irradiation for 
1.5 h. (A) UV-Vis absorption spectra of different runs using recycled catalyst and (B) the 
relative activity plot using the integrated area between 300-600 nm of each run. (C) 
and (D) STEM images of FLPDA particles after 2 h irradiation.  
 The enhanced stability of flavin-polydopamine has already been 
demonstrated in Chapter 2 through charge-transfer processes, which has now been 
proved to be an asset in this enzyme-specific transformation. As mentioned previously 
(Section 3.3.2), HPLC analysis of the reaction mixture catalysed by FLPDA showed the 
formation of lumichrome. This indicates that N10-dealkylation of flavin from PDA 
occurs and hence, decreases the catalytic activity of the nanoparticles. Loss of activity 
during recycling can therefore be in part attributed to this process. It was also 
observed that less particles were retrieved after each centrifugation step which could 
be due to the inherent inefficiencies of the centrifugation process and/or the 
degradation of PDA similar to the reported photodecomposition of melanin.[354] 
However, no considerable differences in particle size and morphology were observed 
after 2 h of irradiation as seen in Figure 3.11C and D which disputes this argument – 
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indicating that loss of particles during centrifugation procedures is the main proponent 
for this observed decrease in material retrieval. It is envisioned that the reusability of 
FLPDA could be improved by addition of magnetic iron oxide nanoparticles to enable 
magnetically aided retrieval, which has already proven effective in various application 
using PDA.[210,211,216,355] 
3.3.4 Further control experiments and possible mechanism of action 
The photocatalytic mechanism of indole photooxidation by FLPDA was investigated by 
the addition of reactive oxygen species (ROS) scavengers. Flavins are well known to 
produce singlet oxygen and superoxide ROS upon photoexcitation and it can be 
assumed that one or a combination of these species is responsible for FLPDA’s 
oxidative activity towards indole.[356,357] (2,2,6,6-Tetramethylpiperidin-1-yl)oxyl 
(TEMPO) was employed as a superoxide scavenger and 1,4-diazabicyclo[2.2.2]octane 
(DABCO) was used to quench singlet oxygen species. As can be seen from the HPLC 
chromatograms of the reactions (Figure 3.12), the addition of these quenchers did not 
appear to inhibit the reaction completely. In fact, it was observed that in the case of 
DABCO, the basic character of the species may have played a role in lowering the 
activity of FLPDA as flavins and PDA are less stable within a basic environment.[358,359] 
In terms of product selectivity, compound 3a was not detected most likely due to 
further oxidisation to isatin 4 which was present at a high concentration of 252 μM as 
a result of the more basic environment (Table 3.2). Based on these observations it 
could be assumed that singlet oxygen plays a minimal role in FLPDA activity as both 
compounds 2 and 4 are obtained in the presence of singlet oxygen quencher. 
 The addition of the superoxide scavenger TEMPO had no deleterious effect on 
FLPDA activity either and in fact, it enhanced the production of 2, 3a and 4 when 
compared to FLPDA alone. TEMPO most likely acts as a redox mediator and co-catalyst 
in the reaction as previously shown for the synthesis of isatin derivatives in the 
presence of hypervalent iodine.[360] TEMPO’s participation in the reactions was 
additionally proved by appearance of the by-product 2,2,6,6-tetramethylpiperidine 
(TMP) at a retention time of 2.49 min, m/z: 142 (LC-MS analysis). It should be noted 
that melanin, which is closely related to PDA, is capable of superoxide radical 
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quenching and it can therefore be assumed that any superoxide radical generated by 
flavin would be quickly quenched by PDA in its immediate proximity.[361] 
 
Figure 3.12: Effect of ROS scavengers on indole photooxidation by FLPDA. HPLC 
chromatograms of reactions irradiated for 2 h in the presence of FLPDA (50 μg/mL) 
and indole (1.0 mM) with singlet oxygen scavenger DABCO (1.0 mM) or superoxide 
scavenger TEMPO (1.0 mM) in H2O/MeCN (1:1, v/v, 2 mL). 
Table 3.2: Amounts and conversions of major compounds identified by HPLC after 
acidification of reaction mixture using commercial standards as external calibration 
references. 







TEMPO 177 278 121 82% 
DABCO 326 143 252 67% 
 
 The mechanism of FLPDA’s photocatalytic activity was further investigated by 
using a fluorescence-based assay to monitor the release of H2O2 in the reaction. H2O2 
is released from the unstable C4a-hydroperoxy-flavin species that forms when reduced 
flavins interact with oxygen.[362] It can therefore be assumed that the concentration of 
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H2O2 detected in the reaction indicates the amount of stabilisation the C4a-
hydroperoxy-flavin species receives. Therefore, the concentration of H2O2 was 
determined for the FLPDA and RBF catalysed photooxidation of indole to be 3.62 ± 
0.18 nmol and 5.13 ± 0.04 nmol respectively (Figure 3.13). The lower value obtained 
for FLPDA suggests potential stabilisation of the C4a-hydroperoxy flavin species by 
PDA, however, this would need to be further characterised by in-situ EPR or NMR 
spectroscopy. 
 
Figure 3.13: H2O2 concentrations from FLPDA and RBF photooxidation of indole. 
Reaction conditions: indole (1.0 mM), FLPDA (20 μg/mL) or RBF (20 μM) in H2O/MeCN 
(1:1, v/v, 2 mL) irradiated for 1h. Error bars are the standard deviation of triplicate 
data. 
 Based on these data, the mechanism shown in Figure 3.14 is proposed. 
Photoexcitation of flavin moieties generates a singlet state flavin that undergoes 
intersystem crossing (ISC) to form the reactive triplet state flavin. PDA features 
tryptophan and tyrosine mimetic residues that have been shown to play a crucial role 
in biological signalling pathways through electron transfer to flavin. It is therefore likely 
that 3FL* can interact with indole and/or PDA resulting in electron transfer to flavin. 
Reduced flavin hydroquinone (FLhq) can then interact with molecular oxygen to form 
C4a-hydroperoxy flavin (FLOOH). Our data suggests that this species is most likely 
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therefore able to hydroxylate indole that is favourably adhered to the FLPDA surface 
via π-interactions. It is noteworthy to mention that the stabilisation of such 
(hydro)peroxy flavin species has also been achieved using H-bonding residues in dark 
catalytic flavin systems.[58,163] Finally, water is eliminated to regenerate oxidized flavin. 
Additionally, it is expected that Type 1 photosensitisation reactions take place in a 
similar fashion to that observed between lumiflavin and indole,[363] as well as RBF and 
tryptophan.[364] In this scenario, radical oxidised indole species (neutral or radical 
cation) are formed that can undergo further oxygenation by ROS or molecular oxygen 
and can also explain the formation of adducts 5 and 6. 
 
Figure 3.14: Proposed mechanism of action involving electron transfer process 
between flavin (FL) and PDA moieties within FLPDA catalyst. 
3.4 Conclusion 
Flavin-polydopamine (FLPDA) has been shown to effectively display activity analogous 
to xenobiotic-degrading enzymes such as FMO evidenced by the oxidation reaction of 
indole to form indigo dye. It is the first time that a flavin photocatalytic system has 
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demonstrated this activity. Interestingly, the nanoparticle FLPDA system displayed five 
times higher selectivity towards indigoid dye formation than homogeneous riboflavin 
photocatalyst, and enhanced photostability demonstrated by a decrease in lumiflavin 
formation. In addition, FLPDA displays recyclable activity up to four cycles. ROS 
scavenging experiments were carried out to identify key species involved in FLPDA’s 
photooxidation mechanism, revealing that neither superoxide nor singlet oxygen were 
solely responsible for indole oxidation. Subsequently, an H2O2 assay discovered that 
FLPDA released less H2O2 in the reaction when compared to homogeneous riboflavin. 
This points towards the stabilisation of C4a-hydroperoxy-flavin as a reactive 
intermediate in the reaction mechanism and rationalises FLPDA’s higher product 
selectivity towards indigo dye formation. The formation of this reactive intermediate is 
usually conserved for natural FMOs due to H-bonding stabilisation by amino acid 
residues. Our hypothesis that polydopamine would enable flavin activity similar to its 
natural enzyme counterpart has therefore been successfully demonstrated. 
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4 INVESTIGATING THE LIGHT-




The diversity of flavoenzyme activity is enabled by their ability to undergo one- or two- 
electron transfer processes with substrates, ranging from oxidations, halogenations, C-
C bond formation, as well as a range of reduction reactions.[365–369] Two distinct 
flavoenzyme classes involved in the catalysis of reduction reactions are the 
azoreductases (AzoRs) and ene-reductases (ERs).[18,19,370–374] Photocatalytic examples 
of reduction reactions using artificial flavin systems are very limited, so this chapter 
aims to develop a methodology to utilise flavin-polydopamine as a photocatalyst for 
reductase type reactions. 
4.1.1 Azoreductase activity and applications 
AzoRs have been identified within various microorganisms as critical enzymes in the 
biotransformation and detoxification of carcinogenic azo dyes, nitro-aromatic and azo-
containing drugs (Figure 4.1). Consequentially, such microorganisms have been applied 
to wastewater treatment processes.[375] They are most commonly characterised by a 
flavin cofactor (FMN/FAD), NAD(P)H dependency, operating in a range of pH, 
temperatures and in aerobic and anaerobic environments. Their substrate scope is 
broad and are not conserved to just reducing azo bonds, also displaying the ability to 
reduce nitro bonds in some cases.[376] With these factors in mind, the usefulness of 
AzoR containing microorganisms for wastewater treatment is very clear, however they 
are limited by running costs, contamination, nutrient addition/recycling and often the 
aromatic amine products from azo dye degradation are more toxic than the azo dye 
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itself.[377] The latter can be avoided by the addition of laccase-containing microbes that 
provide further detoxification via free-radical oxidation.[377,378]  
 The reduction of aromatic azo and nitro bonds is also very useful in synthetic 
organic chemistry and widely employed reactions to access primary aromatic amines 
for further functionalisation towards drugs and other compounds of commercial 
interest. This has historically been catalysed by metals such as Pd and Pt,[379] but 
biocatalytic,[374] and photocatalytic examples provide a greener methodology to 
achieve such transformations.[380,381] There are however almost no examples of flavin 
photocatalysis for azo or nitro bond reduction, with the exception of the 
photoreduction of 4-nitrophenyl phosphate.[382] We therefore saw the demonstration 
of AzoR activity as a crucial assay to initially highlight the reductive capacity of flavin-
polydopamine and identify potential application in water remediation and 
photocatalysis. 
 
Figure 4.1: General reaction scheme of characteristic azoreductase (AzoR from E. Coli, 
PDB Entry - 1V4B) transformations of aromatic azo and nitro containing compounds to 
aromatic amine products. 
4.1.2 Ene-reductase activity and applications 
Ene-reductases (ERs) are flavin and NAD(P)H dependent enzymes found in Nature 
within the ‘Old Yellow Enzyme’ (OYE) family widely distributed in bacteria, fungi and 
plants. In fact, OYE from Baker’s Yeast was the first flavin-dependent enzyme to be 
identified in 1932 by Warburg & Christian and since then, the OYE family has been 
revitalised in the literature of the 21st century thanks to their new-found role in 
biocatalysis by providing green methodology to asymmetric olefin reduction.[18,19,383]  
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 ERs are characterised by the ability to reduce activated C=C bonds such as 
α,β-unsaturated carbonyl species with excellent enantioselectivity (Figure 4.2). The 
mechanism of substrate reduction by ERs follows an overall trans-addition of [H2] 
through hydride transfer from the reduced anionic flavin hydroquinone (FLhq–) to the 
substrate’s β‐C position via a Michael‐type addition. Protonation occurs at the α‐C 
position by a tyrosine residue leaving the reduced product and oxidised flavin moiety. 
A new catalytic cycle is then initiated by NAD(P)H reduction of the oxidised 
flavin.[384,384] 
 
Figure 4.2: General reaction scheme and mechanism of characteristic ene-reductases 
(ER - OYE1 mutant, PDB Entry - 3TXZ) transformations of activated C=C bonds to chiral 
saturated products. R = ribityl phosphate, EWG = electron withdrawing group 
(aldehyde, ketone carboxylic acid, ester, nitrile, nitro etc.)[18,19] 
 This dependency on NAD(P)H however, is one of the major limitation for ERs 
(and many enzymes in general) to achieve efficient and sustainable biocatalytic 
reductions. Consequentially, the need for NAD(P)H has been removed through light-
driven activation of ERs (photobiocatalysis) using sensitizers such as flavins, transition 
metal complexes or nanoparticles.[119,121,122,124,385–388] Poor flavin photostability within 
the enzyme has unfortunately limited the scale-up of these methodologies.[389] Despite 
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this, direct illumination of ER enzymes has granted access to unnatural asymmetric 
radical chemistry, a strategy recently developed by the Hyster group.[137–139] 
 It has yet to be shown whether enzyme-free flavin photocatalysis can 
effectively display ER activity in a biomimetic fashion, whereby FLhq is accessed to 
transfer hydride following flavin photoreduction by a sacrificial electron donator 
species as depicted in Figure 4.3. Our aim was to develop a flavin-polydopamine 
nanoparticle system that could effectively display ER activity under irradiation utilising 
sacrificial electron donors to reduce the flavin groups and undergo hydride transfer to 
a substrate akin to the enzymatic mechanism. Additionally, the possibility of achieving 
enantioselective transformations - a hallmark in biocatalysis - would be an extremely 
powerful methodology, avoiding the use of NAD(P)H and need of a specific protein 
make-up. To that end, a chiral riboflavin-polydopamine nanoparticle conjugate 
(RCPDA) was prepared in order to investigate ER activity. 
 
Figure 4.3: Proposed reaction mechanism of light-driven ene-reductase (ER) activity. 
ED = electron donor. 
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4.2 Experimental 
4.2.1 General information 
All materials were purchased from either Acros Organics (UK), Alfa Aeser (UK), Sigma-
Aldrich (UK) or TCI Chemicals (BE) in the highest purity available and used without 
further purification. RTA was synthesised from (-)-riboflavin (from Eremothecium 
ashbyii, ≥98%, Sigma-Alrich, UK) according to the literature procedure by Metternich et 
al.[180] tert-Butyl (2-bromoethyl)carbamate (4) was prepared according to the literature 
procedure by Luescher et al.[390] S-Acetyl protected Captopril (7) was prepared 
according to the literature procedure by Li et al.[391] PDA NPs were prepared according 
to the literature procedure by Ai et al.[204] rac-1b was prepared by Pd/C hydrogenation 
according to the literature procedure by Hall et al. and used for GC-MS calibration.[392] 
rac-2b was prepared by Pd/C hydrogenation according to the literature procedure by 
Gonçalves et al. and used for GC-MS calibration.[131]  
 1H and 13C NMR measurements were carried out using a 500 MHz DCH Cryoprobe 
Spectrometer. HRMS was recorded on a ThermoFinnigan Orbitrap Classic (Fisher 
Scientific). UV-Vis absorption spectra were obtained with an Agilent Cary 300 
Spectrophotometer. Fluorescence emission spectra were obtained using a Varian Cary 
Eclipse Fluorescence Spectrophotometer using excitation and emission splits of 5 nm 
or 10 nm. DLS and zeta potential measurements were recorded using a Zetasizer Nano 
Range instrument (Malvern Panalytical). SEM images were obtained using a FEI Helios 
SEM at an acceleration voltage of 2.0 kV. Samples were suspended in water and drop 
cast on lacey carbon copper grids (Agar Scientific). GC-MS (Agilent Technologies 7890B 
GC, 5977A MSD) was performed using an HP-Innowax Agilent column (19091N-133, 30 
m x 0.25 mm, 0.25 µm): split 20, flow 40.0 mL min−1, injector: 220°C, detector: 250°C. 
Temperature programme: 110°C hold for 2 min, to 240°C at 20°C min−1, hold for 10 
min. Retention times: 1a = 9.433 min, 1b = 10.615 min; 2a = 4.786 min, 2b = 5.332 min. 
Chiral HPLC analysis was carried out using an Agilent 1260 Infinity Quaternary LC 
equipped with a Chiralcel OD column (10μm, 4.6 mm x 250 mm, Diacel) and diode 
array detector (monitoring at 254 nm). The mobile phase consisted of hexane/i‐PrOH 
(9:1) with retention times: (R)‐1b and (S)‐1b at 20.0 min and 22.0 min, respectively.[393]  
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4.2.2 Synthesis of RFCPT 
(2S,3R,4R)-5-(3-(2-((tert-Butoxycarbonyl)amino)ethyl)-7,8-dimethyl-2,4-dioxo-3,4-
dihydrobenzo[g]pteridin-10(2H)-yl)pentane-1,2,3,4-tetrayl tetraacetate (5): 
 
RTA (1.0 g, 1.84 mmol, 1.0 equiv.) and 5 (2.06 g, 9.18 mmol, 5.0 equiv.) were dissolved 
in dry DMF (18.4 mL) before Cs2CO3 (897.5 mg, 2.75 mmol, 1.5 equiv.) was added. The 
resulting suspension was stirred at room temperature under Ar atmosphere and in the 
dark for 18 h. The reaction mixture was then diluted with water (20 mL) and EtOAc (20 
mL), the aqueous phase was extracted with EtOAc (3x 20 mL) and the combined 
organic phases were dried over Na2SO4 before the solvent was removed in vacuo. 
Purification by silica gel column chromatography (1% MeOH/DCM) yielded the product 
2 as an orange sticky solid (1.07 g, 1.55 mmol, 84%). 
1H NMR (500 MHz, CDCl3) δ = 7.86 (s, 1H, H8), 7.45 (s, 1H, H10), 5.51 (br. m, 1H, H14), 
5.34 (br. m, 1H, H15), 5.27 (br. m, 1H H16), 5.18 (br. s, 1H, -NH-), 4.92 (br. s, 2H, H13), 
4.31 (dd, J = 12.4, 2.7 Hz, 1H, H17), 4.11 (m, 3H, H17, H26), 3.34 (br. m, 2H, H27), 2.44 
(s, 3H, H11), 2.31 (s, 3H, H12), 2.14 (s, 3H, H22/23/24/25), 2.09 (s, 3H, H22/23/24/25), 
1.94 (s, 3H, H22/23/24/25), 1.62 (s, 3H, H22/23/24/25), 1.23 (s, 9H, H30) ppm. 
13C NMR (500 MHz, CDCl3) δ = 170.6 (C18/19/20/21), 170.2 (C18/19/20/21), 169.8 
(C18/19/20/21), 169.7 (C18/19/20/21), 160.0 (C2), 156.0 (C28), 155.1 (C1), 149.0 (C3), 
147.8 (C4), 136.7 (C5), 135.4 (C6), 134.6 (C7), 132.6 (C8), 131.3 (C9), 115.5 (C10), 78.9 
(C29), 70.2 (C15), 69.3 (C14), 69.0 (C16), 61.7 (C17), 44.4 (C13), 41.4 (C27), 39.7 (C26), 
28.2 (C30), 21.4 (C11), 20.9 (C22/23/24/25), 20.7 (C22/23/24/25), 20.6 
(C22/23/24/25), 20.3 (C22/23/24/25), 19.4 (C12) ppm. 
HRMS (ESI) m/z: [M + H]+ Calcd for C32H42O12N5 688.2824; Found 688.2830. 
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(2S,3R,4R)-5-(3-(2-Aminoethyl)-7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-
10(2H)-yl)pentane-1,2,3,4-tetrayl tetraacetate (6): 
 
Trifluoroacetic acid (4 mL) was added dropwise to a solution of 2 (1.03 g, 1.50 mmol) in 
DCM (20 mL) at 0 oC. The resulting mixture was left to warm to room temperature and 
stirred for 4 h. The solvent was then removed in vacuo and residue co-evaporated with 
toluene (3 x 20 mL) to remove excess trifluoracetic acid, yielding an orange oil (871.2 
mg, 1.48 mmol, 99%). 
1H NMR (500 MHz, CDCl3) δ = 7.94 (s, 1H, H8), 7.50 (s, 1H, H10), 5.57 (dt, J = 9.7, 2.8 
Hz, 1H, H14), 5.47 (dd, J = 7.7, 2.2 Hz, 1H, H15), 5.39 (br. m, 3H H16, -NH2), 4.98 (br. s, 
2H, H13), 4.50-4.33 (m, 3H, H17, H26) 4.23 (dd, J = 12.5, 5.1 Hz, 1H, H17), 3.52 (br. m, 
2H, H27), 2.50 (s, 3H, H11), 2.39 (s, 3H, H12), 2.19 (s, 3H, H22/23/24/25), 2.17 (s, 3H, 
H22/23/24/25), 2.05 (s, 3H, H22/23/24/25), 1.65 (s, 3H, H22/23/24/25) ppm. 
13C NMR (500 MHz, CDCl3) δ = 171.5 (C18/19/20/21), 170.8 (C18/19/20/21), 169.7 
(C18/19/20/21), 169.6 (C18/19/20/21), 160.8 (C1), 156.1 (C2), 149.0 (C3), 147.9 (C4), 
137.2 (C5), 135.3 (C6), 134.9 (C7), 132.5 (C8), 131.5 (C9), 115.7 (C10), 70.0 (C15), 69.5 
(C14), 69.0 (C16), 61.6 (C17), 44.4 (C13), 39.6 (C26), 39.1 (C27), 21.5 (C11), 21.0 
(C22/23/24/25), 20.7 (2C, C22/23/24/25), 20.3 (C22/23/24/25), 19.3 (C12) ppm. 
HRMS (ESI) m/z: [M + H]+ Calcd for C27H34O10N5 588.2300; Found 588.2287. 
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(2S,3R,4R)-5-(3-(2-((S)-1-((S)-3-(acetylthio)-2-methylpropanoyl)pyrrolidine-2-
carboxamido)ethyl)-7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-
yl)pentane-1,2,3,4-tetrayl tetraacetate (5): 
 
4 (450 mg, 1.74 mmol, 1.0 equiv.), 3 (1.22 g, 2.08 mmol, 1.2 equiv.) and HATU (1.32 g, 
3.47 mmol, 2 equiv.) were dissolved in dry DMF (20 mL) under Ar atmosphere. A 
solution of DIPEA (0.60 mL) in dry DMF (5 mL) was added dropwise and the reaction 
was left to stir at room temperature for 18 h in the dark. The reaction was then diluted 
with water (30 mL) and EtOAc (30 mL) the aqueous phase was extracted with EtOAc 
(3x 30 mL) and the combined organic phases were dried over Na2SO4 before the 
solvent was removed in vacuo. Purification by silica gel column chromatography (1-3% 
MeOH/DCM) yielded the product 5 as a yellow waxy solid (1.07 g, 1.55 mmol, 84%). 
1H NMR (500 MHz, CDCl3) δ = 7.96 (s, 1H, H8), 7.51 (s, 1H, H10), 7.05 (br. t, J = 5.4 Hz, -
NH-), 5.61 (br. m, 1H, H14), 5.42 (br. m, 1H, H15), 5.38-5.35 (m, 3H H16), 4.89 (br. s, 
2H, H13), 4.41-4.38 (m, 2H, H17, H29), 4.27-4.13 (m, 3H, H17, H26), 3.71-3.66 (m, 1H, 
H32), 3.61-3.57 (m, 1H, H32), 3.49-3.40 (m, 2H, H27), 3.06-2.89 (m, 1H, H36), 2.85-2.75 
(m, 2H, H36, H34), 2.52 (s, 3H, H11), 2.40 (s, 3H, H12), 2.26-2.14 (m, 10H, 
H22/23/24/25, H30/31), 2.03 (s, 3H, H22/23/24/25), 1.84 (br. m, 3H, H30/31), 1.70 (s, 
3H, H22/23/24/25), 1.21-1.16 (m, 3H, H35) ppm. 
13C NMR (500 MHz, CDCl3) δ = 196.1 (C37), 174.5 (C33), 171.8 (C18/19/20/21), 170.7 
(C18/19/20/21), 170.3 (C28), 169.8 (C18/19/20/21), 169.7 (C18/19/20/21), 160.2 (C1), 
155.3 (C2), 149.2 (C3), 147.7 (C4), 136.7 (C5), 135.7 (C6), 134.7 (C7), 132.8 (C8), 131.2 
(C9), 115.4 (C10), 70.4 (C15), 69.3 (C14), 69.0 (C16), 61.9 (C17), 59.9 (C29), 47.2 (C32), 
44.5 (C13), 41.3 (C26), 38.8 (C27), 38.3 (C34), 32.2 (C36), 30.6 (C38), 27.9 (C30), 24.8 
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(C31), 21.4 (C11), 21.1 (C22/23/24/25), 20.8 (C22/23/24/25), 20.7 (C22/23/24/25), 
20.4 (C22/23/24/25), 19.5 (C12) 16.9 (C35) ppm. 





Compound 5 (100 mg, 0.121 mmol) was dissolved in degassed 1M HCl (10 mL) and 
stirred overnight at 60 oC for 18 h under Ar atmosphere in the dark. The solvent was 
removed in vacuo and the resulting orange residue was recrystallised from ethanol to 
give an orange solid (66.3 mg, 0.071 mmol, 59%). 
1H NMR (500 MHz, DMSO-d6) δ = 7.95 (s, 2H, H8, H10), 7.84 (br. t, J = 5.2 Hz, -NH-) 7.50 
(s, 1H, H10), 5.14 (br. m, 1H, H15OH), 4.97 (br. m, 1H, H13), 4.89 (br. m, 1H, H16OH), 
4.78 (br. s, 1H, H14OH), 4.65 (d, 1H, J = 12.0 Hz, H13), 4.51 (t, J = 5.5 Hz, 1H, H17OH), 
4.26 (br. s, 1H, H14), 4.20-4.13 (m, 1H, H21) 4.07-3.90 (m, 2H, H24), 3.65 (m, 3H, 
H15/16/17), 3.54-3.43 (m, 3H, H17, H18), 3.26 (m, 2H, H19), 2.76-2.54 (m, 2H, 
H26/28), 2.49 (s, 3H, H11), 2.41 (s, 3H, H12), 2.38-2.30 (m, 1H, H26/28), 2.25-2.05 (m, 
1H, H22, H23), 1.95-1.77 (m, 3H, H22, H23), 1.05 (m, 3H, H27) ppm. 
13C NMR (500 MHz, DMSO-d6) δ = 172.8 (C25), 171.8 (C20), 159.8 (C1), 154.9 (C2), 
149.5 (C3), 146.4 (C4), 136.0 (2C, C5, C6), 134.4 (C7), 132.1 (C8), 130.8 (C9), 117.6 
(C10), 73.7 (C15), 72.9 (C14), 69.0 (C16), 63.5 (C17), 59.5 (C21), 47.2 (C13), 46.9 (C24), 
41.2 (C26), 40.5 (C18), 36.5 (C19), 29.2 (C22), 27.3 (C28), 24.3 (C23), 20.9 (C11), 18.9 
(C12), 16.7 (C27) ppm. 
HRMS (ESI) m/z: [M + H]+ Calcd for C28H39O8N6S1 619.2545; Found 619.2534. 
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4.2.3 Synthesis of RCPDA 
PDA NPs (PDA-1 or -2, 0.1 mg/mL) were suspended in a solution of TRIS buffer (10 
mM, pH 8.0, 20 mL) and the solution was sparged with Ar gas for 15 min before adding 
dropwise a degassed solution of RFCPT (1-5 mg per mg of PDA). The mixture was 
stirred for 18 h under Ar atmosphere and in the dark. The reaction mixture was then 
centrifuged (15000 rpm for 15 min) and resulting precipitate was washed three times 
with Milli-Q water by centrifugation (15000 rpm for 15 min). The resulting particles 
were then resuspended in Milli-Q water to an approximate concentration of 0.2 
mg/mL and stored at room temperature. 
4.2.4 Homogeneous photoreactions 
General procedure: A mixture of substrate (1-3a, 10 mM) and flavin photocatalyst (10 
mol%) in buffer/MeCN (3:1, v/v, 2 mL) was sparged with Ar gas for 15 min and sealed 
using airtight septa with an Ar balloon. The reaction mixture was then irradiated with a 
450 nm EvoluChem 18W LED (Figure 4.4) for 16-18 h using a cooling fan to maintain 
room temperature. Reaction mixtures were then diluted with Et2O and filtered 
through SiO2 with top a layer of Na2SO4 to remove the flavin. Combined washes were 
then concentrated in vacuo and analysed by GC-MS using limonene internal standard 
or 1H NMR to determine conversion and yield. 
4.2.5 Nanoparticle photoreactions 
General procedure: A mixture of substrate (1-2a, 1 mM) and RCPDA (0.1 mg/mL) in 
buffer/MeCN (3:1, v/v, 2 mL) was sparged with Ar gas for 15 min and sealed using 
airtight septa with an Ar balloon. The reaction mixture was then irradiated with a 450 
nm EvoluChem 18W LED (Figure 4.4) for 24 h using a cooling fan to maintain room 
temperature. The resulting mixture was extracted using EtOAc (3 x 5 mL), dried over 
Na2SO4 and concentrated in vacuo. The resulting residue was re-dissolved in EtOAc (1 
mL) to be analysed by GC-MS using limonene internal standard to determine 
conversion and yield. After analysis, the sample was concentrated in vacuo and re-
dissolved in IPA/Hexane (1:1, 0.5 mL) and analysed by chiral HPLC using a Chiralcel-OD 
column for enantioselective excess (ee) determination. 
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4.2.6 LED emission profile 
 
Figure 4.4: Emission spectrum of EvoluChem LED used for photoreactions (450 nm, 
18W). 
4.2.7 Fluorescence intensity calibration 
Two fluorescence intensity calibration curves (A and B) were utilised to approximate 
flavin wt% loading for RCPDA samples. Triplicate dilutions of RFCPT in water were 
measured with 50 μg/mL PDA to account for excitation/emission absorbance by PDA.  
Table 4.1: Correlation data from fluorescence calibration A and B. Error was calculated 
from the standard deviation of triplicate data. 
RCPDA 
Average Intensity (A.U.) 





1 95.84 A 0.58 ± 0.05 1.2 ± 0.1 
2 150.86 A 0.92 ± 0.05 1.8 ± 0.1 
3 49.05 B 1.87 ± 0.19 3.7 ± 0.4 
 
A For RCPDA-1 and -2, calibration A was used with spectrometer excitation and 
emission slits set at 10 nm:  


























         450nm LED 18W
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B For RCPDA-3 calibration B was used with spectrometer excitation and emission slits 
set at 5 nm:  
 
  



















λmax = 528 nm (with 50 μg/mL PDA)




















λmax = 528 nm (with 50 μg/mL PDA)
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4.3 Results and Discussion 
4.3.1 Azoreductase activity 
The azo dyes, Amaranth (AMT) and Naphthol Blue Black (NBB) were chosen as proof-
of-concept substrates to initially investigate the reductase activity of FLPDA upon blue 
light irradiation in the presence of a sacrificial electron donor (Figure 4.5A). EDTA is 
commonly used as a sacrificial electron donor to reduce flavins and 
flavoenzymes,[114,309,394,395] however its oxidation products have been shown to be 
detrimental to photocatalytic systems by interacting with the catalyst itself.[309,396,397] 
To avoid this, 3-(N-morpholino)propanesulfonic acid (MOPS) buffer at pH 7.5 and 2-(N-
morpholino)ethanesulfonic acid (MES) buffer at pH 6.0 were chosen as suitable buffer 
systems as they have shown to be effective electron donors in flavin photobiocatalysis 
with minimal side reactions or products.[102–104,130,131]  
 Figure 4.5B and C show the kinetic plots of AMT and NBB photoreduction 
using 25 µg/mL of FLPDA as synthesised in Chapter 2 and 3 using a 5:1 ratio of 
dopamine to FLDA. For both model substrates, activity is slightly increased using MES 
as the electron donor rather than MOPS, however blank control experiments revealed 
considerable bleaching in MES pH 6.0 buffer for NBB as shown in Figure 4.6D. In the 
case of AMT there is little bleaching in both buffer systems as shown in Figure 4.6A 
and B showing that a lower pH is slightly more optimal for the reduction of these azo 
species. 
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Figure 4.5: (A) Reaction schematic of AMT and NBB reduction upon blue light 
irradiation (450 nm) in the presence of FLPDA and an electron donor (ED). (B) Kinetic 
plot of AMT photoreduction (λmax = 520 nm). (C) Kinetic plot of photoreduction NBB 
(λmax = 618 nm). Reaction conditions: AMT (0.2 mM) or NBB (0.1 mM), FLPDA (25 
µg/mL) with MOPS buffer (0.1 M, pH 7.5, 2 mL) or MES buffer (0.1 M, pH 6.0, 2 mL), 
irradiated with a 450 nm LED (18W) at RT for 4 h under Ar atmosphere. 
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Figure 4.6: UV-Vis spectra of blank control experiments: (A) AMT in MOPS buffer and 
(B) MES buffer; (C) NBB in MOPS buffer and (D) MES buffer. Reaction conditions: AMT 
(0.2 mM) or NBB (0.1 mM) with MOPS buffer (0.1 M, pH 7.5, 2 mL) or MES buffer (0.1 
M, pH 6.0, 2 mL), irradiated with a 450 nm LED (18W) at RT for 4 h under Ar 
atmosphere. 
 Overall, reaction rates are slow with neither substrate being fully reduced 
after 4 h even at low substrate concentrations with >10 mol% effective flavin loading. 
It was therefore decided that a different strategy was necessary to enhance the 
degradation of the dyes through the anchoring of flavins to a heterogeneous 
semiconductor such as iron oxide (γ-Fe2O3) to be more suitable for water remediation 
applications. The system has the added advantages of being magnetic for ease of 
catalyst removal and biocompatibility (work ongoing in collaboration with Samer I. 
Nehme in the group of Dr. Ljiljana Fruk, Department of Chemical Engineering and 
Biotechnology, University of Cambridge).[398] Nonetheless, as a proof-of-concept, these 
results provided encouraging evidence that high potential reduced flavin species could 
be generated in the presence of PDA using morpholine-based buffers and were able to 
reduce substrates containing azo/nitro species, which has not been reported by an 
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artificial flavin photocatalytic system. With this evidence in hand, efforts were then 
focussed onto investigating ene-reductase activity and future work will involve 
optimising industrially relevant azo/nitro group reductions using flavin photocatalysis. 
4.3.2 Ene-reductase activity  
Three typical ene-reductase (ER) substrates were chosen as model compounds to be 
studied: N-pheny-2-methyl maleimide (1a), ketoisophorone (2a) and α-methyl-trans-
cinnamaldehyde (3a) that can be reduced by ERs to chiral products 1-3b (Figure 4.7). 
[18] 
 
Figure 4.7: Ene-reductase (ER) catalysed bioreduction of N-pheny-2-methyl maleimide 
(1a), ketoisophorone (2a) and α-methyl-trans-cinnamaldehyde (3a).[18] 
4.3.2.1 Homogeneous photoreactions 
As discussed in Section 4.3.1, morpholine-based buffers have recently been shown to 
enhance photocatalytic activity for enzyme activation.[130,131] To see if this extends to 
flavin photocatalysis in general, screening of these electron donating buffers was 
carried out using maleimide 1a following the reported optimised concentration 
equivalence of buffer to substrate.[131] It is important to note that 100 equivalents of 
morpholine buffer was found to be optimal, however 25 equivalents of aliphatic 
amines (EDTA and TEOA) were used to achieve the same relative activity. A 3:1 ratio of 
buffer to MeCN was used in our studies to ensure substrate and buffer solubility. The 
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resulting conversions and yields obtained under these conditions using RBF and RTA 
photocatalysts are summarised in Table 4.2. 
Table 4.2: Buffer screening for homogeneous flavin photoreactions with 1a.a 
           
Entry Buffer Flavin Conversion (%) Yield (%) 
1 
0.25 M EDTA pH 7.5 
RBF 100 1 
2 RTA 84 1 
3 
0.25 M TEOA pH 7.5 
RBF 98 3 
4 RTA 81 2 
5 
1 M MES pH 6.0 
RBF 76 1 
6 RTA 76 1 
7 
1 M MOPS pH 7.5 
RBF 58 6 
8 RTA 99 32 
9 
1 M MMO pH 7.5 
RBF 97 7 
10 RTA 100 28 
11 
1 M HEMO pH 7.5 
RBF 85 23 
12 RTA 77 6 
a Reaction conditions: 1a (10 mM) and either RBF or RTA (10 mol%) in a mixture of buffer and MeCN 
(3:1, v/v, 2 mL) irradiated with a 450 nm LED (18W) at RT for 16 h under Ar atmosphere. 
b Conversion determined by GC-MS using calibration curve of 1a with limonene as the internal 
standard. 
c Yield determined by GC-MS using calibration curve of 1b with limonene as the internal standard. 
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 In the presence of aliphatic amine buffers, EDTA and TEOA (entries 1-4), 1b 
was obtained in yields of <5% despite very high conversions, regardless of the flavin 
photocatalyst. It is therefore apparent that side-reactions occur which consume 1a but 
do not lead to the formation of 1b. The use of a morpholine based buffer greatly 
improves the yield of 1b, as shown for entries 8, 10 and 11, however side-reactions still 
occur limiting the yield of the conversion. Unfortunately, major by-products were not 
observed using the GC-MS method described in Section 4.2.1 in order to account for 
the mass balance of these reactions. Optimal reaction conditions were found using 
RTA and MOPS pH 7.5 which resulted in a yield of 32% with quantitative conversion 
(entry 8) and similar behaviour was also observed with MMO pH 7.5 (entry 10).  
It is also apparent that pH plays a role in the enhancing yield of 1b evidenced by 
entry 5 and 6 where the use of MES at pH 6 results in much lower conversion and yield 
compared to MOPS, 4-(2-hydroxyethyl)morpholine (HEMO) and 4-methylmorpholine 
(MMO) at pH 7.5. The increased efficiency at pH 7.5 could be rationalised through the 
formation of deprotonated flavin hydroquinone (FLhq–) as the pKa of FLhq in RBF is 
~6,[399] which facilitates more effective hydride transfer and catalytic turnover. In 
terms of the flavin photocatalyst used, RTA tends to show better activity than RBF 
which is expected due to its greater photostability.[357] However, entry 11 shows that, 
in the case of HEMO pH 7.5, RBF performs more efficiently than RTA indicating a 
possible stabilising relationship between ribityl side chains and the morpholine R 
group. 
 A kinetic study using MOPS and RTA revealed that yield tends to plateau as 
conversion increases to >99% (Figure 4.8). This provides evidence that side-reactions 
occur that result in consumption of 1a that do not lead to 1b, or there is a catalyst 
deactivation process that inhibits turnover. For example, photobleaching of 1a may 
occur under irradiation which could be enhanced by the flavin photocatalyst that is 
known to oxidise aromatic amines.[90] Interestingly, previous photocatalytic 
hydrogenations of N-phenylmaleimide derivatives using P25 TiO2 and UV light showed 
very low yield (≤5%) for the conversion of 1a to 1b which could indicate the substrate 
has limited photostability.[400]  
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Figure 4.8: Kinetic plot of 1a (10 mM) photoreduction by RTA (10 mol%) in MOPS 
buffer (1 M pH 7.5) and MeCN (3:1, v/v, 4 mL) mixture over 24 h. 
 Further control experiments showed that 1b was not formed in the absence 
of flavin, MOPS, light or in the presence of O2 as summarised in Table 4.3. Conversion 
of 1a occurred in all cases apart from trace amount in the dark (entry 4), further 
highlighting the substrate’s photo-instability. In the case of entry 3 however, where O2 
would be present in the reaction mixture, it can be assumed that photooxidation of 
the substrate would have occurred (no by-products of considerable concentration 
were observed via TLC or GC-MS). 1-Benzyl-1,4-dihydronicotinamide (BNAH), a 
common NADH mimic,[34] was employed in the dark to see whether organocatalytic 
activity could be employed to reduce 1a, avoiding the use of light. It became apparent 
however, that the ability of BNAH to initiate the catalytic cycle is perhaps reserved only 
for enzymes as no product formation or noticeable conversion was observed over a 
period of 24 h (determined by TLC). 
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Table 4.3: Control experiments for the photoreduction of 1a by RTA. 
 
Entry 






1 No MOPS 40 0 
2 No flavin 54 0 
3 Under air 100 0 
4 No light <5 0 
5 
BNAH (2 equiv.)  
no lightd 
tracee 0e 
 We subsequently applied the optimised reaction conditions to other ER 
substrates and gratifyingly found that ketoisophorone (2a) was photoreduced to 2b in 
a good yield of 73% (Figure 4.9). Unfortunately, negligible conversion was observed for 
cinnamaldehyde 3a. Aldehydes are weak electron withdrawing groups, so it is 
envisioned that more activating carbonyl moieties such as carboxylic acid, ester or 
ketone groups may show improved conversion.  
a Standard conditions: 1a (10 mM) and RTA (10 mol%) in a mixture of MOPS (1 M, pH 7.5) and MeCN 
(3:1, v/v, 2 mL) irradiated with a 450 nm LED (18W) at RT for 16 h under Ar atmosphere. 
b Conversion determined by GC-MS using calibration curve of 1a with limonene as the internal 
standard. 
c Yield determined by GC-MS using calibration curve of 1b with limonene as the internal standard. 
d Using KPi buffer (50 mM, pH 7.5) instead of MOPS  
e Determined by TLC over 24 h 
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Figure 4.9: Screening of other ER substrates using optimised conditions: substrate (10 
mM) and RTA (10 mol%) in a mixture of MOPS buffer (1M, pH 7.5) and MeCN (3:1, v/v, 
2mL) irradiated with 450 nm LED (18W) for 16 h under Ar atmosphere. Conversion and 
yield determined by 1H NMR. 
 These initial data indicated that flavin photocatalysis could be utilised outside 
of a natural protein make-up to achieve the reduction of activated C=C bonds using an 
aqueous morpholine-based buffer and MeCN solvent mixture in a homogeneous 
environment. The extent to which this methodology can be applied is yet to be 
determined and future work will focus on extensive substrate screening and additional 
reaction optimisation (effect of co-solvent, other electron donor systems etc.). Our 
main goal was to move towards a flavin-polydopamine nanoparticle system that we 
hypothesised would show improved catalytic activity with low catalyst loading. In 
addition, the surface of the nanoparticle could be modified with chiral moieties which 
we predicted may influence enantioselective product formation. 
4.3.2.2 Nanoparticle synthesis and characterisation 
We chose riboflavin (RBF) as the flavin photocatalyst as it contains an optically active 
ribityl chain at its N10 position which has been shown beneficial in the discrimination 
of certain enantiomers when immobilised within an HPLC stationary phase.[401] 
Conjugation of RBF to monodispersed polydopamine nanoparticles (PDA NPs) was 
chosen as the strategy to introduce flavin moieties to the NPs rather than the co-
polymerisation strategy previously explored (Chapters 2 and 3). By using N3-modied 
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flavins we aimed to avoid N10 dealkylation observed with copolymer flavin-
polydopamine nanoparticles (Chapter 3). The dipeptide, captopril (an ACE 
inhibitor)[402] was selected as a spacer between the flavin and PDA (7, Figure 4.10). 
Captopril has previously been used to synthesise chiral inorganic nanostructures and 
thanks to its thiol functionality it can be easily conjugated to PDA via Michael-addition 
to quinone moieties.[188,403,404] Therefore a riboflavin-captopril derivative, RFCPT was 
designed and synthesised according to the scheme shown in Figure 4.10.  
 
Figure 4.10: Synthesis of RFCPT. Reaction conditions: a) Cs2CO3, DMF, RT, Ar, dark, 18 
h, 84%; b) TFA, DCM, 0 oC – RT, 5 h, Ar, dark, 99%; c) HATU, DIPEA, DMF, RT, 18 h, 84%; 
d) 1 M HCl, 60 oC, Ar, dark, 18 h, 59%. 
 First, an amino group was attached to the N3 position of riboflavin 
tetraacetate (RTA) using the NBoc-protected ethyl bromide, 4. Subsequent 
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deprotection and amide coupling of acetyl-protected captopril achieved the fully 
acetylated riboflavin-captopril conjugate 8 in very good yield (84%). Acidic cleavage of 
acetyl groups resulted in RFCPT in fair yield (59%). Finally, riboflavin-conjugated PDA 
(RCPDA) NPs were attained with different flavin loading percentages (wt%) by mixing 
varied weight ratios of PDA NPs to RFCPT in degassed 10 mM TRIS buffer at pH 8.0 as 
shown in Figure 4.11. The reaction was carried out under inert conditions (Ar 
degassing) in order to avoid thiol oxidation catalysed by the flavin or PDA.[261,405,406]
  
 
Figure 4.11: Synthesis and structural depiction of RCPDA. Reaction conditions: a) TRIS 
buffer (10 mM, pH 8.0), Ar, dark, 18 h. 
 Three batches of RCPDA NPs with different wt% flavin loadings were 
synthesised and analysed for light-driven ER activity. In addition, PDA NPs of different 
sizes were made by the classical Stöber method[204] in order to observe any differences 
in loading capacity and the resulting photocatalytic activity. PDA-1 particles were 
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prepared with an average size (measured by SEM, Figure 4.12) of 93.0 ± 14.2 nm, and 
PDA-2 being slightly smaller at 82.6 ± 11.5 nm (Table 3). Upon addition of RFCPT using 
a 1:1 weight ratio of particle to flavin, relative hydrodynamic sizes of the PDA NPs 
increased from 214.3 ± 1.8 nm to 244.4 ± 1.6 for PDA-1 and RCPDA-1, with a larger 
increase observed for PDA-2 and RCPDA-2 going from 130.0 ± 0.2 nm to 191.3 ± 1.3 
nm. These data provide evidence of successful ligand attachment as the addition of 
hydrophilic RFCPT to the surface of the PDA NPs would be expected to increase the 
hydrodynamic size of the particle. Furthermore, zeta potential measurements 
indicated ligand attachment by a positive shift in values showing a change in particle 
surface charge, although these changes were almost negligible for RCPDA-1 when 
compared to PDA-1. RCPDA-3 was prepared using a larger weight excess of RFCPT and 
followed the same trend in value changes in both hydrodynamic sizes and zeta 
potential.  SEM analysis of the RCPDA particles revealed only slight changes in particle 
diameter by attachment of RFCPT to the NP surface (Table 4.4, Figure 4.12). 
Table 4.4: Size and zeta potential measurements of PDA and RCPDA NPs with their 


















PDA-1 - 93.0 ± 14.2 214.3 ± 1.8 -35.8 ± 0.6 - 
PDA-2 - 82.6 ± 11.5 130.0 ± 0.2 -60.4 ± 0.2 - 
RCPDA-1 1:1 (PDA-1) 92.9 ± 15.6 244.4 ± 1.6 -35.4 ± 0.2 1.2 ± 0.05 
RCPDA-2 1:1 (PDA-2) 85.5 ± 15.2 191.3 ± 1.3 -37.1 ± 0.6 1.8 ± 0.05 
RCPDA-3 1:5 (PDA-2) 88.7 ± 14.1 187.0 ± 3.9 -16.0 ± 3.5 3.7 ± 0.19 
 
 
Finally, a fluorescence intensity calibration was carried out in order to estimate 
the wt% loading of flavin (RFCPT) on the particles (see Section 4.2.7 for full 
a Measured by SEM 
b Measured by DLS 
c Estimated by fluorescence intensity calibration 
 
 
Chapter 4: Investigating the light-driven reductase activity of flavin-polydopamine 
L. B. Crocker – August 2020   123 
experimental details). This revealed that using a 1:1 weight ratio of PDA:RFCPT the 
larger PDA-1 NPs yielded a lower flavin loading of ~1 wt% (RCPDA-1) when compared 
to the smaller PDA-2 NPs that had ~2 wt% loading (RCPDA-2). Increasing the amount 
of RFCPT to 5 times more than PDA resulted in particles with ~4 wt% flavin loading 
(RCPDA-3). 
 
Figure 4.12: SEM images of PDA and RCPDA particles. (A) PDA-1, (B) PDA-2, (C) RCPDA-
1, (D) RCPDA-2 and (E) RCPDA-3. 
 The particles were further characterised by UV-Vis and fluorescence 
spectroscopy as shown in Figure 4.13. The UV-Vis spectrum of both PDA-1 and PDA-2 
show a characteristic broad absorbance profile over the UV-visible range analogous to 
melanin (Figure 4.13A).[407] The absorbance spectrum of RFCPT shown in Figure 4.13B 
displays characteristic isoalloxazine absorption bands at λmax = 449 nm and 374 nm 
corresponding to the S0→S1 (λmax ∼ 442–450 nm) and S0→S2 (λmax ∼ 360–375 nm) 
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transitions.[2] These bands are red-shifted to 458 nm for S0→S1 and 378 nm for S0→S2 
transitions in RCPDA samples (Figure 4.13C and D). This red-shift was also observed for 
the copolymer flavin-polydopamine particles and can be explained by an increase in 
proton donation and electron-withdrawing inductive effects by PDA. [294,295]  
 
Figure 4.13: UV-Vis spectra of (A) PDA NPs, (B) RFCPT, (C) RCPDA samples and (D) 
RFCPT compared to RCPDA-3 with PDA absorbance subtracted. 
The fluorescence emission spectra of RCPDA samples (Figure 4.14A) exhibit 
emission maxima at 528 nm (λex= 450 nm) that increase in intensity relative to wt% 
flavin loading. This value is slightly red-shifted in comparison with RFCPT that exhibits 
an emission maximum at 525 nm (λex= 450 nm). An earlier study in which flavin 
compounds were complexed with melanin similarly showed that flavin emission is red-
shifted once complexed, and that there was no significant fluorescent quenching by 
the polymer.[297] A decrease is observed in the emission intensity of RFCPT when PDA is 
added, which can be corrected by taking into account the relative PDA absorbance at 
excitation/emission wavelengths as previously seen for copolymer flavin-
polydopamine (Figure 4.14B and Chapter 2). Therefore, all fluorescence calibrations 
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were performed using PDA and RFCPT to determine relative flavin loading in order to 
account for this absorption decrease (see Section 4.2.7 for full experimental details). 
 
Figure 4.14: Fluorescence intensity spectra of (A) RCPDA samples and (B) the 
comparison intensity profiles of RFCPT with PDA added.  
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4.3.2.3 Nanoparticle photoreactions 
The light-driven ER activity of RCPDA NPs were then examined by first using 1a and 
applying the methodology developed in homogeneous reaction screening (Section 
4.3.2.1). The 3:1 buffer/MeCN solvent system was kept to ensure substrate solubility 
which is often found to be a restricting factor in biocatalysis as organic solvents, such 
as MeCN, denature the enzyme meaning substrate solubility is often limited.[408] 
Reaction times were increased to account for lower photon absorption efficiency due 
to the introduction of light-scattering nanoparticles. Despite the substrate showing 
some photo-instability from this screening, interesting differences in activity were 
found between the nanoparticle and homogeneous catalyst systems.  
Firstly, the morpholine-based buffer systems used previously were screened 
with RCPDA NP samples in the photoreduction of 1a (Table 4.5). The approximate 
flavin mol% loading in these reactions was kept <1 mol% as this is generally 
characteristic loading in enzymatic biocatalysis. Despite these amounts being far lower 
than that used in the homogeneous reaction screening (10 mol%), conversions and 
yields are relatively comparable or slightly improved between reactions. The 
photoreactions of RCPDA-2 and -3 in HEMO buffer, obtained 1b in yields of 19% and 
20% respectively (entries 8 and 9) with quantitative conversion, whereas the 
analogous HEMO/RBF homogeneous system yielded 1b in 23% yield with 85% 
conversion. This result shows that the covalent immobilisation of the flavin on PDA, 
greatly improves its catalytic activity, most likely through a favourable flavin-PDA-
substrate binding interaction, as previously observed for flavin-polydopamine 
copolymer particles (Chapter 2). MMO proved slightly more effective than the 
MMO/RBF homogeneous system, raising the yield of 1b up to 12% (entry 4) compared 
to 7% with very little catalyst loading. However, MOPS showed poor activity across all 
RCPDA samples like MOPS/RBF with yields <10% (entries 1-3). GC-MS analysis of by-
products from the reactions carried out in HEMO buffer, indicated the formation of 
succinimide 1c (Table 4.5). The mechanism of 1c formation is unknown but might be 
attributed to the flavin-photocatalysed oxidation of 1a/b that leads to cleavage of the 
species. 
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Table 4.5: Morpholine-based buffer screening for RCPDA NP photoreactions with 1a.a 
 












100 mM MOPS 
pH 7.5 
1 0.16 72 3 n.d. - 
2 2 0.32 >95 8 0 - 
3 3 0.65 100 7 0 - 
4 
100 mM MMO 
pH 7.5 
1 0.16 100 12 n.d. - 
5 2 0.32 100 9 0 - 
6 3 0.65 100 10 0 - 
7 
100 mM HEMO 
pH 7.5 
1 0.16 >95 5 n.d. - 
8 2 0.32 100 19 0 - 
9 3 0.65 100 20 23 (R) 
Enantiomeric excess (ee) values were obtained for the reactions catalysed by 
RCPDA-2 and -3 using chiral HPLC in order to determine if the chiral linker between 
flavin and PDA surface has an influence on the stereochemistry of the reaction. 
Interestingly, the reaction catalysed by RCPDA-3 in HEMO buffer showed an ee of 23% 
a 
Reaction conditions: 1a (1 mM) and RCPDA (0.1 mg/mL) in a mixture of buffer and MeCN (3:1, v/v, 
2 mL) irradiated with a 450 nm LED (18W) at RT for 24 h under Ar atmosphere. 
b 
Conversion determined by GC-MS using calibration curve of 1a with limonene as the internal 
standard. 
c 
Yield determined by GC-MS using calibration curve of 1b with limonene as the internal standard. 
d 
ee determined by HPLC using Chiralcel OD column. 
e
 By-product observed by GC-MS for reactions in HEMO buffer. 
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of the (R) enantiomer of 1b (Table 4.5, entry 9). All other reactions showed racemic 
product formation. This result can be attributed to the larger number of flavin active 
sites on the PDA surface of RCPDA-3 compared to RCPDA-1 or -2.  Although this is a 
moderate ee value, it is an encouraging proof-of-concept which demonstrates that the 
inclusion of chiral moities into the design of nanoparticle flavin photocatalysts can 
influence the stereochemistry of the catalysed reactions. Scale-up of this reaction will 
show whether this result is reproducible on a larger scale and whether it is a useful 
methodology for chiral organic synthesis. 
Additional control experiments were carried out that confirmed the formation 
of 1b was dependent on the presence of an electron donor reagent, flavin and light 
(Table 4.6, entries 1-3). Unexpectedly, conversion of 1a was observed in the dark 
experiment (entry 3). This could be a result of a Michael-type reaction between amino 
residues within PDA and the maleimide or π–π stacking of the compound to PDA that 
were not extracted in the reaction workup. EDTA and TEOA buffers were also screened 
but showed very low yields of 1b as expected from homogeneous optimisation (entries 
4 and 5). RBF at 1 mol% provided a yield of 1b at 5% which further exemplified 
RCPDA’s superiority over its homogeneous counterpart (entry 6). Interestingly, the 
addition of PDA-2 (0.1 mg/mL, entry 7) to the same reaction improved the yield of 1b, 
indicating PDA does indeed have an activating effect on the reaction’s pathway, most 
likely through aromatic electrostatic stabilisation of each reactive component even 
without covalent immobilisation of the flavin. The ee of this reaction was found to be 
0% which indicates that the chiral linker used to connect flavin moieties to the PDA 
surface is required for an enantioselective transformation to occur. Finally, a dark 
organocatalytic reaction was attempted with RCPDA-3 with BNAH as the electron 
donor (2 equiv., entry 8) however the reaction was unsuccessful in the formation of 1b 
despite conversion of 1a but there were no clearly identifiable by-products of 





Chapter 4: Investigating the light-driven reductase activity of flavin-polydopamine 
L. B. Crocker – August 2020   129 
Table 4.6: RCPDA NP control experiments.a 
 
Entry 





1 10 mM KPi buffer pH 7.5 100 0 
2 PDA-2 70 0 
3 No light 40 0 
4 25 mM EDTA pH 7.5 100 6 
5 25 mM TEOA pH 7.5 100 5 
6 RBF (1 mol%) 82 5 
7 PDA-2 + RBF (1 mol%) 90 13 (ee = 0%) 
8 BNAH (2 equiv.), no lightd 100 0 
The optimal conditions found for 1a photoreduction were then applied to 
ketoisophorone (2a) in order to see if RCPDA-3 can be applied to another ER substrate. 
Under these conditions however, the product 2b was not detectable by GC-MS after 
extraction with EtOAc and neither was the starting material (Figure 4.15). Additionally, 
a control experiment containing no RCPDA-3 showed the same result, indicating that 
the substrate and/or product are not stable under such reaction conditions and 
prolonged irradiation. Further experiments should therefore focus on a larger scale 
(10-20 mM) kinetic study to optimise irradiation times. 
a 
Standard conditions: 1a (1 mM) and RCPDA-3 (0.1 mg/mL) in a mixture of HEMO buffer (100 mM, 
pH 7.5) and MeCN (3:1, v/v, 2 mL) irradiated with a 450 nm LED (18W) at RT for 24 h under Ar 
atmosphere. 
b 
Conversion determined by GC-MS using calibration curve of 1a with limonene as the internal 
standard. 
c 
Yield determined by GC-MS using calibration curve of 1b with limonene as the internal standard. 
d
 Using KPi buffer (10 mM, pH 7.5).  
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Figure 4.15: Photoreduction of 2a (1 mM) catalysed by RCPDA-3 (0.1 mg/mL) in a 
mixture of HEMO buffer (100 mM, pH 7.5) and MeCN (3:1, v/v, 2 mL). Conversion and 
yield determined by GC-MS using calibration curves of 2a and 2b respectively with 
limonene as the internal standard. 
 Overall, RCPDA NPs exhibit improved photocatalytic properties when 
compared to the homogeneous flavin photocatalysts through comparable or enhanced 
product yield at far lower catalyst loading. Alongside this, enantioselectivity of product 
formation was also observed, exemplifying for the first time that the addition of chiral 
moieties within an advanced flavin photocatalyst can direct the stereochemical 
outcome of the reaction. This small-scale proof-of-concept study indicated the need 
for a larger scale optimisation of the reaction conditions in order to increase the 
efficiency and ensure reproducibility of the catalyst. An important comparison would 
also be the analogous RTA-conjugated system to observe any effects of ribityl-
protection on overall performance and enantioselectivity. 
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4.3.2.4 Analysis of RCPDA post reaction 
Before an attempt was made to recycle RCPDA-3 for a subsequent photoreaction, the 
washed particles and initial reaction supernatant were first analysed by fluorescence 
spectroscopy to confirm particle integrity. Unfortunately, no fluorescence was 
observed for the particles but a large emission at λmax = 527 nm (λex= 450 nm) was 
exhibited by the reaction supernatant (Figure 4.16). This was a clear indication that 
flavin species had detached from the particles leaving them inactive. The 
photodegradation of riboflavin is well understood, ultimately resulting in dealkylated 
lumiflavin or lumichrome compounds.[311] Photodecomposition products of riboflavin 
derivatives with N3 conjugation is less widely understood but it has been shown that 
N3-Me substituted RTA displayed very good stability under UV-irradiation in deaerated 
methanol.[409]   
 
Figure 4.16: Fluorescence emission spectra of RCPDA-3 particles post reaction and 
associated reaction supernatant (λex= 450 nm). 
An ESI mass spectrum of the reaction supernatant was therefore obtained to 
try and identify major photodecomposition products. Expected photodegradation 
products such as lumiflavin, lumichrome, RFCPT or lumiflavin-captopril were not 
identified as major mass adducts. Therefore, possible structures and related mass 
adducts are proposed from the spectra for some major mass peaks observed as shown 
in Figure 4.17A and B. In both cases, the evidence points towards flavin species with 

















 RCPDA-4 post reaction 
 Reaction supernatant
527 nm
Design and Application of Nanostructured Flavin Photocatalysts 
132  L. B. Crocker – August 2020 
PDA-oligomers attached. For m/z ~ 670 a lumiflavin-captopril-leukochrome species is 
proposed (Figure 4.17A) and for m/z ~ 918, a riboflavin-captopril-leukochrome 
oligomer is proposed (Figure 4.17B). Presence of these species indicates that the 
photodecomposition mechanism of RCPDA proceeds through PDA oligomeric units 
rather than the cleavage of RFCPT. This also was evidenced by the observation of a 
stark reduction in the optical density of the washed particles in solution compared to a 
solution of fresh particles at the same approximate concentration.  
The photodecomposition and photo‐induced structural modifications of 
melanin under exposure to UV-light, as well as blue light, is widely studied to 
understand melanogenesis, pigment darkening and melanoma formation.[354] The 
degree to which PDA NPs follow the same photo-induced changes and their 
dependency on factors such as solvent, pH and temperature is not yet fully 
understood. However, the use of PDA as a photosensitiser for TiO2-based 
photocatalytic CO2 reduction did result in clear photodecomposition and mass losses 
when the sample was irradiated with both UV and visible light.[288] One could therefore 
assume it is very likely that long exposure to blue light, especially in a polar solvent 
system (H2O/MeCN) would result in very similar decomposition of RCPDA. Indeed, the 
type of solvent has been shown to affect the stability of other heterogeneous flavin 
photocatalysts, favouring alcoholic solvent systems over MeCN-based ones.[169] Future 
work will therefore focus on what effect these reaction parameters have on the 
stability and activity of RCPDA to identify the optimal conditions for photocatalysis. 
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Figure 4.17: HRMS (ESI) spectra of reaction supernatant with two possible structures 
of photodecomposition products. 
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4.4 Conclusion 
The light-driven reductase activity of flavin-polydopamine (FLPDA) has been 
investigated, at first, through the reduction of azobenzene compounds Amaranth 
(AMT) and Naphthol Blue Black (NBB) using copolymer FLPDA nanoparticles. Despite 
the rate of reduction being low for these reactions, it proved that it was possible for 
flavin moieties to reduce a substrate in the presence of an electron donor whilst being 
covalently attached to PDA. This encouraged the study of ene-reductase type reactions 
due to their relevance in producing compounds of industrial interest.  
Homogeneous reaction optimisation using riboflavin (RBF) and riboflavin 
tetraacetate (RTA) photocatalysts and three typical ene-reductase (ER) substrates 
revealed activity differences in the presence of certain electron donating buffer 
systems. For example, RTA showed the highest activity in MOPS buffer (pH 7.5) 
producing succinimide 1b with a yield of 32% whereas RBF showed the best activity in 
HEMO buffer (pH 7.5) producing 1b in a yield of 23%. Other ER substrates proved more 
suitable for this catalytic system, such as ketoisophorine 2a which was reduced in yield 
of 73% to the levodione product (2b) with RTA/MOPS. However, cinnamaldehyde 3a 
was not able to be reduced under such conditions.  
With this information in hand, a chiral riboflavin-captopril ligand (RFCPT) was 
synthesised to be functionalised onto monodispersed PDA nanoparticles resulting in 
riboflavin-captopril-PDA (RCPDA) nanoparticles. Yields of succinimide 1b produced by 
RCPDA-3 (~4 wt% flavin) were almost equivalent to the homogeneous reaction using 
RBF in HEMO buffer (pH 7.5) at very low catalyst loading (<1 mol%) indicating a clear 
increase in efficacy through the introduction of PDA NPs. Additionally, 
enantioselectivity of the catalysed reaction (23% ee) was observed which can be 
attributed to the use of a chiral linkage between flavin and PDA NP surface. This shows 
for the first time that advanced flavin photocatalysts can be designed to effectively 
display flavoenzyme-like characteristics. 
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Within this thesis, the combination of photocatalytic flavins and nanostructured 
polydopamine has been explored through the design and application of copolymer 
flavin-polydopamine (FLPDA) and riboflavin-captopril-polydopamine (RCPDA) 
nanoparticles. Copolymer FLPDA was synthesised through the copolymerisation of 
dopamine and a DOPAC-flavin monomer (FLDA) to form particles with the sizes of 
~200 nm with large size distribution in samples containing a higher percentage of 
flavin. Initially, a redox dye system based on oxidation and reduction reactions to 
afford the pink coloured resorufin (RF) was utilised to characterise the photocatalytic 
activity of the particles. The highest rates in conversion to RF were achieved using 
FLDPA-5 which contained the largest concentration of flavin moieties (~ 1.0 μmol/mg) 
for both oxidation and reduction processes. It was also found that FLPDA-5 performed 
at a greater efficiency than the homogeneous monomer FLDA which was rationalised 
through an enzyme-like mechanism by using a Michaelis-Menten fit to describe the 
kinetics of the oxidation reaction. Additionally, the photostability of the system was 
found to be improved compared to a DOPAC-free flavin compound through charge 
transfer processes evidenced by fluorescence quenching between the flavin and 
catechol moieties. Finally, in vitro biocompatibility studies of the FLPDA particles 
revealed low cytotoxicity to A549 cells as well as an antioxidative effect which shows 
FLPDA may also be useful in biomedical applications. 
 Following this initial characterisation, FLPDA particles were employed in the 
photooxidation of indole to form indigo and indirubin dyes which is a characteristic 
transformation catalysed by flavin-containing monooxygenase enzymes (FMOs). This is 
the first example of flavin photocatalysis being utilised to produce these valuable dyes 
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which were produced at a five times greater yield using FLPDA than the homogeneous 
riboflavin (RBF) photocatalyst. ROS scavenging experiments were carried out to 
elucidate FLPDA’s photooxidation mechanism, revealing that neither superoxide nor 
singlet oxygen were solely responsible for indole oxidation. Subsequently, it was 
discovered that FLPDA released less H2O2 in the reaction when compared to RBF and 
so, it can be assumed that PDA enables the stabilisation of C4a-hydroperoxy-flavin as a 
reactive intermediate. This can be used to explain FLPDA’s higher product selectivity 
towards indigo dye formation. The stabilisation of this reactive intermediate further 
shows the capacity of FLPDA to demonstrate enzyme-like mechanism characteristics.  
 Characteristic flavoenzyme reduction reactions were then explored by first 
using FLPDA to photoreduce two azobenzene dyes. Despite slow reaction kinetics, it 
was clear that reduced flavin hydroquinone (FLhq) species could be accessed under 
irradiation in the presence of an electron donor and PDA, which then transfers hydride 
to a substrate. The reduction of C=C bonds in α,β-unsaturated ketones and aldehydes, 
characteristic of ene-reductase enzymes (ERs), was then explored. Initially, 
homogeneous riboflavin (RBF) and the more photostable riboflavin tetraacetate (RTA) 
were employed as photocatalyst to optimise reaction conditions by screening various 
electron donating buffer systems. It was found that RTA (10 mol%) performed the best 
in MOPS buffer (pH 7.5 with MeCN, 3:1 v/v) and was able to reduce 2-methyl-N-
phenylmaleimide to 2-methyl-N-phenylsuccinamide (32% yield) and also 
ketoisophorone to levodione (73% yield). On the other hand, RBF performed best in 
HEMO buffer (pH 7.5 with MeCN, 3:1 v/v) producing 2-methyl-N-phenylsuccinamide in 
23% yield. Subsequently, the reactions were performed with PDA NPs bearing chiral 
riboflavin-captopril surface ligands (RCPDA) as the photocatalyst which revealed that 
HEMO buffer also enabled the highest activity (20% yield of 2-methyl-N-
phenylsuccinamide) using very low catalyst loading (<1 mol%). An ee value was also 
determined for this reaction to be 23% which shows, for the first time, that designing 
chiral components into flavin photocatalyst systems can influence the stereochemical 
outcome of a catalysed reaction. 
 Overall, this thesis has extended the known capabilities of flavin 
photocatalysis by the formulation of nanostructured flavin-conjugated polydopamine 
which demonstrated enzyme-like catalytic behaviour under irradiation. It is hoped that 
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this work, along with related future efforts, will help to position the use of flavin 
photocatalyst systems at the forefront of sustainable catalysis. 
5.2 Future work 
5.2.1 Light-driven monooxygenase activity of flavin-polydopamine 
Future work relating to the photooxidation of indole by FLPDA should focus on 
optimising indigo and indirubin dye formation and selectivity, perhaps by the addition 
of amino acids such as cysteine which has been shown to increase indirubin yield,[410] 
or an electron donating buffer system at a particular pH which may enhance activity 
and photostability further.[131] Additional indole derivatives should also be explored 
such as nitro- and bromo-substituted indoles to observe any interplay between 
functional groups, product selectivity and FLPDA’s photocatalytic activity. Other FMO 
type reactions such as Baeyer–Villiger oxidations and sulfoxidations could also be 
investigated to show the extent of FLPDA’s monooxygenase activity. Finally, due to 
initial evidence of the C4a-hydroperoxy-flavin species through ROS scavenging and 
H2O2 assays (Section 3.3.4), further evidence of this species and FLPDA’s 
photocatalytic mechanism should be obtained through NMR and EPR 
spectroscopy.[411,412] 
5.2.2 Light-driven reductase activity of flavin-polydopamine 
The initial homogeneous photoreductions of three ER substrates using RTA and RBF 
photocatalysts showed that the type of electron donating buffer utilised played a 
major role on the efficiency and selectivity of the reaction (Section 4.3.2.1). Namely, 
morpholine-based buffer systems showed the best results when compared to the most 
widely employed electron donors such as EDTA and TEOA. This effect has been 
described previously in terms of photobiocatalytic systems, however it has not yet 
been employed in homogeneous photocatalysis to achieve reactions such as azo, nitro, 
imine, C=O or C=C reduction. This methodology could therefore be applied to this wide 
range of reductions to show that RTA and related derivates can be used as a versatile 
photocatalysts for reduction reactions. Other electron donors should be investigated 
such as ascorbate, which has already been shown to be useful in flavin catalysis,[48,413] 
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and the combination of Lewis acids should increase flavin redox potentials to achieve 
the reduction of wide range of substrates.[106,107] 
 Future work relating to ER substrate photoreductions using RCPDA should 
focus on solvent screening with less polar co-solvents (alcohols) in order to analyse the 
photostability of RCPDA and the effect on product yields. The analogous RTA-
conjugated system should be prepared in order to observe the effects of ribityl-
protection on overall performance, stability and enantioselectivity. Enantioselectivity 
may also be improved by the addition of extra chiral elements to the surface of PDA 
such as amino acids. Larger scale optimisation up to mmol amounts of substrate 
should be demonstrated to further display the usefulness of RCPDA. Finally, the 
photodecomposition mechanism of RCPDA (and FLPDA) should be fully characterised 
in order to improve the next generation of flavin-PDA hybrids. 
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